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P-Rex1 is a guanine-nucleotide exchange factor (GEF) that activates the small G protein Rac, 
thus regulating a wide range of physiological and pathophysiological responses. Neutrophils 
are leukocytes of the innate immune system in which P-Rex1 regulates several Rac-
dependent responses, especially those elicited by GPCR signalling.  
The aim of my project was to assess the functional importance of a new interactor of P-Rex1, 
the GPCR adaptor protein Norbin, in neutrophils. 
Norbin is an essential neuronal protein that binds directly to GPCRs, regulating GPCR 
signalling and trafficking, through unknown mechanisms. Our laboratory recently identified 
that Norbin stimulates P-Rex1 Rac-GEF activity and promotes P-Rex1 membrane localisation. 
Furthermore, we showed that Norbin is expressed in myeloid cells. To investigate, we 
generated mouse strains with conditional deletion of Norbin in myeloid cells and with 
combined Norbin/Prex1 deficiency. 
Unexpectedly, I found increased adhesion, spreading, ROS production and degranulation 
responses in isolated Norbin-deficient neutrophils. Moreover, Norbin-deficient neutrophils 
had an increased ROS-dependent capacity to kill Staphylococcus aureus. In vivo, Norbin 
deficiency provided increased immunity against pulmonary infection with Streptococcus 
pneumoniae, even in immune-deficient Prex‒/‒ mice. Neutrophil depletion showed that 
Norbin deficiency renders neutrophils important for combatting this infection. Mostly, 
Norbin deficiency overrode the functional impairments caused by Prex1 deficiency, although 
some neutrophil responses remained P-Rex1-dependent. Mechanistically, the Norbin 
deficiency caused constitutive upregulation of some GPCRs onto the neutrophil surface and 
promoted the GPCR-dependent activities of Rac and Erk, whereas several other signalling 
pathways and the surface levels of adhesion molecules were not obviously affected. 
Together, my data indicate that the GPCR adaptor and P-Rex1 regulator Norbin plays an 
important role in suppressing the host defence functions of neutrophils. A subset of Norbin 
functions are P-Rex1 dependent, whereas others are likely mediated through other 


























 - Introduction Chapter 1
1.1 Neutrophils 
Neutrophils are an essential component of the innate immune system and are the first cells 
recruited to the site of infection. They provide immunity against bacterial and fungal 
infections, as well as attracting other immune cells to the site of inflammation. This section 
will summarise our current understanding of neutrophil development: how they are 
maintained in the circulation, their recruitment into tissues in response to pathogens, and, 
their functional responses at sites of infection and how they are removed from tissues. 
1.1.1 Neutrophil development 
Neutrophils are produced in the bone marrow. They are polymorphonuclear leukocytes 
(PMNs), the most abundant white blood cells in humans, known for their segmented 
nucleus, for their granules and for being short-lived. Each day, approximately 1011 
neutrophils are produced under normal conditions (Furze & Rankin, 2008; Manz & 
Boettcher, 2014). The rate of neutrophil production is highly dynamic, with neutrophil death 
by apoptosis and immunological stress conditions being the main elements that influence 
this process. One of the main regulatory factors for tuning the production of neutrophils is 
granulocyte-colony stimulating factor (G-CSF) (Metcalf, 2007). G-CSF levels are upregulated 
with neutrophil apoptosis in tissues and reduced when the number of neutrophils in tissues 
is high (Lieschke et al., 1994; F. L. Liu, Wu, Wesselschmidt, Kornaga, & Link, 1996). Under 
immunologically stressed conditions (inflammation and infection), neutrophil numbers rise 
through the increased proliferation and maturation of progenitor cells (granulopoiesis) 
induced in response to the production of several cytokines, e.g. IL-17 (Cua & Tato, 2010), IL-3 
and granulocyte-macrophage colony stimulating factor (GM-CSF) (Skokowa et al., 2006).  
Several stages of neutrophil maturation can be distinguished (Figure 1.1), beginning 
with haematopoietic stem cells (HSCs) in the bone marrow which generate several 
consecutive mitotic pools of progenitor cells that are decreasingly proliferative and 
successively more differentiated, namely myeloblast, promyelocyte, myelocyte and band cell 
stages. These different stages are characterised by the shape of the nucleus, which becomes 
segmented, and by the increasing number of granule subsets. Key transcription factors in the 
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development of neutrophils are PU.1, which is required for myeloid lineage commitment, 
giving rise to both monocytes/macrophages and granulocytes, and C/EBP, which induces the 
granulocyte lineage, followed by Gfi-1 which confers neutrophil differentiation. The bone 
marrow also comprises a reserve pool of mature neutrophils, approximately 20 times the 
number of neutrophils in circulation (Dancey, Deubelbeiss, Harker, & Finch, 1976). These 
fully differentiated mature neutrophils are defined as the post-mitotic pool, ready for on-
demand release (Borregaard, 2010). This terminally differentiated mature neutrophil state 
cannot be reversed, the cells can only live around one day in the circulation and a few days 
at most within tissues before progressing to their death, usually by apoptosis (Klausen, 
Bjerregaard, Borregaard, & Cowland, 2004) (see section 1.1.5). 
 
 
Figure 1.1: Granulocytopoiesis in the bone marrow 
Neutrophil maturation from myeloid progenitors to mature neutrophils. The nucleus becomes ingreasingly 
segmented. The different subsets of neutrophil granules are produced at different stages of maturation, 
starting with azurophil granules which contain myeloperoxidase (red), followed by specific granules that 
contrain lactoferrin (green) and finally gelatinase granules (blue). Figure adapted from (Borregaard, 2010). 
 
1.1.2 Overview of neutrophil recruitment 
Among leukocytes, neutrophils are the first immune cell population to penetrate the 
vascular endothelium. Therefore, understanding the signalling mechanism of neutrophil 
extravasation cascade is critical because it is an initial immune response and also affects the 
mobilisation of other leukocytes. Mature neutrophils circulate in the blood stream, but upon 
receiving inflammatory signals, they must adhere to the endothelial vessel wall and 
transmigrate through it to reach inflamed tissues. In most tissues, the neutrophil 
recruitment cascade occurs in the following steps: tethering, rolling, adhesion, crawling and, 
finally, transmigration (Figure 1.2) (Kolaczkowska & Kubes, 2013). There have been a large 
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number of studies dissecting the multiple steps of neutrophil adhesion and migration across 
the vessel wall (Filippi, 2019; J. Herter & Zarbock, 2013; Kolaczkowska & Kubes, 2013; Ley, 
Laudanna, Cybulsky, & Nourshargh, 2007; Nourshargh & Alon, 2014).  
Briefly, the initial loose adhesion of neutrophils (tethering) is initiated by changes on 
the surface of the endothelium in response to a diverse set of inflammatory mediators, 
including chemoattractants (e.g. IL-8), cytokines (e.g. tumor necrosis factor, TNF), 
endotoxins (e.g. lipopolysaccharide, LPS) and growth factors (e.g. granulocyte macrophage-
colony factor, GM-CSF). Tethering occurs rapidly (within minutes) and proceeds to selectin-
dependent rolling and then integrin-dependent adhesion through the formation of 
additional bonds between adhesion molecules (mainly selectin and integrins) and ligands on 
the neutrophil and the vascular endothelium. Once neutrophils are firmly adhered onto the 
endothelial surface, they undergo spreading and polarisation. These steps are prerequisite 
for the ability of neutrophils to migrate along the vascular wall to find a suitable place for 
transmigration (Filippi, 2019). 
 
 
Figure 1.2: Neutrophil Recruitment Cascade 
Recruitment of neutrophils from the circulation to sites of inflammation is comprised of several steps: 
tethering, rolling, adhesion, spreading, polarisation, intravascular crawling and transmigration. Two 
mechanisms of transmigration are observed: a) paracellular (between endothelial cells) and b) transcellular 
(through endothelial cells). Rolling is mostly selectin-dependent, whereas adhesion, crawling and 
transmigration depend on integrin interactions. The extravasated neutrophil in the tissue then follows 
chemotactic gradients to the site of inflammation or infection, using amoeboid migration that can be 




1.1.2.1  Selectin-mediated tethering, rolling and adhesion 
According to our current understanding, neutrophils first make temporary and reversible 
interactions with the endothelial surface. The initial stage requires the interaction of various 
selectin molecules with their ligands on the interacting cells (McEver & Cummings, 1997; 
Mocsai, Walzog, & Lowell, 2015; Mueller et al., 2010). Endothelial cells can be activated by 
pattern-recognition receptor (PRR)-mediated detection of pathogens, the initial host sensors 
of invading microbes in innate immunity (Janeway & Medzhitov, 2002), as well as cytokines 
and other inflammatory mediators (such as TNF and GM-CSF), that increase the expression 
of adhesion molecules. They upregulate pre-stored P-selectin from secretory granules of the 
endothelial cell, named Weibel-Palade bodies, by fusing with the plasma membrane within 
minutes. Another endothelial selectin that contributes to neutrophil rolling, E-selectin, is 
synthetized de novo in response to various pro-inflammatory molecules such as TNFIL-1 
or LPS (Ley et al., 2007; McEver, 2015; Petri, Phillipson, & Kubes, 2008). E-selectin can be 
detected on the endothelial surface as soon as 2 hours after the induction of an acute 
inflammatory response, and its expression usually turns off within 24 hours.  
Once on the endothelial surface, P-selectin and E-selectin bind to their glycosylated 
ligands on neutrophils, including P-selectin glycoprotein ligand 1 (PSGL-1) (Faurschou & 
Borregaard, 2003; Ley et al., 2007; McEver, 2015; Zarbock, Ley, McEver, & Hidalgo, 2011), 
leading to the tethering (capturing) of free-flowing neutrophils to the surface of the 
endothelium and their subsequent rolling along the vessel wall in the direction of blood 
flow. These two selectins have partially overlapping functions in neutrophil recruitment, but 
P-selectin is responsible more for the initial tethering and rolling, whereas E-selectin slows 
the rolling down. To prevent sheer flow in the blood vessel from forcing detachment, 
neutrophils then begin to firmly adhere to and spread over the endothelium, and this stage 
is primarily mediated by members of the β2-integrin family. 
Over recent years, there is strong evidence that blood platelets are functionally 
important for neutrophil recruitment during inflammation, by interacting both with 
circulating neutrophils and with the inflamed vascular endothelium. Inflammatory stimuli 
promote the interaction of platelets and leukocytes, leading to the formation of platelet-
leukocyte conjugates which have been found free flowing in blood, as well as on the 
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endothelial wall and extravascularly in inflamed tissue, and these conjugates can also can be 
induced to form in vitro (Middleton, Weyrich, & Zimmerman, 2016; Page & Pitchford, 2013; 
Pitchford, Pan, & Welch, 2017). During neutrophil recruitment, platelets effectively form 
bridges between neutrophils and vascular endothelial cells by providing additional selectins 
and integrins, as well as other adhesion molecules (Pitchford et al., 2017). In this manner, 
platelets are required for neutrophil recruitment in many acute and chronic inflammatory 
situations, including acute septic, aseptic or allergic pulmonary inflammation, peritonitis, 
pancreatitis, atherosclerosis, rheumatoid arthritis and encephalomyelitis (multiple sclerosis) 
(Pitchford et al., 2017). 
1.1.2.2 Integrin-dependent firm adhesion and crawling 
Rolling and firm adhesion to the vessel wall is achieved by the upregulation of the major 
neutrophil β2-integrins, macrophage-1 antigen (Mac-1, CD11b/CD18) and lymphocyte 
function-associated antigen 1 (LFA-1, CD11a/CD18), onto the neutrophil surface. These 
integrins must become activated from their closed, low affinity state into their open, high-
affinity conformation. Various agonists trigger integrin activation in neutrophils, including 
chemokines such as interleukin 8 (IL-8) and complement component factor 5a (C5a), 
cytokines such as TNFα and GM-CSF, and the bacterial cell wall component LPS, as well as 
other bacterial products such as the chemoattractant f-Met-Leu-Phe (N-formyl Met-Leu-Phe 
peptide, hereafter referred to as fMLP) (Morikis & Simon, 2018).  
G protein-coupled receptors (GPCRs) play an important role in neutrophil 
recruitment by inducing both the upregulation and the high-affinity state of β2 integrins LFA-
1 and Mac-1. They bind inflammatory chemokines, such as IL-8, C5a and fMLP. IL-8 is 
particularly important for neutrophil recruitment as it is immobilised on the luminal side of 
inflamed vascular endothelial cells, thus providing a ligand for rolling neutrophils, prior to 
firm adhesion (DiVietro et al., 2001). The GPCR-dependent upregulation and activation of 
integrins is also called inside-out signalling (Shen, Delaney, & Du, 2012). Once in a high 
affinity state, the neutrophil integrins bind to ligands such as intercellular cell adhesion 
molecule-1 (ICAM-1) on the endothelium, resulting in enhanced adhesion and spreading (Ley 
et al., 2007).  
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Beside firm adhesion, integrins also initiate intracellular signals in a process known as 
outside-in signalling. Two Src-like receptor tyrosine kinases, Fgr and Hck are essential for this 
signalling pathway, as well as phosphoinositide 3-kinase (PI3K) and G-protein regulators such 
as P-Rex and Vav (see Section 1.5.2) (Abram & Lowell, 2009; L. R. Anderson, Owens, & 
Naylor, 2014; Fumagalli, Zhang, Baruzzi, Lowell, & Berton, 2007; Kovacs et al., 2014). 
Neutrophils that lack β2 integrin-mediated outside-in signalling fail to sustain adhesion and 
detach from the endothelial cells under flow. The importance of integrins for neutrophil 
recruitment is evident in human deficiencies in the common β-chain subunit of these 
integrins, also called the CD18 subunit. This is known to prevent extravasation of leukocytes 
from blood vessels, resulting in a severe immune disorder called leukocyte adhesion 
deficiency type 1 (LAD-I) (Fagerholm, Guenther, Llort Asens, Savinko, & Uotila, 2019).  
Once firmly adhered to the blood vessel wall, the neutrophil polarises and crawls 
along the intraluminal wall, which is primarily mediated by the β2-integrin Mac-1, in order to 
find an ideal place for transendothelial migration (Stephens, Milne, & Hawkins, 2008).  
1.1.2.3 Leukocyte transmigration and interstitial migration 
Neutrophil transmigration occurs either via paracellular (Vestweber, 2007) or transcellular 
(Carman et al., 2007; Carman & Springer, 2004) migration routes. Mostly, neutrophils 
transmigrate paracellularly through endothelial cell junctions, which involves the 
rearrangement of these junctions to facilitate the passage of the neutrophil (DiStasi & Ley, 
2009; Muller, 2016). In contrast, transcellular migration involves the migration of neutrophils 
through the body of endothelial cells and occurs less frequently (Carman & Springer, 2004; 
Voisin & Nourshargh, 2013). This possibly involves the formation of ICAM-1 dependent 
intracellular channels (Millan et al., 2006; Yang et al., 2005).  
After migrating through the endothelial layer, before entering the tissue, neutrophils 
encounter the basement membrane and pericytes. The basement membrane is mostly 
composed of laminin (e.g lamin-8 and -10) and collagen type IV, interconnected by 
molecules such as nidogen-2 and heparin sulphate proteoglycan. Regions of low extracellular 
matrix (ECM) density exist, which interestingly co-localize with gaps between adjacent 
pericytes. Two-photon intravital microscopy, an imaging tool that permits in vivo 
observation of neutrophil extravasation, revealed that neutrophils crawling through gaps 
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between adjacent pericytes requires β2 integrins (Hyun et al., 2012). Under inflammatory 
conditions, these gaps enlarge and are used by neutrophils as points of exit to breach the 
venular wall (Kapur et al., 1999; Proebstl et al., 2012; K. Stark et al., 2013). A recent study, 
again using two-photon intravital imaging, has observed the existence of selective hotspots 
for neutrophil transendothelial migration, with coordinated roles for LFA-1 and Mac-1 (Hyun 
& Choe, 2019). In particular, LFA-1 and Mac-1 control the stages preceding neutrophil 
protrusion from the endothelial basement membrane and pericyte sheath, i.e. from the 
point of entry into the endothelial wall up to exit of the endothelial basement membrane 
and pericyte sheath. 
After transmigration, neutrophils migrate by chemotaxis through the interstitial tissue 
towards the site of inflammation. Both directionality and speed of migration contribute to 
effective chemotaxis. In fact, neutrophils are the fastest chemotaxing cell in the human 
body, with reported speeds of 19 ± 6 μm.min-1 in laboratory settings (Hoang et al., 2013). 
The generation of polarity and subsequent directional migration are regulated by 
intracellular signalling pathways in response to the activation of GPCRs by ligands such as 
fMLP and C5a. The release of Gβγ subunits from activated GPCRs stimulates the production 
of the lipid second messenger phosphatidyl-inositol (3,4,5)-(trisphosphate) (PIP3), via the 
activation of PI3Kγ. This PIP3 is highly localised towards the source of the chemoattractant, 
resulting in polarised signalling to Rho-family small G proteins and the actomyosin 
cytoskeleton, and thus to the formation of a leading edge and polarisation of the cell (G. J. 
Ferguson et al., 2007). Consequently, this leads to coordinated neutrophil migration via the 
spatial organisation of Rho-family small G protein activities (see Section 1.3.2.1) (Hawkins, 
Stephens, Suire, & Wilson, 2010). 
1.1.3 Neutrophil effector responses 
Once at the site of inflammation, neutrophils can perform a wide variety of effector 
responses. Here, they release proinflammatory mediators to attract other inflammatory cells 
and mount effector functions to kill pathogens, including phagocytosis, generation of 
reactive oxygen species (ROS), release of granules and formation of neutrophil extracellular 
traps (NETs) (Nauseef & Borregaard, 2014) (Figure 1.3). In addition to the direct killing of 
pathogens, these combined functions enable neutrophil involvement in progressing 
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inflammation by stimulating macrophage recruitment, M2 macrophage differentiation (the 
class of macrophages associated with wound healing and tissue repair) and activation of the 
adaptive immune system. By influencing these responses, neutrophils also promote other 
physiological and pathophysiological processes, such as angiogenesis and tumour formation 
(Selders, Fetz, Radic, & Bowlin, 2017). 
 
Figure 1.3: Bacterial Killing Mechanisms 
Neutrophils are the major phagocyte and the principal effector cell of innate immunity in humans, with a 
primary role in the clearance of extracellular pathogens. Using a broad array of responses, including 
cytokine production, the secretion of granules and the formation of ROS and neutrophil extracellular traps 
(NETs), neutrophils play a crucial role in host defense against bacterial and fungal infections.  
 
1.1.3.1 Bacterial killing mechanism 
Neutrophils provide the first line of defence of the innate immune system by phagocytosing, 
killing, and digesting bacteria and fungi. Phagocytosis is an actin-based process used by 
neutrophils to clear particles greater than 0.5 μm in diameter (Gordon, 2016). Upon the 
activation of appropriate receptors, such as integrins and Fcγ receptors (FcR), signalling 
pathways are activated which lead to phagocytosis (Gu et al., 2003). The mechanism of 
engulfment can vary depending on the receptor that is activated, for example, the FcRs 
stimulate the generation of membrane protrusion that form a phagocytic cup (extracellular). 
In comparison, integrin-mediated phagocytosis involves the particles sinking into the cell 
rather than the generation of protrusions (intracellular) (Chimini & Chavrier, 2000). 
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Neutrophils engulf pathogens by phagocytosis and kill them via degranulation and 
the action of ROS. Neutrophils contain three populations of secretory granules, including 
azurophil granules which store antimicrobial components such as myeloperoxidase (MPO), 
lysozyme and defensins. These fuse preferentially with phagosomes (Amulic, Cazalet, Hayes, 
Metzler, & Zychlinsky, 2012; Benarafa & Simon, 2017; Borregaard, 2010; Faurschou & 
Borregaard, 2003). The other two types of granules are secondary and tertiary granules, 
which contain lactoferrin and gelatinase respectively. They can fuse either with the plasma 
membrane or with the phagosome, depending on the stimulus. The contents of the granules 
facilitate bacterial death via multiple mechanisms, including the degradation of the bacterial 
cell wall by lysozyme or the permeabilisation of membrane bilayers and inhibition of DNA 
synthesis by defensins (Amulic et al., 2012; Borregaard, 2010; Lacy, 2006). 
Microbial killing also occurs through the release of ROS into the phagosome or into 
the extracellular environment. ROS is produced by the Nicotinamide Adenine Dinucleotide 
Phosphate (NADPH) Oxidase complex (Nox2, also commonly referred to as phagocyte 
oxidase) which makes superoxide that subsequently forms various ROS, including hydrogen 
peroxide (H2O2) (Dupre-Crochet, Erard, & Nuss, 2013; El-Benna et al., 2016; Paiva & Bozza, 
2014). The multicomponent NADPH oxidase enzyme complex contains at least six essential 
protein components, two in the membrane and four in the cytosol. It comprises of the 
membrane bound gp91phox and p22phox and the cytosolic subunits p40phox, p67phox, p47phox, 
and the small GTPase Rac2 (Babior, Lambeth, & Nauseef, 2002). Binding of ligands to GPCRs, 
toll-like receptors (TLRs) and cytokine receptors (e.g. TNFRs) can prime the cells (see section 
1.1.4) for a more robust response of the oxidase complex, by stimulating the fusion of 
secretory vesicles and granules with the plasma or phagosomal membrane, thus delivering 
the oxidase components gp91phox and p22phox into these membranes. Upon receptor 
activation and signalling, the p47phox component is heavily phosphorylated (Heyworth, 
Shrimpton, & Segal, 1989), and the cytosolic components of the NADPH oxidase complex 
translocate to the plasma, or phagosomal, membrane forming a functional ROS producing 
complex (Cross & Segal, 2004; El-Benna et al., 2016; Hallett & Lloyds, 1995). The 
phosphorylation of p40phox by PKCδ and its binding to the phosphoinositide PI3P are also 
required for full activation of the oxidase complex (K. E. Anderson et al., 2010). Even in the 
absence of priming, some receptors are localised constitutively on the neutrophil surface, 
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such as the GPCRs for IL-8, CXCR1 and CXCR2, which can stimulate the activation of the 
NADPH oxidase, triggering low levels of ROS production. In contrast to the other oxidase 
subunits, Rac2 must be activated by GTP-loading in order to form part of the complex. Once 
assembled, the oxidase complex produces superoxide anions by electron transport from 
NADPH to O2, and the superoxide is further converted to other ROS such as H2O2 and HOCl, 
by superoxide dismutase and myeloperoxidase, respectively. The importance of ROS 
formation in neutrophil function is illustrated in chronic granulomatous disease (CGD), which 
is caused by mutations in various proteins of the NADPH oxidase complex and is 
characterised by the inability of phagocytes to kill invading pathogens. This results in 
patients having severe recurrent fungal and bacterial infections (Dinauer, 2016; O'Neill, 
Brault, Stasia, & Knaus, 2015). 
A third mechanism that neutrophils use to kill pathogens is the more recently 
identified neutrophil extracellular trap (NET). This involves the secretion of granule proteins 
and the active release of chromatin via a unique cell death pathway called NETosis (Fuchs et 
al., 2007). Granule proteins and chromatin together form extracellular fibres which bind 
bacteria (Brinkmann et al., 2004). The production of ROS is essential for NET formation. 
Multiple pathways that induce ROS production are known to lead to NETosis, especially 
those that also mobilise azurophil granules. For example, using a chemical library screen in 
human neutrophils, Hakkim et al. have shown that the Raf-MEK-ERK pathway is involved in 
NET formation through activation of the NADPH oxidase (Hakkim et al., 2011). In addition to 
NETosis, which takes several hours, Kubes et al. have described an alternative mechanism 
termed “non-lytic NETosis” that leads to the rapid release of NETs within minutes of 
exposure to S. aureus, via the secretion of chromatin and granule contents in the absence of 
cell death (Pilsczek et al., 2010). Furthermore, the importance of NETs in fighting infections 
may be illustrated by the increased virulence exhibited by DNase expressing bacteria 
(Buchanan et al., 2006; Schonrich & Raftery, 2016). The formation of NETs has also been 
implicated in several pathological conditions, for example the excessive formation of NETs 
has been linked to several autoimmune diseases, sepsis, and cancer (Jorch & Kubes, 2017; 
Kaplan, 2013; Khandpur et al., 2013; Saffarzadeh et al., 2012; Yipp et al., 2012). 
The non-specific nature of the tools that neutrophils use to clear microorganisms 
means that these cells can also damage host tissues. During the resolution of inflammation, 
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neutrophils normally undergo apoptosis and are cleared by macrophages or other 
phagocytic cells (Haslett, 1999). However, the disruption of this process, by the prevention 
of apoptosis or due to excessive stimulation, can result in the dysregulation of neutrophil 
functions leading to ROS- or granule-mediated tissue damage (Kruger et al., 2015; McDaniel, 
Roy, & Wilgus, 2013; Segel, Halterman, & Lichtman, 2011). As a result, neutrophils are a 
major cause of tissue damage during inflammatory conditions such as rheumatoid arthritis, 
bronchiolitis and cystic fibrosis, as well as cardiovascular conditions such as acute myocardial 
infection and stroke (Cowburn, Condliffe, Farahi, Summers, & Chilvers, 2008). Therefore, 
investigating how neutrophils are activated and how they can become dysregulated is 
extremely important to understanding how they can maintain their beneficial roles in 
microbial killing whilst avoiding tissue damage (Gomez-Moreno, Adrover, & Hidalgo, 2018; 
Mocsai, 2013; Phillipson & Kubes, 2019; J. Wang, 2018). 
1.1.4 Neutrophil priming 
One of the mechanisms that allows neutrophils to be rapid effectors of the innate immune 
response while preventing their inadvertent activation is priming. Neutrophil priming has 
been extensively described (Guthrie, Mcphail, Henson, & Johnston, 1984), (Condliffe, 
Chilvers, Haslett, & Dransfield, 1996), (El-Benna, Dang, & Gougerot-Pocidalo, 2008; Wright, 
Thomas, Moots, & Edwards, 2013) and is defined as an enhanced response to activating 
stimuli. Exposure to pro-inflammatory cytokines, chemokines, growth factors, lipid-derived 
signalling molecules, as well as bacterial and viral products, induces neutrophils to transition 
from a basal into a primed state. Examples of such priming pathways are those mediated by 
the LPS receptor TLR4 and by receptors for the cytokines TNF and GM-CSF. Upon exposure 
to such priming agents, neutrophils undergo a series of phenotypic changes (Miralda, 
Uriarte, & McLeish, 2017). Those include the shedding of L-selectin, and the fusing of 
secretory vesicles and granules with the plasma membrane, which leads to increased surface 
expression of integrin allowing primed cells to adhere to endothelial cells, as well as the 
upregulation of other surface receptors. These phenotypic changes are associated with the 
release of granule contents into the extracellular space, including matrix metalloproteases, 
which facilitate neutrophil migration through tissues by degrading the extracellular matrix. 
When primed neutrophils encounter bacteria, their microbicidal activities (ROS production, 
granule release, phagocytosis and NET formation) are increased due to the upregulation in 
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the number and affinity of receptors on the plasma membrane. Furthermore, priming 
prolongs neutrophil lifespan by activating anti-apoptotic signal transduction pathways and 
suppressing the transcription of pro-apoptotic factors. 
Initially, priming has been reported as an in vitro phenomenon to enhance ROS 
production (see also section 3.6.2, Chapter Materials and Methods), degranulation, 
chemotaxis and NET formation, triggered by subsequent stimuli at concentrations that alone 
would not be sufficient to activate the cells. However, neutrophil priming is clearly also 
important in vivo, as priming agents are released in response to infection, trauma and 
haemorrhage, and deficiency in priming pathways leads to reduced neutrophil-mediated 
immunity (Deng et al., 2013; Miralda et al., 2017; Wieland et al., 2005). 
1.1.5 Neutrophil lifespan and clearance 
The great majority of mature neutrophils reside in the bone marrow. Studies in mice have 
shown that the half-life of neutrophils under non-inflammatory conditions is regulated by 
GM-CSF in the bone marrow (Semerad, Liu, Gregory, Stumpf, & Link, 2002). There is 
controversy in the literature regarding the half-life of neutrophils, and it appears that this is 
highly dependent on the method used to measure their lifespan (Bekkering, 2013). Several 
studies have reported that, within the circulation, the lifespan of neutrophils is roughly 12 
hours (Basu, Hodgson, Katz, & Dunn, 2002; Summers et al., 2010), whereas one other study 
claimed that circulatory neutrophils have a lifespan of 5.4 days (Pillay et al., 2010). Although 
there is some discrepancy between these findings, it is well established that once 
neutrophils migrate into tissue, they are exposed to survival signals that increase their 
lifespan to around one week, and disease states can either up- or downregulate lifespan 
(Tak, Tesselaar, Pillay, Borghans, & Koenderman, 2013). 
Neutrophil homeostasis is maintained through a balance of neutrophil production, 
release from the bone marrow (governed mainly by the opposing actions of CXCR4 and 
CXCR2) (see sections 1.2.2.3 and 1.2.2.4), and clearance from the circulation (Christopher & 
Link, 2007; Strydom & Rankin, 2013). Therefore, the homeostatic removal of neutrophils 
from the circulation must match their production, and this is mediated by macrophages in 
the liver, bone marrow stroma and the marginal zone of spleen (Gordy, Pua, Sempowski, & 
He, 2011; Summers et al., 2010). Mechanistically, neutrophil ageing is linked to IL-8 receptor 
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expression. Indeed, as neutrophils become senescent, expression of CXCR2 decreases, while 
the expression of CXCR4 increases (Martin et al., 2003; Nagase et al., 2002), thus increasing 
the responsiveness of the cells to stromal cell-derived factor (SDF-1α), the ligand of CXCR4, 
and resulting in the homing of senescent neutrophils to the bone marrow. Therefore, CXCR4 
is not only a signal to retain new neutrophils in the bone marrow, but also homes the 
senescent cells back into the bone marrow for destruction. There, the senescent neutrophils 
undergo apoptosis and are subsequently phagocytosed by stromal macrophages (Bratton & 
Henson, 2011; Furze & Rankin, 2008). In parallel, phagocytosis of neutrophils in the bone 
marrow stimulates GM-CSF levels which in turn induces new neutrophil production. In this 
way, there is a positive feedback loop for neutrophil production, in which, apoptotic 
neutrophils in the circulation are cleared by the liver and the spleen, whereas senescent 
neutrophils can migrate into the bone marrow and are cleared there while at the same time 
stimulating the production of new neutrophils, thus maintaining a homeostatic balance 
(Furze & Rankin, 2008). Therefore, clearance in the bone marrow leads to new neutrophil 
production, while clearance in the spleen, liver and tissues reduces tissue damage. 
Moreover, under steady state conditions, apoptotic neutrophils are also phagocytosed by 
reticular endothelial macrophages in the spleen and liver, while the production of GM-CSF is 
suppressed to limit inflammation (Fadok, McDonald, Bratton, & Henson, 1998).  
Once neutrophils have completed their anti-pathogen responses at the site of 
inflammation it is essential that they become apoptotic and are cleared by macrophages, to 
avoid tissue damage (Soehnlein & Lindbom, 2010). Under normal circumstances, this 
clearance process initiates a feed forward pro-resolution programme that is characterised by 
the release of the tissue-repairing cytokines transforming growth factor-β (TGFβ) and 
interleukin-10 (IL-10). When this clearance does not occur appropriately, neutrophils 
undergo necrosis and release intracellular contents that can damage the tissue and extend 
the inflammatory phase. However, neutrophils do not always die at the site where they are 
recruited. Early evidence suggested that neutrophils accumulating at inflamed sites do not 
necessarily undergo apoptosis followed by phagocytosis by macrophages (Hughes et al., 
1997). Recent studies have shown that neutrophils can leave the site of tissue damage in a 
process termed reverse migration, which means that interstitial tissue-infiltrated neutrophils 
migrate away from inflamed sites (Powell et al., 2017). A study combining intravital imaging 
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and photoactivation techniques also demonstrated that murine neutrophils perform reverse 
migration from an injury site, moving back into the circulation and eventually homing back 
into the bone marrow (J. Wang, 2018). Moreover, another process referred to as reverse 
transendothelial migration (rTEM) has been described which contributes to neutrophil 
clearance by returning the cells into the blood stream. However, further studies need to be 
carried out to further clarify the fate of reverse-migrated neutrophil and the regulation of 
the death process that takes place in the tissues. 
 
1.2 GPCRs and heterotrimeric G proteins 
Signalling processes are tightly regulated spatially and temporally, thus integrating a 
multitude of different pathways and effectors in order to generate specific cell responses 
and localised effects. In this scenario, Guanine-nucleotide binding proteins (G proteins) are 
particularly important molecular tools for the coordination and interpretation of the signals 
provided by the external environment. There are two main classes of G proteins, monomeric 
G proteins (small G proteins or small GTPases), which will be introduced later in section 1.3, 
and heterotrimetric G proteins (large G proteins), which signal by coupling to G protein-
coupled receptors (GPCRs). Both classes are characterised by their capability of binding GTP 
and GDP, and switching their state of activity between GTP-bound (active state) and GDP-
bound (inactive state). The activation of the two classes of G proteins involves similar 
mechanisms, and both are important in controlling a wide variety of signalling events. 
In this project, I study the regulation of the small G protein Rac and related signalling 
proteins in neutrophil GPCR signalling pathways, as well as the regulation of the trafficking of 
GPCRs that signal to Rac. Each of these topics will be introduced in detail in this chapter, 
beginning with GPCR signalling and trafficking. 
1.2.1 G protein-coupled receptors 
G protein-coupled receptors (GPCRs) are the largest family of cell surface receptor proteins. 
They are mainly located at the plasma membrane, and they are characterised by a signature 
seven transmembrane structure (Pierce, Premont, & Lefkowitz, 2002). They signal through 
heterotrimeric G proteins, trimeric protein complexes consisting of Gα, Gβ and Gγ subunits, 
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that are localised on the inner leaflet of the plasma membrane and associated with the 
GPCRs. GPCRs and the GPCR-coupled heterotrimeric G proteins are important regulators of 
physiological processes such as vision and smell, behaviour and mood, but also cell density 
and growth, immune surveillance and inflammation. 
The main activation steps of GPCRs and their associated heterotrimeric G proteins 
have been elucidated in great detail (Lefkowitz, 2013; Pierce et al., 2002). The Gα subunit is 
a guanine-nucleotide binding protein with GTPase activity, similar to a small G protein. It is 
bound to GDP in basal conditions, and in response to activation by its GPCR, binds GTP. In 
humans, 16 different Gα subunits exist, mainly of Gαi/o, Gαs, Gαq or Gα12/13-type, which all 
signal through different downstream effectors. The Gβ and Gγ subunits are a tightly bound 
dimer with a strong coiled-coil interaction (Sondek, Bohm, Lambright, Hamm, & Sigler, 
1996). Under basal conditions, the Gβγ dimer exists in a complex with the GDP-bound Gα 
subunit. In humans, 6 different Gβ subunits are found and 12 Gγ, giving 72 possible dimer 
combinations, although not all of these occur. When the GPCR bound to the heterotrimer is 
activated by agonist binding on the extracellular side, it undergoes conformational change 
that allows it to act as a GEF to promote the exchange of GDP for GTP on the Gα subunit. 
This results in a conformational change in Gα, releasing the Gβγ dimer. The separated Gα 
subunit and Gβγ dimer are now able to interact with their respective effector proteins, 
leading to downstream signalling events (Lambright et al., 1996). The GTP-bound Gα subunit 
can interact with regulators of G-protein signalling (RGS) (Chen, Young, & Jones, 2001; 
Oldham & Hamm, 2008) which act as a GTPase activating protein (GAP), activating the 
GTPase function of the Gα subunit and resetting the system to basal state, by Gβγ re-




1.2.1.1 Heterotrimeric G protein signalling pathways 
The different classes of heterotrimeric G proteins are defined by their Gα subunits, and 
broadly speaking, different classes couple to different signalling pathways, although the 
plasticity and redundancy between these signalling networks is immense. Generally, Gαs-
type heterotrimeric G proteins are defined by their ability to activate adenylyl cyclase, thus 
promoting the production of cAMP and activation of PKA, whereas Gαi/o type G proteins 
(which are pertussis toxin, PTX, sensitive) inhibit adenylate cyclase. Gαq type heterotrimeric 
G proteins are the archetypical activators of phospholipase C β (PLCβ), which produces 
diacylglycerol (DAG) and inositol 3-phosphate (IP3) from the membrane lipid 
phosphatidylinositol 4,5‐bisphosphate (PIP2). DAG then activates PKC, and IP3 leads to 
intracellular Ca2+ rises (Neves, Ram, & Iyengar, 2002). Gα12/13 type heterotrimeric G proteins 
activate RhoA-specific GEFs to modulate the structure of the cytoskeleton (Siehler, 2009). 
However, all heterotrimeric G proteins tend to signal through multiple pathways, for 
example most can activate the PLC, PLD, PI3K and Ras/Mek/Erk pathways in more-or-less 
direct ways. The typical signalling pathways of the different Gα protein families are 
summarised in Figure 1.5. 
 
 
Figure 1.4: Activation cycle of heterotrimetric G proteins 
Activation of a GPCR causes the receptor to act as a guanine nucleotide exchange factor (GEF), promoting 
GDP release from the Gα subunit of heterotrimeric G proteins, allowing GTP to bind. This leads to 
dissociation of Gα from Gβγ. Both Gα and Gβγ can now interact with effectors to mediate downstream 
signalling. The system is reset as a Regulator of G protein Signalling (RGS) interacts with the Gα subunit, 
acting as a GTPase-activating protein (GAP). This facilitates the Gα subunit’s GTPase activity, hydrolysing 
GTP to GDP. The inactive GDP-bound Gα subunit reforms a complex with Gβγ subunits. Figure adapted from 




1.2.1.2 GPCR trafficking 
As GPCRs are enormously important for normal cell function, both their levels and their 
activity must be tightly controlled. Hence, the regulation of their expression level, their 
trafficking to and from the membrane, and the mechanisms of their inactivation are equally 
as important for homeostasis as their activation by agonists. As typical transmembrane 
proteins, GPCRs are de-novo synthesised in the ER and are transported constitutively to the 
plasma membrane through the Golgi and trans-Golgi network (TGN). For most GPCRs, their 
activation and signalling at the plasma membrane (as described here above) is followed by 
desensitisation and then receptor internalisation, particularly upon prolonged agonist-
stimulation (S. S. G. Ferguson, 2001; Reiter & Lefkowitz, 2006; Tan, Brady, Nickols, Wang, & 
Limbird, 2004). Desensitisation and internalisation are controlled by a number of different 
pathways (DeWire, Ahn, Lefkowitz, & Shenoy, 2007; Drake, Shenoy, & Lefkowitz, 2006; 
Hanyaloglu & von Zastrow, 2008; Sorkin & von Zastrow, 2009). One of the principal 
pathways is by members of the G protein-coupled receptor kinase (GRK) family which 
recognise active GPCRs and phosphorylates serine or threonine residues in the GPCR’s 
 
Figure 1.5: Schematic overview of heterotrimeric G protein family signal transduction 
Schematic showing characteristic examples of the signalling of different Gα protein families downstream of 
an activated coupled receptor. Gαs and Gαi/o have opposing effects on adenylate cyclase (AC) activity whilst 
the Gβγ proteins activate PI3K and Rac GEFs, and inhibit AC. The Gαq family signals to activate PLCβ, 
resulting in the production of IP3 and DAG from PI(4,5)P2. IP3 mediates Ca
2+
 rises and DAG activates PKC. The 
Gα12/13 family activate Rho-GEFs to stimulate RhoA activity and subsequently cytoskeleton dynamics. Figure 
adapted from (Yong Huang, Zheng, Su, & Gu, 2009). 
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cytoplasmic C-terminus (Reiter & Lefkowitz, 2006). This is followed by recruitment of β-
arrestin proteins to the phosphorylated receptor, forming a high affinity interaction. This 
sterically impedes the coupling of the GPCR to the heterotrimeric G protein (Shenoy & 
Lefkowitz, 2003), and so the GPCR can no longer transmit downstream signals, which results 
in fast signal desensitization and is followed by rapid internalization of the receptor 
(Krupnick & Benovic, 1998; Pitcher, Freedman, & Lefkowitz, 1998). β-Arrestin proteins have 
a dual role: on the one hand, they lead to signal desensitisation by competing with G 
proteins for binding to the receptor, on the other hand they promote receptor 
internalisation by interacting with key proteins such as clathrin adaptor AP2 (Laporte et al., 
1999), ADP ribosylation factor 6 (Claing et al., 2001) and clathrin itself (Goodman et al., 
1996), leading to clathrin-mediated endocytosis of the GPCR (Doherty & McMahon, 2009; 
Shenoy & Lefkowitz, 2003). It is important to bear in mind that for some GPCRs, 
desensitisation can occur in a GRK-independent manner, and phosphorylation of the C 
terminus may also induce mechanisms of internalisation that are clathrin independent. 
Internalised GPCRs can follow varying trafficking paths (Irannejad, Tsvetanova, Lobingier, & 
von Zastrow, 2015; Sorkin & von Zastrow, 2009). However, generally, they are sorted into 
the endosomal compartment, where they become dephosphorylated. Once the GPCR is 
dephosphorylated, it may either be recycled to the plasma membrane or be transported to 
the lysosome for degradation, leading to receptor downregulation (Reiter & Lefkowitz, 
2006). While the agonist-induced phosphorylation of GPCRs has been studied in great detail, 
the mechanisms and outcomes of receptor dephosphorylation are comparatively less well-
understood. One study using the Sst2A somatostatin receptor as model has identified 
protein phosphatase 1β as a major player leading to the disruption of the β-arrestin/GPCR 
complex (Poll, Doll, & Schulz, 2011). A different study identified protein phosphatase 2A as 
responsible for the recycling of metabotropic glutamate receptor 1 (mGluR1) (Pandey, 
Mahato, & Bhattacharyya, 2014), suggesting that there may not be a common 
dephosphorylation mechanism for all GPCRs, and that similar dephosphorylation events can 
have different outcomes. 
Contrary to the dogma of phosphorylation-dependent receptor desensitisation and 
switching off by internalisation, in many cases, GPCR internalisation does not attenuate the 
cellular effects of receptor activation, but instead signalling continues after internalisation 
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from within the cell, for example in the Golgi apparatus (Godbole, Lyga, Lohse, & Calebiro, 
2017). Infact, many recent studies have provided strong evidence that internalised receptors 
can take part in intracellular signalling events (Calebiro & Godbole, 2018). To complicate 
matters further, “Hot Spots” on the plasma membrane have recently been identified 
through single-molecule imaging, where receptors and G proteins are more often found, and 
therefore, even within the plane of the plasma membrane, there are regions with more or 
less GPCR signalling (Sungkaworn et al., 2017).  
In neutrophils, GPCR trafficking is even more complicated, as many neutrophil GPCRs 
are stored on the membrane of secretory vesicles and granules that can rapidly fuse with the 
plasma membrane upon neutrophil priming, allowing the cells to increase their 
responsiveness to chemotactic cues that are present at sites of in vivo inflammation, 
although other GPCRs are constitutively localised on the neutrophil surface (see section 
1.2.2).  
Overall it can be stated that membrane trafficking dictates the signalling pattern of 
GPCRs (Hanyaloglu & von Zastrow, 2008), placing a high importance on elucidating the 
mechanisms that control this receptor trafficking. 
1.2.2 Chemokine receptors in neutrophils 
Neutrophil mobilisation from the bone marrow into the blood stream and neutrophil 
recruitment to sites of inflammation, infection or injury is primarily regulated by chemokines 
such as C5a, fMLP and IL-8. Upon tissue injury, these chemokines are produced locally by 
various cell types, including neutrophils, macrophages, fibroblasts, and endothelial cells, or 
by the pathogens (Abtin et al., 2014; Pober & Sessa, 2007). Neutrophils express more than 
30 types of GPCR, which can bind to a broad array of ligands, many of which are chemokines 
(Lammermann & Kastenmuller, 2019). 
Chemokine receptors are typical members of the rhodopsin or serpentine 
superfamily of GPCRs, with the characteristic seven hydrophobic transmembrane structure. 
They mediate cellular responses to chemokines, a large family of cytokines which regulate 
leukocyte trafficking and migration. In addition, “atypical chemokine receptors” also exist, 
which act as chemokine scavengers to downregulate inflammation (Bachelerie et al., 2014). 
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Some chemokine receptors pair uniquely with one chemokine ligand, but most are more 
promiscuous, although restricted to one chemokine group. Major chemokine receptors that 
control the trafficking and chemotaxis of neutrophils are introduced here. The signalling 
through these GPCRs, and how these signals guide neutrophil recruitment into the blood 
stream and into inflamed or infected tissues, has been of interest to the research community 
for decades. 
1.2.2.1 Complement Component 5a Receptor 1 
One typical example of chemokine receptors is the Complement Component 5a Receptor 1 
(C5aR1), a 351 amino acid GPCR which recognises the 74 amino acid peptide ligand 
complement component 5a (C5a, which is one of the anaphylatoxins) (Boulay, Mery, Tardif, 
Brouchon, & Vignais, 1991). This receptor is widely expressed, with high levels in cells of the 
myeloid linage, including neutrophils and macrophages (Monk, Scola, Madala, & Fairlie, 
2007). Importantly for my project, this receptor is found at low levels constitutively at the 
plasma membrane of basal neutrophils, and is upregulated to the plasma membrane from 
secretory vesicles and granules upon neutrophil priming (Monari, Kozel, Bistoni, & 
Vecchiarelli, 2002; Sengelov, 1995).  
The crystal structure of C5aR1 has recently been solved at 2.7 Å resolution in 
complex with a small-molecule antagonist (Robertson et al., 2018). It is similar, overall, to 
other GPCR receptors, consisting of the canonical seven-transmembrane (TM1–TM7) helix 
arrangement, except for an extra-helical negative allosteric-binding pocket between 
transmembrane regions TM3, TM4 and TM5 that is distinct from conventional orthosteric 
sites for GPCRs antagonists.  
C5aR1 primarily couples to Gαi/o (Kolev, Le Friec, & Kemper, 2014) and is pre-coupled 
to the G protein in the absence of C5a ligand (Raffetseder et al., 1996; Siciliano, Rollins, & 
Springer, 1990). In response to C5a binding, C5aR1 signals through many different pathways, 
including PI3Kγ, phospholipase-C β, and MEK/ERK (Rabiet, Huet, & Boulay, 2007). PI3Kγ 
activity is stimulated directly by Gβγ subunits, resulting in the generation of PIP3 (Stoyanov 
et al., 1995) and thus PI3K signalling and multiple PI3K-dependent cell responses, including 
polarisation and migration. Phospholipase-C β is another direct target of Gβγ subunits, and 
its activation results in the generation of diacylglycerol (DAG), which activates protein kinase 
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C, and of inositol trisphosphate (IP3), which stimulates the release of calcium from 
intracellular stores (Rabiet et al., 2007). The activation of these pathways, along with the 
C5aR1-mediated activation of kinases such as MEK/ERK, results in adhesion, migration and 
ROS production by cells such as neutrophils (Rabiet et al., 2007). 
As with other GPCRs, the agonist-dependent internalisation of C5aR1 requires the 
phosphorylation of its cytoplasmic C-terminus, on residues S332, S334 and S338 (Bock et al., 
1997; Naik, Giannini, Brouchon, & Boulay, 1997). In response to C5a stimulation, Ca5R1 
internalises into endosomes within 5 to 10 minutes (Bock et al., 1997; Naik et al., 1997). The 
kinases GRK2 and GRK3 mediate the agonist-stimulated phosphorylation of C5aR1 
(Langkabel, Zwirner, & Oppermann, 1999; Suvorova, Gripentrog, Oppermann, & Miettinen, 
2008). Furthermore, L318 in the C-terminal region also plays an important role in C5Ra1 
internalisation, supposedly by stabilising structural elements of the receptor that are 
important for phosphorylation (Suvorova et al., 2008). 
The importance that the C5aR1 receptor plays in the innate immune response is 
demonstrated by the increased mortality of C5aR1-deficient mice infected with P. 
aeruginosa (Hopken, Lu, Gerard, & Gerard, 1996). Neutrophils lacking C5aR1 also fail to 
initiate arthritis in the neutrophil-dependent K/BxN serum transfer model of autoimmune 
rheumatoid arthritis (Monach et al., 2010). A recent follow-up paper has provided new 
mechanistic insight by showing that C5aR1 cooperates with another neutrophil GPCR, the 
leukotriene B4 receptor, to recruit neutrophils into the inflamed tissue in this arthritis model 
(Sadik, Miyabe, Sezin, & Luster, 2018). 
1.2.2.2 fMLP Receptor 
Two further chemokine receptors expressed by neutrophils bind formylated peptides such as 
fMLP, which can be derived from bacteria but also from damaged host tissue and are 
considered potent chemoattractants. FPR1 binds fMLP with high affinity, and FPR2 has lower 
affinity. FPR1 is expressed at low levels on the surface of basal neutrophils, whereas the bulk 
of FPR1 is localised on secretory vesicles and various granule subtypes (Rorvig, Ostergaard, 
Heegaard, & Borregaard, 2013) including azurophil granules (Cowland & Borregaard, 1999; 
Sengelov, Boulay, Kjeldsen, & Borregaard, 1994), and is rapidly upregulated to the plasma 
membrane in response to priming with inflammatory stimuli. In vitro, these stimuli include 
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LPS, platelet activating factor (PAF), TNF and GM-CSF (Hayashi, Means, & Luster, 2003; 
Kitchen, Rossi, Condliffe, Haslett, & Chilvers, 1996; Oflaherty, Rossi, Redman, & Jacobson, 
1991; Sengelov et al., 1994). In response to low doses of stimuli such as PAF, secretory-
vesicle FPR1 alone is mobilised; however, in response to powerful stimuli such as phorbol 
myristate acetate, even azurophil-granule FPR1 also localise to the cell surface (Sengelov et 
al., 1994). When activated, FPR1 triggers a variety of functions, including chemotaxis, 
degranulation, ROS production, and phagocytosis (Boulay, Tardif, Brouchon, & Vignais, 
1990).  
FPR1 has been classically described to play a role in the migration of neutrophils into 
sites of infection as well as for their killing of microorganisms. Most of the current 
understanding of this receptor in vivo has been obtained through the generation of FPR1 
knockout mice (Gao, Lee, & Murphy, 1999). In L. monocytogenes-infected FPR1-deficient 
mice, an increased bacterial load was observed in both the liver and spleen compared to 
wild-type mice, with reductions in neutrophil migration and ROS production (Gao et al., 
1999; M. Y. Liu et al., 2012). Furthermore, S. pneumoniae-induced meningeal infection is 
associated with poorer outcome in FPR1-deficient animals although, interestingly, with a 
paradoxical increase in neutrophil numbers within the brain that was postulated to be due 
to the compensatory upregulation of other chemokine receptors (Oldekamp et al., 2014). 
Finally, FPR1 receptor up-regulation has been described in the circulating neutrophils of 
patients with emphysema, Crohn’s disease, and sepsis (Anton, Targan, & Shanahan, 1989; 
Stockley, Grant, Llewellynjones, Hill, & Burnett, 1994; Tennenberg & Solomkin, 1988). 
1.2.2.3 IL-8 Receptors 
IL-8 (CXCL8) was the first chemokine identified as a neutrophil chemoattractant (Yoshimura 
et al., 1987). It binds to two chemokine receptors expressed on the neutrophil surface in 
mice, CXCR1 (also known as IL-8 receptor-) and CXCR2 (IL-8 receptor-) (Chuntharapai, Lee, 
Hebert, & Kim, 1994; Sabroe, Williams, Hebert, & Collins, 1997). 
CXCR1 binds IL-8 with high affinity, whereas CXCR2 binds IL-8 as well as other ligands, 
including melanoma growth stimulatory activity GRO/MGSA (CXCL1) (Sabroe et al., 2002), 
neutrophil activating protein-2 NAP-2 (CXCL7) and epithelial cell-derived neutrophil-
activating factor-78 amino acids ENA-78 (CXCL5) (Ahuja, Lee, & Murphy, 1996). Granulocytic-
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chemoattractant protein-2 GCP-2 (CXCL6) is an equipotent agonist for both CXCR1 and 
CXCR2 (Murphy et al., 2000; Wolf et al., 1998). CXCR2 is the major receptor involved in 
promoting neutrophil mobilisation from the bone marrow into the blood stream, and is also 
crucial for neutrophil recruitment to sites of inflammation both in humans and mice (Eash, 
Greenbaum, Gopalan, & Link, 2010; Sabroe, Jones, Whyte, & Dower, 2005). The interaction 
of these chemokines with CXCR1 and/or CXCR2 triggers the extravasation and subsequent 
directed migration of circulating neutrophils to injury sites (Martins-Green, Petreaca, & 
Wang, 2013; Murdoch & Finn, 2000). 
IL-8 binding to CXCR1 or CXCR2 leads to the activation of pertussis toxin (Ptx)-
sensitive Gαi/o–type G proteins and their many downstream pathways, including 
phospholipase C, which, results in the formation of the PKC activator DAG and of IP3 which 
elevates the cytosolic calcium concentration (Richardson, Marjoram, Barak, & Snyderman, 
2003; Richardson, Pridgen, Haribabu, Ali, & Snyderman, 1998). Unlike several other 
neutrophil GPCRs, CXCR1 and CXCR2 are constitutively expressed on the plasma membrane 
rather than being stored in secretory vesicles or granules, presumably to ensure instant 
activation by immobilised IL-8 on the endothelial surface during neutrophil recruitment. 
However, like most GPCRs, CXCR1 and CXCR2 are rapidly down-regulated from the 
neutrophil surface upon activation by IL-8, by clathrin-mediated internalization, which as 
usual is followed by proteolytic degradation in lysosomes or by recycling back to the 
neutrophil surface (Samanta, Oppenheim, & Matsushima, 1990). During this process, CXCR2 
internalises more rapidly and recovers to normal cell surface levels more slowly than CXCR1 
(Barlic et al., 1999; Chuntharapai & Kim, 1995; Feniger-Barish, Ran, Zaslaver, & Ben-Baruch, 
1999; Prado, Suzuki, Wilkinson, Cousins, & Navarro, 1996). Furthermore, CXCR2 is special 
among GPCRs as its proteolytic cleavage upon priming (for example following TNFα 
stimulation) can shed the receptor from the neutrophil surface (Asagoe, Yamamoto, 
Takahashi, Suzuka, et al., 1998; Sabroe et al., 2005). 
1.2.2.4 SDF-1 Receptor 
CXCR4, the receptor for stromal cell-derived factor 1 (SDF-1, CXCL12), is another important 
chemokine receptor in neutrophils, which plays a key role in maintaining neutrophil 
homeostasis by counter-acting the effects of CXCR2 in the bone marrow, signalling to 
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prevent neutrophils from being mobilised prematurely out of the bone marrow into the 
blood stream (Eash et al., 2010; Link, 2005; von Vietinghoff, Asagiri, Azar, Hoffmann, & Ley, 
2010). CXCL12 is constitutively produced in the bone marrow and essential for retaining 
mature neutrophils there by binding to CXCR4 (De Filippo & Rankin, 2018). High levels of 
CXCL12 are expressed by ‘CXCL12-abundant reticular’ (CAR) cells, but also other stromal cells 
of the bone marrow, including osteoblasts (Strydom & Rankin, 2013; Sugiyama, Kohara, 
Noda, & Nagasawa, 2006). In neutrophils freshly isolated from bone marrow, the levels of 
CXCR4 on the cell surface are low and intracellular levels of CXCR4 are high, whereas in 
medium starved of CXCL12, the cell upregulates CXCR4 onto the surface within hours (De 
Filippo & Rankin, 2018; Martin et al., 2003). These findings suggested receptor 
desensitization and internalization in response to constitutively high local concentrations of 
CXCL12 in the bone marrow microenvironment. Moreover, these data underlined that 
neutrophils receive constant CXCL12 signals, which position them in the bone marrow, 
probably by activating integrin-mediated adhesion to stromal cells (Petty, Lenox, Weiss, 
Poynter, & Suratt, 2009). While high concentrations of CXCL12 retain neutrophils in the bone 
marrow via CXCR4 signalling, low concentrations of CXCR2 ligands produced by endothelial 
cells and megakaryocytes facilitate neutrophil mobilisation via CXCR2 (Strydom & Rankin, 
2013). This signal balance can be shifted in both directions between retention and 
mobilisation. GM-CSF treatment or acute inflammation, which increases blood serum levels 
of GM-CSF and CXCR2 ligands, shifts the balance toward neutrophil mobilisation from the 
bone marrow (Kohler et al., 2011; Semerad et al., 2002). GM-CSF, can lead both to the 
downregulation of CXCL12 levels in the bone marrow or enhance the release of CXCR2 
ligands from endothelial cells or megakaryocytes. The same shift toward neutrophil 
mobilisation occurs in mice with conditional gene deletion of CXCR4 or CXCL12 (Eash, 
Means, White, & Link, 2009; Tzeng et al., 2011). 
The plasticity of neutrophil responses to chemotactic cues allows these cells to use 
various navigation strategies to reach sites of inflammation and infection (Lammermann & 
Kastenmuller, 2019). Intravital microscopy studies using mice with GPCR-deficient 
neutrophils and/or use of blocking antibodies has provided insight into how different GPCRs 
cooperate to arrange the physiological and pathological trafficking paths of neutrophils and 
has revealed a hierarchy of directional cues. For example, several studies have reported that 
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over-stimulation of C5aR1 due to high levels of C5a production has major consequences in 
sepsis and anaphylaxis, and provides a potential therapeutic target for the treatment of 
acute inflammatory conditions (Czermak et al., 1999; Guo & Ward, 2006; Herrmann et al., 
2018; Karasu, Nilsson, Kohl, Lambris, & Huber-Lang, 2019). Moreover, signalling through the 
fMLP receptor FPR1 has been seen to be required for interstitial chemotaxis in the necrotic 
zone during a sterile inflammation model of heat-induced liver necrosis, whereas signalling 
through CXCR2 was shown to be crucial for the extravasation of neutrophils (McDonald et 
al., 2010). In a mouse skin wound model, the chemokine leukotriene B4 (LTB4), which binds 
to the GPCR BLT, was shown to be critical for neutrophil infiltration into the inflamed skin, 
followed by neutrophil swarming which required CXCR2 and fMLP receptors (de Oliveira, 
Rosowski, & Huttenlocher, 2016). 
 
1.3 Small GTPases 
The Ras superfamily of small G proteins consists of 166 human members that regulate a 
multitude of cellular functions, including cell growth, proliferation, differentiation, 
morphology, motility and intracellular transport. Most of them can be can be subdivided into 
five families (Ras, Rab, Arf, Ran and Rho), and specific cellular functions can be assigned to 
each family. In general terms, the Ras-family regulates gene expression and proliferation, the 
Rho-family cytoskeletal reorganisation, the Ran-family nucleo-cytoplasmic transport and the 
Rab and Arf-families direct intracellular vesicle trafficking (Takai, Sasaki, & Matozaki, 2001; 
Wennerberg, Rossman, & Der, 2005). 
1.3.1 Rho GTPases 
The Rho-family includes 21 members, including Rac1, RhoA and Cdc42 (Burridge & 
Wennerberg, 2004). They regulate cytoskeletal organisation, cell adhesion and migration, 
ROS production, vesicular transport, gene expression and cell division (Nathan, 2006; Weiss, 
1989). One of the best-characterised Rho-family functions is their control of cell migration 
via regulation of the actin cytoskeleton. Rac1, RhoA and Cdc42 regulate the formation of 
membrane ruffles/lamellipodia, actin stress fibres and filopodia respectively, thus 
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modulating cell morphology, adhesion and motility (Kay, Langridge, Traynor, & Hoeller, 
2008; Ley et al., 2007). 
Typically, the activity of Rho-family GTPases is regulated by cycling between an active 
(GTP-bound) and inactive (GDP-bound) state, under the control of guanine-nucleotide 
exchange factors (GEFs) and GTPase-activating proteins (GAPs) (Figure 1.6). GEFs catalyse 
the exchange of GDP for free GTP, which is available in excess in eukaryotic cells, thus 
activating the small G protein which adopts a conformation that allows it to bind to its 
downstream effectors. GAPs bind the GTP-bound small G-proteins and stimulate their 
intrinsic GTPase activity, thus accelerating the hydrolysis of GTP to GDP and Pi, and 
inactivating the small G protein (Stephens et al., 2008). An extra level of regulation involves 
the interaction of Rho-GTPases with guanine-nucleotide dissociation inhibitors (GDIs) 
(Michaelson et al., 2001). GDIs play a dual inhibitory regulatory role by preventing GDP-
dissociation (and thus GDP-GTP exchange) from the Rho protein, as well as blocking the 
translocation of the Rho protein from the cytoplasm to the plasma membrane, thus holding 
it in an inactive state within the cytoplasm. GDIs prevent Rho proteins from translocating to 
the membrane by binding with high affinity and so shielding the prenylated C-terminus of 
the GTPase, which serves to anchor these proteins in the membrane (Michaelson et al., 










Figure 1.6: Regulation of Rac activity 
Diagram representing the regulation of classically regulated Rho family Small G proteins, such as Rac, 
showing the cycle between the inactive GDP-bound and the active GTP-bound conformation. The activation 
of the small G protein into its GTP-bound conformation is regulated by the action of a guanine-nucleotide 
exchange factor (GEF) which catalyses the exchange of GDP for GTP, whereas inactivation is mediated by a 
GTPase activating protein (GAP) which catalyses the hydrolysis of GTP to GDP. The active form of the small G 
protein interacts with effectors to mediate downstream signalling. In addition to this, guanine nucleotide 
dissociation inhibitors (GDIs) sequester inactive Rho-family small G proteins by burying the hydrophobic 
prenyl modification of the small G protein within a pocket of the GDI, thus promoting their cytosolic 
localisation. In addition, GDIs inhibit nucleotide dissociation from the G protein. Figure adapted from 
(Pantarelli and Welch 2018). 
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1.3.2 Rac GTPases  
Rac (Ras-related C3 botulinum toxin substrate) proteins are small G proteins (GTPases) of 
the Rho family (Heasman & Ridley, 2008; Wennerberg et al., 2005), and consist of four 
isoforms: Rac1, Rac2, Rac3 and RhoG. The Rac2 and Rac3 isoforms are 92% identical to Rac1 
in amino acid sequence (Hajdo-Milasinovic, Ellenbroek, van Es, van der Vaart, & Collard, 
2007), whereas RhoG is 72% identical to Rac1 (Wennerberg & Der, 2004). There is also a 
splice variant of Rac1, Rac1b, which contains a 19 amino acid insertion near the switch II 
region. 
Rac1 and RhoG are both ubiquitously expressed, whereas Rac2 is restricted to cells of 
the haematopoietic lineage (Wennerberg & Der, 2004), and Rac3 is mainly found in neurons 
(Haataja, Groffen, & Heisterkamp, 1997). In contrast, Rac1b expression is largely restricted 
to cancer cells, particularly in breast and colon cancer (Jordan, Brazao, Boavida, Gespach, & 
Chastre, 1999; Schnelzer et al., 2000). Rac1 and Rac2 differ in the C-terminal region in seven 
of the fifteen most C-terminal residues, attributing a charge of +7 and +4 for Rac1 and Rac2 
respectively (Magalhaes & Glogauer, 2010). It has been proposed that this may result in a 
different localisation of active Rac1 and Rac2 in neutrophils where Rac1 is localised at the 
plasma membrane whereas Rac2 localises to internal membranes (Kraynov et al., 2000; 
Michaelson et al., 2001).  
The members of the Rac-like subfamily are classically regulated by GEFs, GAPs and 
GDIs, as described in section 1.3.1, except that they show relatively high intrinsic GTPase 
activity, and thus have a propensity to auto-inactivate (Wennerberg & Der, 2004). The only 
exception is Rac1b, which cannot bind to Rho-GDI and has reduced intrinsic GTPase activity, 
hence it is mainly bound to the plasma membrane and displays constitutive activity (Fiegen 
et al., 2004; Matos, Collard, & Jordan, 2003). 
1.3.2.1 Rac functions 
Rac-GTPases control the structure of the actomyosin cytoskeleton by signalling through 
several pathways. Active Rac induces lamellipodia formation and membrane ruffling 
(Machesky & Hall, 1997). Lamellipodia are large sheet-like protrusions attached to the 
substratum that form at the leading edge of migrating cells. Membrane ruffles are part of 
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the lamellipodium that have detached from the substratum and folded backwards. The 
formation of lamellipodia is achieved by Rac through the activation of IRSp53 and WAVE, 
which couples to the actin-nucleating protein Arp2/3 (Machesky & Insall, 1998; Miki, 
Suetsugu, & Takenawa, 1998). This results in the formation of actin filaments into a 
branched network structure at the cell edge. In addition to this, the activation of the protein 
kinase Pak by Rac can also guide lamellipodia formation by regulating the cofilin-dependent 
turnover of actin downstream of LIM-kinase activity (N. Yang et al., 1998). Finally, Rac also 
regulates gene expression through kinases such as Pak and Jnk, which signal to a range of 
downstream effectors, including transcription factors (Baker, Pan, & Welch, 2016). 
1.4 Rac-GEFS 
Rac family small G proteins can be activated by two types of guanine nucleotide exchange 
factors (GEFs), Dbl-type and DOCK-type. Although these GEFs have distinct catalytic domains 
(DH and DHR2 domains, respectively), they work in a similar way to catalyse the exchange of 
GDP for GTP, and thus induce the active conformation of Rac, which is able to bind 
downstream effector proteins and induce a wide variety of cellular functions. 
This thesis focuses on Rac-GTPases and the Dbl-type Rac-GEF P-Rex1 in neutrophil 
responses; therefore, a more extensive description of the roles of these proteins within their 
pathways can be found in Section 1.5. 
1.4.1 P-Rex1 
The phosphatidylinositol-3,4,5-trisphosphate-dependent (PREX) protein family consists of P-
Rex1, P-Rex2 and the splice variant P-Rex2b. P-Rex1 and P-Rex2 have similar size, 185 kDa 
and 183 kDa, respectively, whereas the P-Rex2b splice variant is 112 kDa. P-Rex1 was the 
first of the family to be identified, during a search for factors that activate Rac in response to 
the second messenger PIP3 (Welch et al., 2002). Part of this introduction on P-Rex is taken 




1.4.2 P-Rex Structure 
P-Rex family GEFs are multi-domain proteins that have a catalytic N-terminal Dbl homology 
(DH) domain which confers Rac-GEF activity, in tandem with a C-terminally adjacent 
pleckstrin homology (PH) domain. The DH/PH domain tandem is characteristic for Dbl-type 
Rho-GEFs (Rossman, Der, & Sondek, 2005). The PH domain of P-Rex1 binds PIP3 and thereby 
contributes to membrane attachment. Following the DH/PH domains there are two 
Dishevelled, EGL-10, Plekstrin (DEP) domains and two Postsynaptic-density protein, Disc 
large, Zona occludens-1 (PDZ) domains. These domains commonly participate in protein-
protein interaction. The C-terminal half of P-Rex1 and P-Rex2 consists of a large inositol 
polyphosphate 4-phosphatase (IP4P) like domain that lacks phosphatase activity. This last 
domain is absent in the P-Rex2b splice variant (Figure 1.7). The crystal structure of the P-
Rex1 DHPH tandem (Figure 1.8) has recently been solved in complex with constitutively 
active (G12V) Rac1 (Lucato et al., 2015) or nucleotide-free Rac1 (Cash, Davis, & Tesmer, 
2016) and has served as a template for modelling these proteins in complex with Gβγ 





Figure 1.7: Multi-domain structure of P-Rex family Rac-GEFs 
PREX1 and PREX2 are Dbl-type Rho-GEFs and share an identical domain structure. At their N-terminus, they 
have a DH domain, which confers Rac-GEF activity, in tandem with the adjacent PH domain, which binds PIP3 
followed by two DEP, and two PDZ protein interaction domains. In their C-terminal half there is an inositol 
polyphosphate 4-phosphatase (IP4P) domain, which harbours no phosphatase activity and has weak homology 






Figure 1.7: Crystal structure of the catalytic core of P-Rex1 
Crystal structure of the DHPH domain tandem of P-Rex1 (electrostatic surface view) in complex with Rac1, 
shown alongside modelling of G and PIP3 binding. This research was originally published in the Journal of 
Biological Chemistry (Lucato et al. 2015 © the American Society for Biochemistry and Molecular Biology) 
and is reproduced here with kind permission from the authors. The crystal structure confirmed that 
residues Glu56 and Asn238 in the P-Rex1 DH domain are crucial for Rac1 binding, and that the DH domain is 
sufficient for catalysis. The modelling suggested furthermore that PIP3 and G binding sites are situated 
away from the Rac1 binding site and that G contacts both the P-Rex1 DH and PH domains. Cash et al. 
(2016) reported a similar structure and also crystalized the PH domain in complex with the soluble PIP3 









1.4.3 P-Rex tissue distribution 
P-Rex1 was first discovered in neutrophils, where it makes up 0.1% of the cytosolic protein 
(Welch, Coadwell et al. 2002). However, P-Rex1 is also expressed in other types of 
leukocytes, like macrophages (Z. Wang, X. Dong, Z. Li, J. D. Smith, & D. Wu, 2008), as well as 
in platelets (Aslan et al., 2011; Qian et al., 2012a), endothelial cells (Carretero-Ortega et al., 
2010) and neurons (Yoshizawa et al., 2005), and at lower levels in many other cell types. 
Northern blot and western blot studies on mouse tissues have found that P-Rex1 is 
expressed widely throughout the brain and is also present in bone marrow, thymus, spleen, 
lymph nodes, and lung (Hill et al., 2005; Welch et al., 2002), whereas P-Rex2 has a more 
widespread distribution (Donald et al., 2004). In adult mice, western blots studies showed 
that P-Rex2 protein is abundant in the brain, especially in the Purkinje neurons of the 
cerebellum, and in the lungs, while a low level of expression is detectable in liver, thymus 
and spleen (Donald et al., 2008; Hodakoski et al., 2014). However, unlike P-Rex1, P-Rex2 is 
not detectable in peripheral blood leukocytes (Damoulakis et al., 2014; Lawson, Donald, 
Anderson, Patton, & Welch, 2011; Welch et al., 2005). Last, P-Rex2b is also absent from 
leukocytes but is expressed in the heart and in endothelial cells (Donald et al., 2008; Z. Li, 
Paik, Wang, Hla, & Wu, 2005; Rosenfeldt, Vazquez-Prado, & Gutkind, 2004). 
1.4.4 P-Rex1 regulation and binding partners 
The structural complexity of P-Rex proteins allows for a number of distinct modes of 
regulation which have been studied in quite some detail (Hornigold K, 2018).  
P-Rex family Rac-GEFs are activated synergistically by PIP3 and Gβγ subunits via the 
DHPH tandem, whereas domains in the C-terminal half of the protein have a negative 
regulatory function, keeping the basal activity of P-Rex low (Barber et al., 2007; Hill et al., 
2005). The Gβγ subunit acts through the DH domain to promote P-Rex GEF activity, while 
PIP3 binds to the PH domain (Hill & Welch, 2006). However, modelling based on the crystal 
structure of the DHPH tandem of P-Rex1 indicated that Gβγ proteins may form contacts with 
elements of both the DH and PH domains (Lucato et al., 2015). Two other proteins are 
known to have direct positive and negative regulatory roles on both P-Rex1 and P-Rex2 
activity, namely activation by PP1α (through dephosphorylation of Ser1165) (Barber et al., 
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2007) and inhibition by PKA (through phosphorylation of Ser436) (Chavez-Vargas et al., 
2016) (Figure 1.9). 
 
 
Figure 1.8: Regulation of P-Rex1 
In basal cells, P-Rex1 is largely cytosolic and has low catalytic activity, due to intramolecular inhibition. In the 
cytosol, P-Rex1 binds constitutively to the serine phosphatase PP1, the GPCR adaptor protein Norbin, the 
protein kinases PKA and mTOR and the gelsolin superfamily adaptor protein FLII. PP1 binds to the RVXF 
motif (residues 1146–1149) of P-Rex1 and dephosphorylates Ser1165, which is sufficient to weakly stimulate 
P-Rex1 Rac-GEF activity. Upon cell stimulation, P-Rex1 is recruited to the plasma membrane, and its GEF 
activity is stimulated synergistically by interactions with PIP3 and with Gβγ proteins. The PIP3 is produced by 
PI3K activity downstream of various receptor types including receptor tyrosine kinases (RTK). In contrast, the 
Gβγ proteins are released from activated GPCRs in response to ligand binding. Other mechanisms of P-Rex1 
activation include Norbin (described later in section 1.6.2) and PP1 (as described hereinabove), as well as 
the phosphorylation of Ser1169 by unidentified serine kinases. Negative regulation: PKA binds to the PDZ1 
domain and inactivates P-Rex1 by phosphorylating Ser436 in the DEP1 domain, which promotes an inhibitory 
intramolecular interaction with the catalytic core. In addition, PKA also regulates (possibly indirectly) an 
intramolecular interaction of the C-terminal half with the catalytic core. The Rac1-GTP-dependent kinase PAK 
can also phosphorylate P-Rex1 directly (at unknown sites) and inhibits P-Rex1 activity (possibly indirectly) 
within cells, which led to the proposal of a negative feedback loop involving P-Rex1, Rac1, and PAK to limit P-




Moreover, PIP3 and Gβγ also control the sub-cellular localisation of P-Rex. Under basal 
conditions, P-Rex1 is located in the cytosol, but in response to PIP3 and Gβγ production, it 
translocates to the plasma membrane. Either PIP3 or Gβγ alone can trigger weak recruitment 
to the plasma membrane but, as with the stimulation of GEF activity, both stimuli are 
required to promote robust membrane localisation of the Rac-GEF (Barber et al., 2007; Zhao 
et al., 2007). Deletion of the DEP tandem, PDZ tandem and IP4P-like domains in P-Rex1 
increases translocation to the plasma membrane suggesting that these domains restrict 
access of the DHPH domain to the membrane, thereby maintaining P-Rex1 in the cytosol 
under basal conditions. Furthermore, GEF activity is not required for the membrane 
translocation of P-Rex1, as a GEF-dead E56A/N238A mutant can still translocate (Barber et 
al., 2007).  
Apart from the regulators described above, the number of binding proteins of P-Rex1 
identified to date is remarkably small. Only proteins known to bind P-Rex1 directly are 
mentioned in Figure 1.9. The Vazquez-Prado lab identified the serine kinase mTOR as a direct 
binding partner of P-Rex1, binding through the DEP domains. Through mTOR, P-Rex1 
interacts with both mTOR-containing protein complexes, TORC1, which is central in cell 
growth, and TORC2 (also known as PDK2), which controls cell morphology and migration. 
The Malliri lab recently performed a SILAC screen to identify proteins that interact with Rac1 
specifically in the presence of P-Rex1. This identified the actin remodelling protein FLII 
(flightless-1 homolog), a member of the gelsolin superfamily, as a P-Rex1 binding protein 
(Marei et al. 2016). P-Rex1 bound directly to FLII, independently of its Rac-GEF activity. P-
Rex1 interacted with the C-terminal GEL domain of FLII (Figure 1.9), whereas Rac1 bound to 







1.4.5 Functional roles of P-Rex1  
In order to study the functional roles of P-Rex family GEFs, our lab has generated Prex1, 
Prex2 and Prex1/Prex2 knockout mouse strains. All strains are fertile but display several 
specific phenotypes, which describe the physiological and pathological effects of these 
proteins, as summarised in this section. 
P-Rex1 is highly expressed in leukocytes, and its functions have mostly been studied 
in neutrophils and macrophages (see section 1.5.1.1). Other roles of P-Rex1 are in 
melanoblast migration during mouse development (Lindsay et al., 2011; Lindsay et al., 2015), 
in social behaviours, associated with a role in hippocampal plasticity (J. Li et al., 2015) and, 
together with P-Rex2, in motor coordination, associated with the control of synaptic 
plasticity in cerebellar Purkinje neurons (Donald et al., 2008; Jackson, Welch, & Bellamy, 
2010). 
Knockdown of endogenous P-Rex1 in neuronal PC12 cells inhibits lamellipodia 
formation, membrane ruffling, spreading and migration (Yoshizawa et al., 2005); however, P-
Rex1 plays no obvious role in neuronal morphology or migration during development 
(Donald et al., 2008). Single nucleotide polymorphisms (SNPs), copy number deletions and 
reduced mRNA levels of PREX1 are seen in children with autism spectrum disorders (J. Li et 
al., 2015). Evaluation of Prex1 knockout mice in behavioural models of autism revealed 
deficits in social recognition, reversal learning and fear extinction (J. Li et al., 2015). Recently, 
a deep learning approach that was used for analysing GWAS data from a large cohort of 
Taiwanese patients with severe depression, and this identified a SNP, rs4810894 adjacent to 
the PREX1 gene as a predictor of the responsiveness to antidepressant treatment (Lin et al., 
2018). However, the functional relevance of the effects of this SNP on antidepressant 
treatment response is yet to be investigated. 
Several studies have associated P-Rex1 with tumour growth and metastasis. P-Rex1 
has a key role in cancer cell proliferation (Wong et al., 2016), and cooperates with platelet-
derived grow factor receptor (PDGFR) to drive cancer cell migration (Campbell et al., 2013). 
P-Rex1 is overexpressed in several cancers via gene amplification (Dillon et al., 2015) or 
changes in epigenetic regulation (Barrio-Real et al., 2014; Wong et al., 2011). P-Rex1 mRNA 
is up-regulated in breast, prostate, thyroid, lymphoid, ovarian, adrenal, and kidney cancers 
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(Barrio-Real et al., 2014; Sosa et al., 2010), as well as in melanoma (Barrio-Real et al., 2014; 
Lindsay et al., 2011; Sosa et al., 2010). At the protein level, P-Rex1 overexpression has been 
observed in breast cancer, (Lindsay et al., 2011; Montero, Seoane, Ocana, & Pandiella, 2011; 
Sosa et al., 2010), prostate cancer (Qin et al., 2009), and melanoma (J. H. Wang et al., 2017). 
P-Rex1 signalling has been extensively studied in breast cancer, but there is still controversy 
in the literature over whether P-Rex1 contributes to mitogenic signalling in breast cancer 
cells (Barrio-Real et al., 2018; Dillon et al., 2015; Kazanietz, Barrio-Real, Casado-Medrano, 
Baker, & Lopez-Haber, 2018; H. J. Liu et al., 2016; Lopez-Haber, Barrio-Real, Casado-
Medrano, & Kazanietz, 2016). 
A few reports link P-Rex1 to metabolism. P-Rex1 was shown to mediate insulin 
signalling in several studies (Balamatsias et al., 2011; Ghalali, Wiklund, Zheng, Stenius, & 
Hogberg, 2014; E. K. Kim et al., 2012; Montero, Seoane, & Pandiella, 2013) and was show to 
be important for the insulin-stimulated upregulation of the glucose transporter GLUT4 into 
the plasma membrane of adipose cells (Balamatsias et al., 2011). Furthermore, P-Rex1 was 
shown to regulate the thermogenic potential of human brown adipose tissue (Xue et al., 
2015). SNP analysis also suggested a potential linkage for P-Rex1 to the likelihood of obesity 
developing into type 2 diabetes (Lewis et al., 2010). However, there has been no 
investigation yet into the importance of P-Rex1 in metabolism in vivo. Therefore, another 
PhD student in our lab, Elpida Tsonou, has been investigating the roles of P-Rex1 in glucose 
homeostasis, and has discovered a role in glucose tolerance (unpublished data). 
P-Rex1 has been shown to be required for pulmonary fibrosis, a late phase of 
pulmonary inflammation which can result in loss of lung function. Prex1 knockout mice 
exhibited reduced early leukocyte infiltration and development of fibrosis, in a bleomycin-
induced model of pulmonary fibrosis which drastically increased survival (Liang et al., 2016). 
In addition to neutrophils, P-Rex1 is also expressed in platelets (Qian et al., 2012b). 
Prex1 knockout mice show mild defects in haemostasis, and GPCR-dependent aggregation 
and dense granule secretion is partially impaired in Prex1-deficient platelets (Qian et al., 
2012b). However, P-Rex1/Vav expression in platelets was found to be important for the 
platelet-dependent vascular adhesion and recruitment of neutrophils and eosinophils (Pan 
et al., 2015) (see section 1.5.2). 
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Finally, a recent study has shown that P-Rex1 protein is upregulated in the lung of 
asthma patients. P-Rex1 overexpression stimulated the proliferation of primary airway 
smooth muscle cells derived from patients with asthma, in response to stimulation with 
either PDGF or EGF, whereas downregulation of P-Rex1 in these cells had the opposite 
effect, suggesting that P-Rex1 might contribute to the development of airway hyper-
responsiveness (AHR) in asthma. However, further studies are required to elucidate the 
exact role of P-Rex1 in this process (Y. Huang et al., 2019). 
 
1.5 Rac-GTPases in neutrophils 
Part of this introduction on Rac-GTPases and Rac-GEFs has been adapted from a recent 
review which I co-authored (Pantarelli & Welch, 2018).  
Among Rac-GTPases, neutrophils express the ubiquitous isoform Rac1, the 
haematopoietic Rac2, and the widely expressed RhoG, but not the neuronal isoform Rac3 
(Baker et al., 2016; Pantarelli & Welch, 2018). These GTPases are key regulators of 
neutrophil functions.  
The Rac-dependent pathways that control actomyosin cytoskeletal dynamics (see 
section 1.3.2.1) are central to neutrophil adhesion and spreading, as well as to the formation 
of the leading edge during polarisation which provides force to push the plasma membrane 
forward to allow the cell to migrate (Johnsson et al., 2014; Ridley, 2015) (Figure 1.10). 
Indeed, the use of photoactivatable Rac has shown that localised activation of Rac at the 
leading edge is sufficient for inducing directional neutrophil migration in zebrafish (Yoo et 
al., 2010). As well as cell morphology, adhesion, polarisation and migration, Rac-GTPases 
also control other neutrophil responses that require cytoskeletal dynamics, such as 
phagocytosis and degranulation. Furthermore, as mentioned in section 1.1.3.1, active Rac2 is 
an integral part of the NADPH oxidase enzyme complex, and is thus directly involved in ROS 
production. In turn, ROS is required to make NETs, and both are crucial responses for killing 





Figure 1.9: Rac-dependent neutrophil responses 
One of the key molecular mechanisms underlying neutrophil responses is the small G protein Rac. Rac 
controls diverse processes, includings adhesion and spreading, migration, degranulation, phagocytosis and 
ROS formation, as well as contributing to gene regulation. The pathways depicted are thought to be 
important in all cell types, but not all have been specifically studied in neutrophils. Figure adapted from 
(Pantarelli & Welch, 2018). 
 
Rac1 and/or Rac2 deficient mouse models have been used to study the role of Rac1 
and Rac2 in neutrophil functions. Global Rac1 deficiency is embryonic lethal in mice, but 
drug-inducible conditional Rac1-deficiency in myeloid cells results in neutrophils with a 
migration defect (Gu et al., 2003). The cells can still move (Glogauer et al., 2003) but are 
unable to migrate directionally within a chemotactic gradient (Sun et al., 2004). In vivo, mice 
with conditional Rac1-deficiency, show impaired neutrophil recruitment during sterile 
peritonitis (Glogauer et al., 2003) and during acute fMLP-induced lung inflammation (Filippi, 
Szczur, Harris, & Berclaz, 2007). Furthermore, from work on macrophages, it is known that 
Rac1 is also necessary for FcR-mediated phagocytosis (Massol, Montcourrier, Guillemot, & 
Chavrier, 1998). 
In contrast to Rac1, which controls cell spreading and directional migration, Rac2 is 
critical for neutrophil migration overall. Indeed, Rac2-deficient mice show reduced actin 
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polymerisation, L-selectin-dependent rolling and integrin-dependent spreading, and are 
unable to form stable leading edges and thus exhibit defects in neutrophil migration (Gu et 
al., 2003; Roberts et al., 1999; Troeger & Williams, 2013). Consequently, neutrophil 
recruitment is reduced in Rac2-deficient mice during sterile peritonitis and during immune-
complex induced acute lung injury (Dooley et al., 2009). Interestingly, Rac2-deficient 
zebrafish larvae also show reduced neutrophil recruitment to cut wounds and poor 
immunity against P. aeruginosa infections (Keszei & Westerberg, 2014). 
As mentioned above, in addition to their role in neutrophil migration and 
recruitment, Rac proteins also regulate other neutrophil responses. Isolated neutrophils 
from Rac2-deficient mice have a defect in superoxide production (C. Kim & Dinauer, 2001), 
and ROS production in Rac2-deficient cells can be restored by the reintroduction of wild-type 
Rac2 using retrovirus-mediated gene transfer (Filippi et al., 2004). Rac2-deficient murine 
neutrophils have reduced exocytosis of azurophil granules (Abdel-Latif et al., 2004; Gu et al., 
2003). In vivo, they have reduced immunity to the pathogen A. fumigatus (Roberts et al., 
1999). 
While no Rac1 mutation is known to cause human immunodeficiency, a rare 
dominant-negative mutation in Rac2 (D57N) results in severe neutrophil dysfunction. This 
mutation causes an inability for neutrophils to be recruited to sites of infection and to clear 
infections, due to a marked deficiency in adhesion and chemotaxis, as well as an inability of 
neutrophils to kill ingested microbial targets, due to reduced ROS production and release of 
primary granules (Accetta et al., 2011; Ambruso et al., 2000; Williams et al., 2000). 
Rac1 and Rac2 have non-redundant roles in neutrophil migration. Consequently, 
combined deficiency of Rac1 and Rac2 has more severe effects. It abolishes neutrophil 
recruitment to lungs infected with E. coli (Koh, Sun, Zhu, & Glogauer, 2005). It also delays 
recruitment into the synovial fluid of inflamed joints in an arthritis model triggered by C. 
trachomatis infection. This ameliorates the acute phase but causes more severe disease 
during the chronic phase (Zhang et al., 2005). Interestingly, reduced levels of Rac1 (and 
other Rho-GTPases and their regulators) were recently linked to the upregulation of 
microRNAs in human myelodysplastic syndrome, a condition characterised by a range of 
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functional neutrophil defects (Cao et al., 2017). However, further study is required to 
establish causal relationships and specificity. 
Finally, the Rac-GTPase RhoG can signal upstream of Rac1 and Rac2, and might 
therefore be expected to have similar importance for neutrophil adhesion and migration. 
Indeed, RhoG does contribute to full polarisation of actin filaments at the leading edge of 
chemoattractant-stimulated neutrophils. However, unlike Rac1 and Rac2, RhoG is 
dispensable for the chemoattractant-stimulated actin polymerisation and migration of 
mouse neutrophils, as well as for neutrophil recruitment during sterile peritonitis, and seems 
therefore to play an unexpectedly minor role in neutrophil responses (Condliffe et al., 2006; 
Damoulakis et al., 2014). 
1.5.1 Neutrophil Rac-GEFs 
Several Rac-GEFs are known to have important roles in controlling neutrophil function 
(Figure 1.11). Among the 20 Dbl-family and 7 DOCK-family Rho-GEFs that are known to 
catalyse the activation of Rac, only a subset of these are known to be expressed in 
neutrophils. These include, P-Rex1 (Welch et al., 2002), Vav1, 2, and 3 (Gakidis et al., 2004), 
Pixα (Z. Li et al., 2003) and Tiam2 from the Dbl-family (Boespflug et al., 2014), as well as 
DOCK2 and DOCK5, which are from the DOCK family (Kunisaki, Nishikimi, et al., 2006). 
These GEFs show preferences for activating different Rac isoforms, which are 
determined by the precise structure of their catalytic DHPH or DHR2 domains, for Dbl and 
DOCK-type Rac-GEFs, respectively. Some Rac-GEFs can also activate other types of Rho-
GTPases. For example, Vav can activate RhoA as well as Rac (Bustelo, 2014). In addition to 
their catalytic domains, Rac-GEFs have varied multidomain structures that couple each GEF 
to specific upstream and effector proteins. Together, these mechanisms determine the cell 
responses controlled by Rac (Baker et al., 2016; Lawson & Ridley, 2018). Therefore, the 
activity of Rac-GEFs must be tightly regulated, through a combination of mechanisms, 
including phosphorylation, protein and lipid binding, unique to each type of GEF (Lawson & 





Figure 1.10: Signalling pathways of neutrophil Rac-GEFs 
The Rac-GEF P-Rex1, which mediates signalling through GPCRs, E-selectin and TLR4 (not all shown here for 
simplicity), is activated by the lipid second messenger PIP3 and by the G subunits of heterotrimeric G 
proteins. The Vav family Rac-GEFs, which are activated by tyrosine phosphorylation, are important in 
integrin and FcR signalling, but they also couple to TLR4 and GPCRs. It is currently unknown, which 
mechanisms control Tiam2 in neutrophils, except that this GEF controls chemoattractant induced 
responses. DOCK2 also signals upon GPCR stimulation. It is activated by RhoG and recruited to the plasma 
membrane by PIP3 and phosphatidic acid (PA). The preferred Rac isoform for each Rac-GEF is shown here, 
but usually, the GEFs can activate both Rac1 and Rac2 to some extent. P-Rex1 can also activate RhoG and 
may thus signal in sequence with DOCK2 in some pathways. Figure adapted from (Pantarelli & Welch, 2018). 
 
A central mechanism of neutrophil regulation is the lipid second messenger 
phosphatidylinositol-(3,4,5)-trisphosphate (PIP3), which is produced by phosphoinositide 3-
kinase (PI3K) within the cell membrane (McCormick, Chu, & Vermeren, 2019). Without PIP3, 
neutrophils cannot generate stable polarity and migration (Hawkins & Stephens, 2015; 
Norton et al., 2016). PIP3 localizes several Rac-GEFs, and other signalling proteins, to the 
plasma membrane and activates some directly, by binding to their PH domain. This enables 
the activation of Rac at the cell periphery which confers the firm adhesion and spreading of 
neutrophils. Polarized production of PIP3 and activation of Rac induce the formation of a 
leading edge, neutrophil polarisation and migration (Johnsson et al., 2014). Importantly, 
42 
 
PIP3-dependent regulation of neutrophil Rac-GEFs always occurs in conjunction with other 
signalling mediators that are unique to each GEF. One such example is P-Rex1, which is 
activated both by PIP3 and by the Gβγ subunits of heterotrimeric G proteins, as described in 
section 1.5.1.1. 
P-Rex1 is known to signal downstream of GPCRs, E-selectin and TLR4 in mouse 
neutrophils (Welch, 2015). Like P-Rex1, the Rac-GEF DOCK2 also signals in response to GPCR 
stimulation. However, in contrast to P-Rex1, DOCK2 is activated by the binding of active 
RhoG to its adaptor protein ELMO, and it is recruited to the plasma membrane by PIP3 and 
phosphatidic acid (PA), a product of phospholipase D (PLD) or diacylglycerol (DAG) kinase 
activity (Damoulakis et al., 2014; Nishikimi et al., 2009) (see scheme in Figure 1.5). 
Interestingly, P-Rex1 can also activate RhoG and may thus signal in sequence with Dock2 in 
some pathways (Damoulakis et al., 2014). Upon GPCR stimulation, P-Rex1 can activate RhoG 
as well as Rac1 and Rac2. As active RhoG is an upstream regulator of DOCK2 (through Elmo), 
P-Rex1 might signal through RhoG to activate DOCK2. Vav family Rac-GEFs, instead, are 
activated by protein tyrosine kinases downstream of various types of receptors, including 
integrins, FcR, GPCRs and TLR4 (Bustelo, 2014). Tiam2 is another Rac-GEF that has been 
discovered relatively recently in neutrophils and little is currently known about its role in 
these cells (Boespflug et al., 2014). Tiam-family Rac-GEFs are generally directly activated by 
Ras and modulated by a variety of mechanisms, including phosphorylation, and they 
translocate to the plasma membrane upon binding PIP3 (Boissier & Huynh-Do, 2014). In 
neutrophils, Tiam2 was shown to regulate chemoattratant-stimulated responses. However, 
the mechanisms of Tiam2 regulation in these cells remain to be elucidated. 
1.5.1.1  P-Rex1 
The description of P-Rex structure, mechanism of regulation, binding proteins and functions 
in other cell types than neutrophils was described in Section 1.4.1. The following section 
described the role of P-Rex1 in neutrophils. 
The first study on P-Rex1 showed that knockdown of P-Rex1 in neutrophil-like NB4 
cells provided the first evidence that P-Rex1 is important for myeloid cell function reducing 
fMLP-stimulated ROS production (Welch et al., 2002). Since then, most our current 
understanding of the role of P-Rex1 in neutrophils has been obtained through studies using 
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genetically modified mice. Prex1 knockout murine neutrophils have been shown to have 
reduced GPCR-dependent Rac2 and RhoG activity, whereas Rac1 activity was comparatively 
unchanged, thus demonstrating that P-Rex1 acts primarily on Rac2 and RhoG in neutrophils 
(Welch et al., 2005). 
The chemotaxis of isolated Prex1 knockout neutrophils, as well as F-actin 
polymerisation and polarisation, are only partially reduced when compared to wild-type. 
They also have a migration defect, which comes from a reduction in cell speed 
(chemokinesis), whereas the directionality of migration (chemotaxis) is normal (Dong et al., 
2005; Welch et al., 2005). However, in vivo, Prex1 knockout mice show a profound 
impairment in neutrophil and macrophage recruitment during sterile and septic 
inflammation (Welch et al., 2005). P-Rex1 mediates the E-selectin-dependent activation of 
the neutrophil integrin LFA-1 under flow conditions, thus controlling the slow rolling of 
neutrophils along the endothelial vessel wall, as well as the activation of the integrin Mac-1, 
to regulate neutrophil crawling along the vessel wall (J. M. Herter, Rossaint, Block, Welch, & 
Zarbock, 2013). Isolated Prex1 knockout neutrophils also show a substantial defect in GPCR-
dependent ROS production when primed with lipopolysaccharide, whereas this defect is less 
pronounced in unprimed or TNFα-primed cells, suggesting that P-Rex1 controls neutrophil 
priming through TLR4 (Welch et al., 2005). 
1.5.1.2  Vav 
The Vav family consists of three members, Vav1, Vav2 and Vav3. They can activate all Rac 
isoforms, including RhoG, as well as Cdc42 in vitro and in vivo, although their cellular activity 
against Cdc42 is disputed and seems to be context dependent. Moreover, they can also 
activate RhoA in vitro but possibly not in vivo (Bartolome et al., 2006; Movilla, Dosil, Zheng, 
& Bustelo, 2001; Turner & Billadeau, 2002).  
Vav-family GEFs have a molecular weight of approximately 100 kDa and are 
characterised by similar domain structures: the catalytical DH/PH domain tandem, a 
calponin homology CH domain, an acidic domain (AD), a zinc finger domain, a short proline-
rich region and two SH3 domains flanking a single SH2 domain. The SH2 domain mediates 
recruitment of Vav to cytoplasmic or receptor-associated tyrosine kinases (Bustelo, 2000). 
Uniquely among Rho GEFs, the Vav family are largely controlled by tyrosine-phosphorylation 
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dependent relief of inhibitory intramolecular interactions. Their most important and highly 
conserved tyrosine residue, Tyrosine 174 in Vav1 (Tyr 173 in Vav3), are located in the SH2 
domain and AD domain respectively (Bustelo, 2002). Non-phosphorylated Vav-proteins are 
inactive in a “closed” conformation mediated by intramolecular interactions between the 
CH-AD region and the catalytic DH-PH domain. Upon phosphorylation of the SH2 domain 
(Y174 in Vav1) by Src- and Syk- family kinases, these interactions are lost and the active 
catalytic site is released in order to initiate activation of Rac and of Rac-dependent responses 
(Aghazadeh, Lowry, Huang, & Rosen, 2000; Bustelo, 2014; Han et al., 1997). 
Among Vav family GEFs, all three isoforms are expressed in white blood cells, and 
only Vav1 is haematopoietic cell specific (Turner & Billadeau, 2002). In neutrophils, Vav3 is 
expressed 30-fold more than that of Vav1, and 150-fold more than Vav2 (Gakidis et al., 
2004).  
Vav-family GEFs are best known for being activated downstream of RTKs, integrins, 
Fc receptors and cytokine receptors (e.g. TNFα and GM-CSF receptors). The SH2 domains 
mediates Vav recruitment to activated receptors, either by direct binding to RTKs or through 
intracellular protein tyrosine kinase signalling complexes which are formed upon receptor 
activation (Bustelo, 2000). 
Vav Rac-GEFs are required for neutrophil adhesion and spreading upon GPCR 
stimulation and for complement or Fc receptor-induced phagocytosis and ROS formation 
(Gakidis et al., 2004; C. Kim, Marchal, Penninger, & Dinauer, 2003; Utomo, Cullere, Glogauer, 
Swat, & Mayadas, 2006). Mice lacking Vav1 and/or Vav3 or the entire Vav family have been 
used to study the functional roles of these GEFs in neutrophils (Swat & Fujikawa, 2005). 
However, deletion of either single Vav isoforms or combinations show only mild or no 
defects in migration, suggesting that, just like the P-Rex family, the Vav family alone is not 
enough for neutrophil migration. Specifically, Vav1-deficient neutrophils have an impairment 
in fMLP-stimulated actin polymerisation and chemotaxis (C. Kim et al., 2003). They also show 
reduced Mac-1-dependent crawling under flow conditions, both in vitro and in MIP-2 
inflamed cremaster muscle venules (Phillipson et al., 2009). However, neutrophils from 
Vav1/Vav3 deficient mice can adhere and chemotax towards fMLP, but show defects in 
either FcR- or integrin-dependent adhesion and spreading. This is not seen in cells lacking 
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either Vav isoform alone (Gakidis et al., 2004; Utomo et al., 2006). Furthermore, the firm 
adhesion of neutrophils to fMLP-inflamed cremaster muscle venules is reduced in Vav1/Vav3 
deficient mice (Gakidis et al., 2004). Vav1/Vav2/Vav3 deficient neutrophils (Vav-null) show a 
substantial spreading defect (J. M. Herter et al., 2013). Yet surprisingly, neutrophil 
recruitment is largely normal during sterile peritonitis in Vav1 and Vav1/Vav3 deficient mice 
(Gakidis et al., 2004; C. Kim et al., 2003; Phillipson et al., 2009), upon immune-complex 
deposition in the skin or lung in Vav1/Vav3 deficient mice (Utomo et al., 2008), and during S. 
aureus infection of the lung in Vav-null mice (Graham et al., 2007). Despite this relatively 
normal neutrophil recruitment, Vav-null mice are less able to clear pulmonary infections of 
P. aeruginosa or S. aureus (Graham et al., 2007). This is likely due to a failure in bacterial 
killing rather than impaired recruitment of neutrophils to the site of inflammation, as Vav-
null mice recruit similar numbers of neutrophils to the peritoneal cavity after thioglycollate 
challenge as control mice. In addition, these mice show impaired interstitial neutrophil 
migration during L. monocytogenes infection in the footpad, which suggests a prominent 
role of the Vav family in integrin-independent amoeboid neutrophil migration (Graham et 
al., 2009). Vav3-deficient neutrophils have defects in FcR-dependent phagocytosis and have 
reduced GPCR-dependent ROS formation, which is further exaggerated when cells lack both 
Vav1 and Vav3 (Utomo et al., 2006). Indeed, both Vav1 and Vav3 are essential in some (but 
not all) forms of complement-mediated phagocytosis, as well as Fcγ receptor-dependent 
phagocytosis and ROS production. Neutrophils missing the entire Vav family have partially 
impaired TLR- and GPCR-dependent ROS formation, whereas integrin-dependent ROS 
formation is completely lost. It is clear that the Vav family of GEFs are important for the 
regulation of Rac-dependent functions in neutrophils; however, there is a substantial level of 
redundancy between isoforms. Moreover, recent discoveries from our lab have shown a 
certain level of cooperation between P-Rex1 and Vav1 (see also Section 1.5.2). 
1.5.1.3  PIX 
One further Dbl-type GEF expressed in neutrophils is PIX, which is known to activate both 
Rac and the related GTPase Cdc42 in other cell types. The predominant role of PIXα is in 
neutrophil chemotaxis, regulating directional sensing. However, this GEF was shown to 
activate Cdc42 rather than Rac during chemoattractant signalling (Z. Li et al., 2003). Another 
study suggested that PIXα can directly couple its associated GTPases within a complex 
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containing the kinase Pak1 and the Arf-GAP Git2, thus regulating the membrane localisation 
and activity of Rac1 under similar conditions (Mazaki et al., 2006). In general, the substrate 
specificity of PIXα (Rac vs Cdc42) depends on its dimerisation state, with the binding of G 
subunits turning the GEF monomeric and Cdc42-specific (Feng, Baird, & Cerione, 2004). 
Although this remains to be confirmed, the little literature available suggests that PIXα might 
activate Rac through Gβγ-independent neutrophil signalling pathways. 
1.5.1.4  Tiam 
The Tiam-family Rac-GEF Tiam2 was identified in neutrophils as a target of the transcription 
factor ATF3. When Tiam2 was knocked-down in mouse haematopoietic stem cells that were 
then differentiated in culture into neutrophil-like cells, these cells show an inhibition in 
chemotaxis, but increased fMLP-stimulated actin polymerisation and integrin clustering, 
which suggests that expression of this GEF may limit adhesion rather than promote it as 
other neutrophil Rac-GEFs do (Boespflug et al., 2014). However, the consequences of Tiam2 
expression on other neutrophil responses and on recruitment in vivo remain to be 
investigated. Furthermore, the Tiam2 homologue Tiam1, which is widely expressed, 
including in some types of leukocytes, is currently under investigation in neutrophils by Dr 
Kirsti Hornigold in our lab, and found to regulate specifically adhesion-dependent neutrophil 
responses (unpublished data). 
1.5.1.5  DOCK 
DOCK2 and DOCK5 are the two known DOCK Rac-GEF family members expressed in 
neutrophils. Murine deficiency in these DOCK-type Rac-GEFs causes profound defects in 
neutrophil chemoattractant signalling, thus impairing actin polarisation, leading edge 
formation and migration speed, although these cells retain 2-integrin-mediated adhesion 
and directional sensing (Kunisaki, Nishikimi, et al., 2006; Nishikimi et al., 2009). Defects in 
GPCR-dependent ROS production were also reported in DOCK2 deficient neutrophils, 
although these could possibly be due to defects in the assembly of the NADPH oxidase 
complex because receptor-independent ROS production is also impaired (Kunisaki, Nishikimi, 
et al., 2006). Furthermore, DOCK5 deficiency alone has little effect on neutrophil function. 
However, the use of DOCK2/DOCK5 deficient neutrophils demonstrated that the combined 
deficiency exacerbates the migration impairments caused by DOCK2 deficiency (Kunisaki, 
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Tanaka, et al., 2006; Watanabe et al., 2014). The importance of these DOCK GEFs for 
neutrophil recruitment in vivo remains to be tested. Interestingly, a similar effect on 
migration as the mouse knockout was obtained when treating isolated neutrophils with 
CPYPP, a small-molecule inhibitor of these DOCK GEFs (Watanabe et al., 2014).  
1.5.2 P-Rex1 and Vav1 cooperate in neutrophil responses 
Neutrophils from mice deficient both in Prex1 and in the Vav-family Rac-GEF Vav1 have 
more profound defects in GPCR-dependent Rac activity, ROS formation, adhesion, and 
migration than cells that lack either the whole Prex or the whole Vav family (Lawson et al., 
2011). This suggested that Prex1 and Vav1 can cooperate to generate robust levels of Rac 
activity in neutrophils (Figure 1.12). Furthermore, our lab showed recently that Prex1/Vav1 
and Prex1/Vav3 deficient mice also have more profound impairments in neutrophil 
recruitment than mice lacking either GEF family, thus demonstrating in vivo synergy 
between these GEF families (Pan et al., 2015). In addition to this, intravital imaging revealed 
that this recruitment defect is caused by the loss of L-selectin and E-selectin-dependent 
neutrophil adhesion to the postcapillary endothelial microvasculature prior to extravasation. 
One of the most striking discoveries in this study was the requirement for P-Rex1, Vav1 and 
Vav3 to be expressed in platelets in order to mediate intravascular neutrophil adhesion and 
therefore recruitment in mice (Pan et al., 2015). Indeed, Prex1/Vav deficiency in platelets 
was sufficient to block neutrophil adhesion to the vessel wall. Prex1/Vav1 and Prex1/Vav3 
deficient platelets had low surface levels of the selectin-ligand PSGL-1, and the mice showed 
a reduced occurrence of platelet-neutrophil adhesion in the circulation, which is prerequisite 
for leukocyte extravasation (Pan et al., 2015). Furthermore, platelets expressing of Prex1 and 
Vav were also important for the recruitment of other types of inflammatory cells. During 
allergic inflammation, the pulmonary recruitment of eosinophils, monocytes and 
lymphocytes was compromised by Prex1/Vav1 or Prex1/Vav3 deficient platelets, and airway 
inflammation was essentially abolished in Prex1/Vav1 and Prex1/Vav3 deficient mice, 
resulting in improved airway responsiveness (Pan et al., 2015).  
Functions of P-Rex1 are less well-defined in macrophages and other types of 
leukocytes. Unlike in neutrophils, where Prex1 mainly mediates the activation of Rac2 and 
RhoG, and to a lesser extent Rac1, P-Rex1 is a major Rac1 regulator in macrophages (Z. L. 
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Wang, X. M. Dong, Z. Li, J. D. Smith, & D. Wu, 2008). Experiments with Prex1/Vav deficient 
animals have shown that these GEFs are also required for monocyte and macrophage 






Figure 1.11: P-Rex and Vav family GEFs regulate Rac-dependent neutrophil functions 
Proinflammatory signals activate various neutrophil receptors, including TLRs, FcRs, integrins and GPCRs. 
Vav family GEFs are activated downstream of these receptors via protein tyrosine kinase-dependent 
phosphorylation, whereas P-Rex1 is synergistically activated by the Gβγ subunits released upon GPCR 
engagement and by PIP3, the lipid product of PI3Kγ and possibly other neutrophil class I PI3Ks. P-Rex1 and 
Vav catalyse the GTP-loading of Rac1 and Rac2, which in turn signal to a variety of downstream effectors 





Norbin, also known as neurochondrin or NCDN, is an essential, yet understudied, 79 kDa 
cytosolic adaptor protein. Norbin is a highly conserved protein among vertebrates 
(Mochizuki et al., 1999), without any catalytic activity or homology to other known proteins 
(Shinozaki, Maruyama, Kume, Kuzume, & Obata, 1997). The murine Norbin gene consists of 
7 exons and spans about 10 kb on chromosome 4. The human Norbin protein is leucine rich 
(16% of leucine residues), consisting of 732 amino acids, with a molecular weight of 79 kDa. 
Structurally, it is predicted to consist entirely of armadillo repeats (Dr Simon Andrews, 
Babraham Institute Bioinformatics Facility, personal communication). A shorter splice variant 
has also been identified which lacks transcription from the first exon (Mochizuki-Sakisaka et 
al., 2004b; Mochizuki et al., 1999). 
Norbin distribution was originally thought to be exclusively neuronal (Shinozaki et al., 
1997), however, the protein has been also detected in chondrocytes, osteoblasts and 
osteocytes (Ishiduka et al., 1999), and lately our lab has shown its expression in 
macrophages and neutrophils (Pan et al., 2016). This supported a more general role for 
Norbin protein than previously expected. The expression of Norbin in neutrophils from the 
major focus of my study. 
The protein is mostly cytosolic (Shinozaki, Kume, Kuzume, Obata, & Maruyama, 1999) 
and our knowledge of Norbin’s functions is limited to the nervous system, where the protein 
is crucial. Norbin is abundant in neuronal tissue (Mochizuki et al., 1999), where it positively 
regulates neurite outgrowth and promotes synaptic plasticity (Shinozaki et al., 1999; 
Shinozaki et al., 1997). It was originally discovered in a screen for proteins that are 
upregulated in potassium channel blocker-induced long-term potentiation (LTP) in rat 
hippocampal slices (Shinozaki et al., 1997). Its expression induces neurite outgrowth 
(Shinozaki et al., 1997), whereas knockdown limits it (H. Wang et al., 2013). Two years later 
during an independent screen, Norbin was found capable of regulating the hydroxyapatite 
resorption activity of osteoclasts (Ishiduka et al., 1999). 
Murine Norbin deficiency is early embryonic lethal (Mochizuki et al., 2003; H. Wang, 
Nong, Bazan, Greengard, & Flajolet, 2010), but targeted deletion in mouse neural stem cells 
revealed impairment in spatial learning and sensorimotor gating, causing epilepsy (Dateki et 
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al., 2005; H. Wang et al., 2009). Targeted deletion in postnatal forebrain impairs 
hippocampal plasticity, leading to schizophrenia-like behaviours (H. Wang et al., 2009), and 
deletion in cortical and hippocampal neurons disrupts adult neurogenesis and causes 
depression-like behaviours (H. Wang et al., 2015). These rodent phenotypes may be 
pertinent to humans, as Norbin levels are down-regulated in patients with epilepsy and 
dysregulated in schizophrenia (Matosin et al., 2015; Xu et al., 2017).  
It has also been seen that Norbin is a neuronal target antigen in autoimmune 
cerebellar degeneration (Miske et al., 2017) and anti-Norbin autoantibodies might be 
associated with chorea minor (Rommel et al., 2017). Recently Norbin antibody has been 
identified as a possible new target of autoantibodies against neural cell-surface and 
intracellular antigens in patients with suspected autoimmune encephalitis, epilepsy or 
marked epileptiform activity in electroencephalography (Schumacher et al., 2019). 
Furthermore, clinical studies reported that Norbin antibody is associated with autoimmune 
ataxia (Weihua et al., 2019). 
1.6.1 Norbin in GPCR signalling and trafficking 
Mechanistically, Norbin binds directly to numerous GPCRs (33 GPCRs out of 45 tested in pull 
down studies with recombinant protein). Examples include GPCRs from GPCR superfamily A 
such as the melanin-concentrating hormone receptor-1 (MCHR1), and from GPCR 
superfamily C (mGluR1 and mGluR5). Norbin binds through its own C-terminus at the 
membrane-proximal part of the intracellular C-terminal tail of the GPCR (Francke et al., 
2006; H. Wang et al., 2009; Ward, Jenkins, & Milligan, 2009). It can affect the constitutive 
(agonist-independent) trafficking of these GPCRs to and from the plasma membrane. 
Furthermore, Norbin can affect GPCR signalling, resulting in altered intracellular Ca2+ levels 
and Erk activity (Francke et al., 2006; H. Wang et al., 2009; Ward et al., 2009). For example, 
the interaction of Norbin with melanin concentrating hormone receptor-1 (MCHR1) was 
shown to inhibit the receptors’ Gαi/o and Gαq dependent downstream signalling, but had no 
effect on the MCH-stimulation dependent internalisation of the receptor (Francke et al., 
2006). In contrast, the co-expression of metabotropic glutamine receptor-5 (mGluR5) with 
Norbin had positive effects on the downstream signalling, transiently increasing intracellular 
calcium levels, as well as increasing the constitutive surface expression of the receptor on 
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the neuronal surface, controlling synaptic plasticity (H. Wang et al., 2009). Therefore, the 
regulation of GPCR surface expression and signalling by Norbin is context-dependent with 
regard to the GPCR it couples to. However, it is not possible to predict, from the primary 
structure of the GPCR, whether Norbin can bind to it, although it seems clear that Norbin 
only affects those GPCRs that it can bind to directly. Furthermore, it is not possible to predict 
the effect of Norbin binding on the trafficking and signalling of a GPCR, nor are the 
mechanisms known through which Norbin binding affects the trafficking and signalling of 
GPCRs. However, within a clinical context recent studies show that mGluR5 hypofunction is 
integral to glutaminergic dysregulation in schizophrenia and an altered protein-protein 
interaction of mGluR5 with Norbin suggests that protein-protein interactions in mGluR5-
GluN complexes could play as potential targets for intervention in schizophrenia (Wang et 
al., 2018). 
1.6.2 Interaction between P-Rex1 and Norbin 
As mentioned in section 1.4 above, Rac-GEF activities are often regulated through complex 
formation between the GEF and other cellular proteins (Rossman et al., 2005). However, 
relatively few binding partners of P-Rex1 have been identified (Hornigold K, 2018; Welch, 
2015) (see section 1.4.4). Therefore, our laboratory recently conducted a screen for more P-
Rex1 binding proteins and this study identified Norbin as new binding partner of P-Rex1 in 
mouse brain (Pan et al., 2016).  
This screen was initiated by former PhD student Mark Barber in the Welch lab (Dr 
Mark Barber, PhD Thesis, University of Cambridge, 2010). Possible candidates were 
coimmunoprecipitated with recombinant P-Rex1 from mouse brain cytosol fractions and 
identified by mass spectrometry. Norbin was identified in this process as a novel binding 
partner of P-Rex1. Afterwards, another previous PhD student (Dr Dingxin Pan, PhD Thesis, 
University of Cambridge, 2013) characterised the interaction between Norbin and P-Rex1 
using a number of biochemical and cell-based assays and generated genetically modified 
mice deficient in Prex1 and Norbin, as described in Materials and Methods (see section 2.2). 
In her study, Dr Pan used purified recombinant proteins to show that Norbin interacts 
directly with P-Rex1. Furthermore, mutagenesis experiments showed that Norbin interacts 
with P-Rex1 via the PH domain both in vitro and in vivo. Using a liposome-based Rac-GEF 
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activity assay, she showed that Norbin stimulates the Rac-GEF activity of P-Rex1 in vitro. 
However, the Norbin effect on P-Rex1 Rac-GEF activity was minor compared with Prex1 
activation by PIP3 or Gβγ (Hill et al., 2005; Welch et al., 2002), and it occurred additively with 
these stimuli, which suggested that Norbin might activate P-Rex1 by increasing the 
availability of P-Rex1 in the liposomes. Nonetheless, in vivo, using overexpression of both 
proteins in HEK293 cells, the stimulating effect of Norbin on P-Rex1 Rac1-GEF activity was 
quite robust upon stimulation of the cells with the GPCR ligand LPA. This suggested that the 
in vitro assay was not able to mimic the in vivo conditions completely. Importantly, Norbin 
and P-Rex1 promoted each other’s plasma membrane localisation and together stimulated 
the formation of lamellipodia, membrane ruffling and cell spreading upon overexpression in 
endothelial PAE cells. The effect of Norbin on the membrane translocation of P-Rex1 was as 
large as that achieved by synergistic stimulation with PIP3 and Gβγ. Therefore, Norbin is a 
major regulator of the subcellular localisation of P-Rex1. Altogether, from this study we 
concluded that Norbin is a positive regulator of P-Rex1 function that promotes P-Rex1 Rac1-
GEF activity largely by increasing the membrane localisation of the GEF (Figure 1.13).   
 
 
Figure 1.12: Schematic model of P-Rex1 regulation by Norbin 
Norbin is a major regulator of the subcellular localisation of P-Rex1 (and vice versa). Norbin recruits P-Rex1 
to the plasma membrane, bringing P-Rex1 into closer contact with its other activators (PIP3 and G) and 
with its substrate Rac1. Thereby, Norbin facilitates the P-Rex1-mediated activation of Rac1 and Rac1-

























 - Hypothesis Chapter 2
The identification of P-Rex1 expression in neutrophils and the generation of Prex1 knockout 
mouse strains by our lab (Welch et al., 2005) have allowed an extensive investigation of this 
Rac-GEF in neutrophils. These studies showed that P-Rex1 is required for Rac2 activity, ROS 
production, actin polymerisation and migration speed in neutrophils, and for neutrophil 
recruitment to sites of inflammation (Pantarelli & Welch, 2018). Moreover, the lab has 
recently identified a direct interaction between P-Rex1 and the neuronal GPCR adaptor 
protein Norbin in vitro and showed that Norbin increases P-Rex1 function by promoting the 
membrane localisation of P-Rex1. Importantly, the study showed furthermore that Norbin is 
not only expressed in neurons but also expressed in neutrophils (Pan et al., 2016) (see 
section 1.6.2).  
My PhD project builds on this previous research. The main aim of my PhD was to 
assess the role of Norbin in neutrophils and the importance of the Norbin/Prex1 interaction 
for these cells. From the previously published work (Pan et al., 2016), I expected that – if 
Norbin played any important role in neutrophils at all – it would probably act as a promoter 
of Prex1 function. Therefore, my hypothesis was that myeloid Norbin deficiency would 
reduce the Prex-dependent functions of neutrophils. 
My study had three parts, which were chosen to evaluate my hypothesis and provide 
a comprehensive overview of the role of Norbin and the Norbin/Prex interaction in 
neutrophils. First, I used isolated neutrophils from mice with myeloid Norbin deficiency and 
mice with combined Norbin and Prex deficiency to investigate neutrophil responses. This 
included the investigation of adhesion and spreading, ROS formation, degranulation and 
bacterial killing (Chapter 4). The second part is a study of the signalling pathways and cell 
surface receptors of neutrophils from mice with myeloid Norbin deficiency and with 
combined Norbin/Prex deficiency (Chapter 5). The final part investigated mice with myeloid 
Norbin deficiency and with combined Norbin/Prex deficiency in vivo, testing neutrophil 
recruitment in a model of aseptic peritonitis and innate immunity in a model of pulmonary 

























 - Materials and methods Chapter 3
3.1 Materials 
All general laboratory reagents were purchased from Bio-Rad, Fisher Scientific, Invitrogen or 
Sigma-Aldrich, unless otherwise stated. 
3.2 Mouse strains 
All mouse strains used in this project were already available in the Welch lab. They are bred 
and housed in individually ventilated cages (IVC) at the Babraham Instiute’s Biological 
Services Unit with 12 h lighting cycles with dusk and dawn settings, and with chow diet and 
water ad libitum in accordance with United Kingdom Home Office regulations. For infection 
with S. pneumoniae, animals were housed in isocages in a category II isolator facility. All 
mice in the facility are routinely tested for 64 pathogens, and no contamination has been 
found. Animal breeding and experiments were carried out with approval from the local 
ethics committee under the British Home Office Animal Scientific Procedures Act 1986.  
All mouse strains are on C57BL/6 genetic background. Prex‒/‒ mice were generated in the lab 
as previously described (Donald et al., 2008). Prex1‒/‒Prex2‒/‒ (Prex‒/‒) and Prex1+/+Prex2+/+ 
(Prex+/+) mice were originally mixed C57BL/6 and 129/OLA background but were backcrossed 
five times to C57BL/6 background. Since then, they were inter-crossed at least once every 
two years to minimise genetic drift. Dr Dingxin Pan, a former PhD student in the lab (PhD 
Thesis, University of Cambridge, 2013), generated a genetically modified mouse strain with a 
conditional Norbin deletion in mature myeloid cells by breeding a strain with a floxed Norbin 
allele (Ncdnfl/fl) (Mochizuki-Sakisaka et al., 2004b), with a strain that expresses Cre 
recombinase under the regulation of the myeloid differentiation-specific mouse Lysozyme M 
promoter (LysMCre) on chromosome 10 (Clausen, Burkhardt, Reith, Renkawitz, & Forster, 
1999). The resulting homozygous strain is here called Ncdn‒/‒ for brevity. Ncdn‒/‒ mice are 
born with the expected Mendelian frequency, appear healthy, are fertile, and have normal 
neutrophil development (see Chapter 4, Section 4.2). Efficient deletion of Norbin in the 
myeloid lineage was verified by western blotting (Appendix A, Supplementary Figure 1). In 
order to study the physiological role of the interaction between Norbin and Prex1 in myeloid 
cells, the Ncdn‒/‒ strain was crossed to Prex‒/‒ mice to generate a strain with myeloid-
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specific Norbin and general Prex deficiency, called here Ncdn‒/‒ Prex‒/‒ for brevity. This 
corresponds effectively to a Norbin/Prex1 double deficiency in neutrophils, monocytes and 
macrophages, as Prex2 is not expressed in these cells. Ncdnfl/fl, LysMCre and Prex+/+ mice 
were used as control strains throughout. The panel of published and unpublished mouse 








Figure 3.1: Diagram of mouse strains used in this study 
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3.3 Molecular Biology Techniques 
3.3.1 Purification of genomic DNA 
Isolation of genomic DNA from tissue culture cells was performed using the Wizard Genomic 
DNA Purification Kit (Promega, A1120) according to the manufacturer’s instructions. Briefly, 
cells were harvested using a 0.25% (w/v) Trypsin-0.53 mM EDTA solution, collected in a 1.5 
mL micro-centrifuge tube and pelleted by a 10 s centrifuge at 16000 xg. The supernatant was 
removed, and the cell pellet was washed with PBS prior to being centrifuged again. PBS was 
removed, leaving behind the cell pellet with residual liquid to resuspend cells by vortexing. 
Cells were then lysed with the provided Nuclei Lysis Solution, treated with RNase Solution 
and incubated at 37oC for 30 min. Afterwards, Protein Precipitation Solution was added and 
samples were kept on ice for 5 min prior to being centrifuged at 16000 xg for 4 min to pellet 
the proteins. DNA precipitation was performed by transferring the supernatant to a new 
tube containing isopropanol, centrifuging at 16000 xg for 1 min, washing the DNA pellet with 
70% ethanol and air-drying it. The dry DNA pellet was then rehydrated with nuclease-free 
water at 65oC for 1 h.  
To isolate genomic DNA from tissue biopsies, ear or tissue biopsies were collected in 
1.5 mL micro-centrifuge tubes. Tissues were lysed with 500 μL of tissue lysis buffer (100 mM 
Tris-HCl, pH 8.5, 200 mM NaCl, 5 mM EDTA, 0,2% SDS) supplemented with 10 mg.mL-1 
proteinase K in 10 mM Tris, pH 8.1, 1 mM EDTA, 50% glycerol. Samples were then incubated 
at 55oC for 4 h, and DNA was precipitated by adding 350 μL of isopropanol, mixing by 
inversion and centrifuging at 12000 xg for 10 min. The supernatant was removed, and the 
DNA pellet was washed with 70% ethanol. Following this, samples were centrifuged again at 
12000 xg for 5 min, the supernatant was removed, and the DNA pellet was left to air-dry. 
The dry DNA pellet was then rehydrated with 30 μL of TE buffer (10 mM Tris, pH 8.0, 1 mM 
EDTA) at 37oC for 1 h. 
3.3.2 Polymerase Chain Reaction (PCR)  
PCR was performed according to the guidelines provided by the manufacturer of the Pfu 
DNA polymerase (Promega, M774A). Amplifications were carried out in 50 l reaction 
volumes containing 100 ng template DNA, 5.5 μM forward and reverse primers (Sigma), 0.2 
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mM dNTPs (Bioline), 1 unit Pfu Polymerase in the manufacturer’s supplied buffer and, when 
necessary, 5% DMSO. Reaction conditions for standard PCRs were: initial denaturing step at 
95oC for 5 min, followed by 30 cycles of denaturing at 95oC for 30 s, re-annealing for 30 s at 
60oC (or the optimal temperature for the primer pair as stated by the manufacturer; Sigma), 
extension at 74C for 2 min/kb of DNA and completion with a final extension at 74oC for 5 
min. The relevant DNA was isolated by agarose gel electrophoresis.  
3.3.3 Mouse genotyping 
Mouse genotyping of the Ncdnfl/fl, LysMCre, Ncdn‒/‒, Prex+/+, Prex‒/‒ Prex+/+, Prex‒/‒ and Ncdn‒
/‒ Prex‒/‒ double knockout mouse strains was routinely performed in the lab by research 
assistant Laraine Crossland. Genomic DNA was isolated from mouse ear biopsies as 
described in section 3.3.1, and the genotyping was done by PCR following the protocol 
described in section 3.3.2. The sequences of the primers used are detailed in the table 3.1 
below. 
 






TCCTGCGCCTGGCAGTCAGC TCCCCGAGCCCATGGATCGG 140 bp 
Norbin  
Recombined allele 
TCCTGCGCCTGGCAGTCAGC ACAGACACGGGTCAAGTTCG 200 bp 
CRE allele TACCTGGCCTGGTCTGGACACAGTG ATGGCTAATCGCCATCTTCCAGCAG 190 bp 






























Table 3.1: List of primer pairs used for the genotyping of genetically modified mouse strains 
 61 
 
3.4 Protein Detection Techniques 
3.4.1 SDS-PAGE 
To separate proteins by size for coomassie staining or western-blotting, the BioRad Mini 
Protean II gel electrophoresis system was used to perform sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE). For some experiments, gels of 1.5 mm 
thickness were prepared. The resolving parts were cast first, followed by the stacking gels, 
using 2x buffer stocks. The amounts of acrylamide (37.5:1, 30% stock, BioRad) and water 
used for both the stacking and resolving gels and the final concentrations of the resolving 
gels are listed in Table 3.2. Otherwise precast gels for SDS-PAGE (4-15% Mini-PROTEAN, 
BioRad, 456-1086) were used. 
 
 
Gels were polymerised with 0.1% Tetra-methyl-ethylenediamine (TEMED) (BioRad) and 
0.05% ammonium persulphate (APS), from a freshly prepared 10% stock. Full Range (12-225 
kDa) pre-stained molecular weight markers from GE Healthcare were used as standards. 
Electrophoresis was performed at 120 volts through the stacking gel and 180 volts through 
the resolving gel in 1x running buffer (10x running buffer stock: 0.25 M Tris, 1.92 M glycine, 
1% SDS). SDS-PAGE sample buffer (Laemmli buffer, 4x: 0.4 M DTT, 160 mM Tris pH 6.8, 8% 
SDS, 50% glycerol, 0.012% bromophenol blue) was added to samples to a final 1.3x 
concentration (1.3x: 24 mM Tris pH 6.8, 21.6% glycerol, 6% β-mercaptoethanol, 1.3% SDS, 
0.006% bromophenol blue), and samples were boiled for least 5 min prior to loading. 
Sometimes, samples were snap-frozen in liquid N2 and stored at -80°C. They were 
Table 3.2: Resolving and stacking buffer recipe. The volume of Resolving and Stacking buffer, Bis-acrylamide, 
water, 10% APS and TEMED required for making up two 1.5 mm thick gels. 
Separating/Resolving gel Stacking gel 
2x Separation Buffer 
(0.75 M Tris, 0.2% SDS, pH 8.8) 
7.5 mL 
2x Stacking Buffer 
(0.25 M Tris, 0.2% SDS, pH 6.8) 
7.5 mL 
30% Acrylamide 37.5:1 3 mL 30% Acrylamide 37.5:1 2.5 mL 
Water 4.5 mL Water 5 mL 
10% APS 75 μL Bromophenol Blue 35 μL 
TEMED 15 μL 10% APS 75 μL 
  TEMED 15 μL 
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transported in liquid N2 prior to reuse and were thawed by transferring from liquid N2 into a 
boiling heat-block with boiling for at least 5 min. Samples were spun at 12,000 xg for 10 s to 
sediment condensation and were briefly vortexed to re-homogenise prior to loading onto 
the gel. 
3.4.2 Transfer of proteins onto Polyvinylidene fluoride (PVDF) membrane 
Following SDS-PAGE, proteins were transferred to PVDF membrane (Millipore) using a 
standard wet transfer protocol. Transfer buffer contained 24 mM Tris, 193 mM glycine and 
methanol (5% methanol for proteins between 120-200 kDa, or 10% methanol for proteins 
<100 kDa). Transfers were done using a mini trans-blot electrophoretic system (Bio-Rad), 
usually at 100 volts for 120 min, all with constant stirring and using cool packs. 
3.4.3 Detection of proteins by western-blot 
After transfer of proteins to PVDF, membranes were incubated for 1 h at room temperature 
in TBS-T (20 mM Tris pH 8, 150 mM NaCl, 0.05% Tween-20) plus 5% non-fat milk powder. 
Blots were then incubated overnight with primary antibody, at 4°C, in an appropriate 
blocking buffer (Table 3.3). Membranes were washed 5 × 10 min in TBS-T before incubating 
for 60 min with horseradish peroxidase (HRP) coupled goat anti-rabbit (Bio-Rad, 1:3000 in 
TBS-T/5% milk), or goat anti-mouse (Bio-Rad, 1:3000 in TBS-T) secondary antibodies, as 
appropriate. Blots were then washed a further 5 × 10 min in TBS-T. Proteins were detected 
by enhanced chemiluminescence (ECL) or ECL Prime (GE Healthcare) according to the 
manufacturer’s instructions. Films were developed using an X-ray film processor (Xograph 
Imaging Systems).  
3.4.4 Stripping and re-blotting of the membrane 
If required, bound antibodies on western-blotting membranes were stripped off in stripping 
buffer (25 mM glycine, pH 2.0, 1% SDS) for 5 min at room temperature. Membranes were 








3.4.5 Coomassie-staining of proteins 
To determine the presence of proteins and assess the quantity and purity of protein 
preparations, gels or western-blots were coomassie stained. Gels were incubated in the 
coomassie staining solution (0.1% Coomassie Brilliant Blue R-250, 50% methanol, 10% acetic 
acid) for 1 h, followed by several washes in gel de-staining solution (10% methanol, 7% 
acetic acid). Western-blots were stained with the same staining solution for 5 min, follow by 
several changes of blot de-staining solution (50% methanol, 7% acetic acid). 
3.4.6 Densitometric Analysis of Western Blot X-Ray Films 
X-ray films were scanned on a flatbed scanner (Epson V200 photos) and protein band 
intensities were analysed using Image-J software.  
3.5 Neutrophil Purification 
Table 3.3: Antibodies used for protein detection 
 
Antibody target Source Dilution Blocking Conditions 
Norbin C1 
Rabbit 
Dr Kie Mayuyama 














Cell Signalling (9211) 





Cell Signalling (9212) 




Cell Signalling (9106) 
1:1000 5% milk/TBS-T 
p44/42 MAPK 
Rabbit polyclonal 
Cell Signalling (9102) 




Cell Signalling (9251) 
1:200 5% BSA/TBS-T 
SAPK/JNK 
Rabbit polyclonal 
Cell Signalling (9252) 
1:200 5% BSA/TBS-T 
Phospho-AKT 308 
Rabbit polyclonal 
Cell Signalling (9275) 
1:200 5% BSA/TBS-T 
Phospho-AKT 473 
Rabbit polyclonal 
Cell Signalling (9271) 
1:200 5% BSA/TBS-T 
AKT 
Rabbit polyclonal 
Cell Signalling (9272) 
1:200 5% BSA/TBS-T 
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All experiments were performed with mature primary neutrophils isolated from the bone 
marrow of age- and sex-matched, young adult (8-14 week-old) mice. Neutrophils were 
prepared fresh each day. Endotoxin-free media was used throughout. The neutrophil 
purification was done at 4°C using two successive Percoll Plus density gradient 
centrifugations to ensure that the final preparation gave a pure and basal population of 
neutrophils. 
Mouse bone marrow cells were flushed from femurs, tibias and pelvic bones with ice-
cold Hank’s Balanced Salt Solution (Sigma H6648), without Ca2+ or Mg2+, and with 15 mM 
HEPES, pH 7.4 (RT), and 0.25% endotoxin-free and fatty acid-free (FAF) BSA (Sigma A8806), 
HBSS--++, followed by trituration and filtering through a 40 μm cell strainer into a 50 mL 
polypropylene Falcon tube. A 12 mL layer of 58% Percoll Plus (GE Healthcare, 17544501) was 
carefully underlayed beneath the bone marrow cell suspension to create a step-gradient, 
and samples centrifuged at 1620 ×g, brake 0 (Beckman Coulter Allegra X-30R), for 30 min at 
4°C. The cells in the lower 5 mL were collected, resuspended as previous, and the Percoll 
Plus gradient was repeated one more. Cells at the interphase (lymphocytes, monocytes and 
immature neutrophils) and the majority of the Percoll Plus were removed. The lower 5 mL 
(neutrophils and erythrocytes) were resuspended in ≥40 mL HBSS--++. Cells were spun at 326 
×g, brake 7, for 10 min at 4°C and the supernatant discarded. Erythrocytes were lysed by 
resuspending cells in 3 mL of fresh Geye’s solution (130 mM NH4Cl, 5 mM KCl, 780 µM 
Na2HPO4, 176 µM KH2PO4, 5.5 mM glucose, 1 mM MgCl2, 280 µM MgSO4, 1.54 mM CaCl2, 
13.4 mM NaHCO3) for 3 min at room temperature. Ice-cold HBSS
--++ was then added to a 
volume of ≥30 mL to dilute the Geye’s solution and cells spun at 326 ×g, brake 7, for 10 min 
at 4°C. The supernatant was discarded and neutrophils resuspended in 10 mL Dulbecco’s 
Phosphate Buffered Saline (DPBS, Thermo Scientific Fisher, 14040117) containing 0.1% 
glucose and 4 mM NaHCO3 (DPBS++) per mouse used. Aliquots of 150 μL were taken for cell 
counting and for checking cell purity by haemocytometer and cytospins, respectively (Figure 
3.2). Cells were then spun at 326 ×g, brake 7, for 10 min at 4°C and the supernatant 
discarded before the cells were resuspended in the final assay buffer at the appropriate 





Figure 3.2: Schematic representation of the steps for neutrophil purification 
 
 
3.5.1 Preparation of neutrophil lysates for Norbin western blot 
To determine Norbin expression in isolated neutrophils, 1 x 107 cells.mL-1 were treated with 
the protease inhibitor diisopropyl fluorophosphate (DFP, 7 mM) (Sigma, D0879) for 10 min at 
room temperature, washed with endotoxin-free DPBS++, and boiling 4x SDS-PAGE sample 
buffer was added to a final concentration of 1.3x and samples boiled for 5 min. Due to the 
toxicity of DFP, the treatment was done under a chemical fume hood in the presence of 
another lab member, and DFP wash was disposed as recommended by the manufacturer. 
While the samples were boiling in sample buffer, the DNA was sheared by trituration 
through a 25G needle. Total cell lysates were separated by SDS-PAGE and western blotted 
with the appropriate antibody. 
3.6 Neutrophil Responses 
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3.6.1 Adhesion, Spreading and Polarisation assays 
Purified bone marrow derived neutrophils were resuspended at 2 × 106 cells.mL-1 in DPBS++. 
Cells were left unprimed on ice or were primed with 20 ng.mL-1 murine TNFα and 50 ng.mL-1 
GM-CSF, for 45 min at 37°C, before 500 μL of cells were added to each well of a 24-well plate 
(Thermo Fisher, Nunc 142475) containing uncoated 13 mm glass cover slips and 500 μL of 2x 
fMLP stimulus in DPBS buffer or buffer alone. This resulted in 1 mL of 106 cells.mL-1 being 
stimulated with 1.5 μM fMLP. Cells were incubated for 10 or 25 min at 37°C, 5% CO2, before 
being fixed for 15 min in 4% paraformaldehyde in DPBS, pH 7.4 at room temperature. Cells 
were washed twice in PBS and stained for the neutrophil specific marker Gr1 and for DNA 
(Ly6G & Ly6C) with a cocktail of FITC-Gr1 antibody (Table 3.4) and 20 mM Hoechst stain 
(Thermo Fisher, 62249), and Fc block (BD Biosciences, 553141) diluted 1:1,000 in PBS, for 30 
min at room temperature. The coverslips were then washed three times in PBS and rinsed 
once in sterile H2O before being mounted onto slides with ProLong Gold Antifade (Life 
Technologies, P36934). 
 For each coverslip, images were taken using a Nikon Eclipse Ti-E widefield system. 
The large image capture function was used to capture 27 images for each condition: three 
acquisitions of 9 adjacent fields of view each were taken at magnification 100X, placing the 
beam first at the centre and then to the right and left areas of the coverslip. The mean 
number of neutrophils was counted manually, and each cell was manually assigned to one of 
four different categories depending on its morphology (Table 3.5). The mean area of the 
neutrophils was calculated by drawing a mask around each cell (size: micron˄2, 8000-infinity, 
pixel units) and establishing a threshold of saturation using Fiji X64 software. Finally, 
statistical analysis was performed using one-way Anova with Tukey’s multiple comparison 

























3.6.2 ROS production assays 
Purified bone marrow-derived neutrophils were suspended at 1.5 × 106 cells.mL-1 in DPBS++ in 
the presence of 16 units.mL-1 horseradish peroxidase (HRP, Sigma, P8375) and 120 µM 
luminol (Sigma-Aldrich, 123072). ROS production was measured using a luminol-dependent 
Antibody target Fluorochrome 
Clone/Source 
and Provider 
















1:1000 (flow cytometry)  
Table 3.5: Categories of neutrophils depending on their different morphologies 
Category Example Features 
Spread Polar 
 Spread cells with lamellipodia 
formation, membrane ruffling 
and clear front/back polarity 
Spread Round 
 
Spread cells without clear 
polarity 
Unspread Polar 
 Evidence of lamellipodia and 








chemiluminescence assay. Luminol detects intracellular, as well as extracellular, superoxide 
production, as it is cell-permeable. Endogenous myeloperoxidase provides the peroxidase 
activity that is required for the intracellular production of light by luminol. The addition of HRP 
also allows the detection of extracellular ROS production. For experiments with unprimed 
neutrophils, cells were kept on ice after preparation, and were prewarmed for 5 min at 37°C 
prior to the assay. Alternatively, neutrophils were primed (or mock-primed) with 50x stocks of 
250 ng.mL-1 TNFα (R&D Systems, 410-MT-010) and 5 g.mL-1 GM-CSF (Petrotech, 315-03) for 
45 min at 37°C or with 50 g.mL-1 Escherichia coli LPS (Sigma, L3024) (50x stock) for 90 min at 
37°C prior to stimulation. Prewarmed 2.5x stocks of soluble agonists, 7.5 M fMLP, 62.5 
nMC5a (Sigma, C5788), or 1.25 M Phorbol 12-myristate 13-acetate (PMA) or buffer-only 
mock stimuli, were then added to the cells and real time ROS production recorded at 37°C 
using a Berthold MicroLumat Plus luminometer (Berthold Technologies). The automatic 
injection port of the luminometer was used for the addition of fMLP and C5a as they elicit 
responses within seconds, whereas PMA was added manually. This resulted in final stimulus 
concentrations of 3 M fMLP, 25 nM C5a and 500 nM of PMA. To illustrate the basal state of 
the cells obtained using the neutrophil preparation technique (described in section 2.4), 
Figure 3.3 shows that GPCR-stimulated ROS production was not observed unless the cells 
were primed beforehand to upregulate the receptors onto the cell surface. 
For ROS assays with yeast particles, Zymosan A S. cerevisae particles (unlabelled, 
Thermo Fisher, Z2849) were washed twice and resuspended in DPBS++. The particulate 
Zymosan stimulus was then manually added to the cells at a concentration of 1.125 × 
106.mL-1 (equal to 3 yeast particles per neutrophil). For ROS assays with bacteria (S. aureus 
Wood 46), bacteria were washed in DPBS++ and opsonised by incubation in DPBS++ with 
10% mouse serum for 15 min at 37°C, followed by resuspension in DPBS++. The bacterial 
stimulus was then added manually to cells that had been primed with 5 ng.mL-1 murine TNFα 
and 100 ng.mL-1 GM-CSF (final concentration) for 45 min at 37°C at a concentration of 1.875 







Figure 3.3: Neutrophil priming 
Priming is a special mechanism for neutrophils to upregulate receptors that are stored on the secretory 
vesicles and granules onto the cell surface by degranulation (middle panel). Neutrophils were left unprimed 
on ice (top panel) or were primed with 5 ng.mL
-1
 TNF and 100 ng.mL
-1
 GM-CSF (bottom panel) for 45 min 
at 37°C prior to stimulation with 3 M fMLP and assessment of ROS production by luminometer. The data 
are representative from one of ≥10 experiments. 
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3.6.3 Bacterial killing assay in vitro 
Staphylococcus aureus bacteria (S. aureus Wood 46) were stored at -80°C as glycerol stocks 
and subcultured in Luria Broth medium (LB) at 37°C to logarithmic growth from overnight 
cultures. Bacteria were washed in DPBS++ and opsonised by incubation in DPBS++ with 10% 
mouse serum for 15 min at 37°C, followed by washing in DPBS++. Opsonised bacteria were 
resuspended in DPBS++ with 10% mouse serum at 1 x 108.mL-1 or 5 x 107.mL-1. Opsonised S. 
aureus cells (5 x 106.mL-1 or 2.5 x 106.mL-1) were added to 5 x 106.mL-1 (final concentration) 
primed purified bone marrow derived neutrophils (2.5 x 107.mL-1 BMNs) for 15 min at 37°C, 
at ratio of either 1:1 bacteria or 2:1 bacteria per neutrophils when tested in the presence of 
increasing doses of the ROS inhibitor diphenyleneiodonium (DPI, 10 M stock) (Sigma, 
D2926). After the indicated time, 50 L aliquots were removed from each sample and added 
to 950 L ice-cold LB containing 0.05% saponin. Samples in saponin were sonicated in a 
Misonix 3000 Probe Sonicator (output 1.5 for 10 s) to liberate intracellular bacteria and were 
returned to ice. Suspensions were serially diluted, plated onto LB-agar and incubated 
overnight at 37°C to enumerate surviving bacterial colonies. Parallel bacterial incubations 
were also run in the absence of neutrophils, and with or without DPI as controls. 
3.6.4 Degranulation assay 
The degranulation protocol was adapted from a protocol by Dr Sonja Vermeren, Centre for 
Inflammation Research, University of Edinburgh. Purified bone marrow derived neutrophils 
were resuspended at 5 × 106 cells.mL-1 in DPBS++. Cells were left unprimed on ice or were 
primed with 20 ng.mL-1 murine TNFα and 50 ng.mL-1 GM-CSF, for 45 min at 37°C, before 80 
μL of cells were added to each well of a 96-well plate (Nunc). The plates had been previously 
blocked using 10% HI-FBS for 1 h at room temperature, and contained 20 μL of the indicated 
concentrations of fMLP in DPBS++ and/or cytochalasin B, or buffer alone. Cytochalasin B is 
an agent that prevents the polymerisation of F-actin, and as granule secretion is usually 
inhibited by the neutrophil cortical F-actin, cytochalasin B was added as a positive control to 
induce maximal gelatinase granule secretion. During stimulation with fMLP (or mock 
treatment), cells were incubated for 30 min at 37°C, 5% CO2, followed by centrifugation at 
300 ×g for 10 min at 4°C. Following this, 40 μL of the supernatant was removed, without 
disturbing the cells at the bottom of the well, and added to 20 μL 4x non-reducing SDS-PAGE 
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sample buffer (no β-mercaptoethanol or DTT) (Table 3.6). Samples were mixed without 
boiling, and 5 μL were loaded onto an SDS-PAGE gel incorporating gelatine (Table 3.7) and 
left to run for 20 min at 150 volts through the stacking and the resolving gels in 1x running 
buffer. Gels were equilibrated in 2.5% Triton X-100 for 30 min at room temperature to wash 
off the SDS. Gels were developed in developing buffer (Table 3.8) to allow the gelatinase to 
work by degrading the gelatine in the gel under gentle rocking overnight at room 
temperature. Gels were rinsed in dH2O prior to coomassie staining, followed by several 
washes in gel de-staining solution (25% ethanol and 3% glycerol). Gels were scanned on a 
flatbed scanner (Epson V200 photo), and gelatinase activity intensities were analysed using 
Image-J software. 
 
Separating/Resolving gel Stacking gel 
2x Separation Buffer 
(0.75 M Tris, 0.2% SDS, pH 8.8) 20 mL 
2x Stacking Buffer 
(0.25 M Tris, 0.2% SDS, pH 6.8) 7.5 mL 
30% Acrylamide 37.5:1 5.3 mL 30% Acrylamide 37.5:1 2.5 mL 
Water 2.7 mL Water 5 mL 
1% gelatin B 




10% APS 100 μL 10% APS 75 μL 
TEMED 20 μL TEMED 15 μL 
 
 
Table 3.6: 4X SDS loading buffer (non-reducing) (left) 
Table 3.7: Developing buffer recipe (right) 
 
 
Table 3.8: Resolving and stacking buffer recipe. Bis-acrylamide, water, 10% APS and TEMED required for 
making up two 1.0 mm thick gels 
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3.7 Pak-CRIB Pull down of active Rac 
In order to investigate the effect of Norbin deficiency and/or Prex1 deficiency on fMLP-
stimulated Rac activity in primary bone marrow derived neutrophils, PAK-CRIB pull down 
assays were performed. This allows isolation of GTP-bound active Rac1 and Rac2 from total 
neutrophil lysates, compared to the total lysate controls, allowing the percentage of Rac that 
is in its active conformation to be calculated. 
3.7.1 Production of GST-Pak-CRIB loaded beads 
A GST-tagged version of the Cdc42/Rac-interactive binding domain of p21-activated kinase 
(GST-Pak-CRIB) was purified from transformed BL21 E. coli (Sander, ten Klooster, van Delft, 
van der Kammen, & Collard, 1999). The pellet from a 50 mL bacterial culture was 
resuspended in bacterial lysis buffer (20% sucrose, 10% glycerol, 50 mM Tris pH 8, 200 µM 
Na2S2O5, 2 mM MgCl2, 2 mM DTT, 100 µM PMSF, and 10 µg.mL
-1 each of leupeptin, 
pepstatin-A, aprotinin and antipain) at 4°C, followed by three rounds of sonication using a 
Misonix 3000 Probe Sonicator at 21 W for 15 s on ice. The cell lysate was ultracentrifuged at 
118,000 ×g for 30 min, at 4°C, and the resultant supernatant incubated with prewashed 
glutathione sepharose 4B beads (GE Healthcare, 17075601) for 2 h with end-over-end 
rotation on ice. Beads were then washed three times in bacterial lysis buffer, followed by 
two washes in GST-FISH buffer (10% glycerol, 50 mM Tris pH 7.4, 100 mM NaCl, 1% NP-40, 2 
mM MgCl2). The GST-Pak-CRIB beads were stored in GST wash buffer (GST-FISH buffer plus 2 
mM DTT, 100 µM PMSF, 10 µg.mL-1 each of leupeptin, pepstatin A, aprotinin and antipain) at 
4°C for up to one week. The quality and purity of GST-Pak-CRIB immobilised on glutathione 




Figure 3.4: Coomassie-stained SDS-PAGE gel showing GST-PAK-CRIB production 
After preparation of GST-PAK-CRIB coupled to glutathione sepharose beads, aliquots of the beads (volumes 
indicated) were boiled in SDS-PAGE buffer, separated on a 12% SDS-PAGE gel and the gel coomassie stained 
to evaluate the quality and purity of GST-PAK-CRIB production, compared to BSA standards of known 
quantity. 
 
3.7.2 Rac activity assay 
Purified bone marrow derived neutrophils were resuspended at 1 × 107 cells.mL-1 in DPBS++ 
and pre-warmed for 10 min at 37°C. Aliquots of 200 L aliquots were then either stimulated 
between 0 and 15 s with 1, 3 or 10 M fMLP (Sigma, F3506) or left unstimulated. The 
reaction was stopped by the addition of 1 mL of ice-cold lysis buffer (GST wash buffer, plus 
an extra 0.2% NP-40, to give a final concentration of 1% NP40) for 2 min. Samples were 
centrifuged at 12,000 xg for 3 min at 2°C, the supernatant transferred into fresh precooled 
tubes, and 2% of the supernatant removed as a total lysate control. The remaining sample 
was incubated with 10 μL of GST-Pak-CRIB beads, rotating end-over-end for 15 min on ice. 
The beads were then washed 5 times in GST-wash buffer, each time spinning at 18,000 xg 
for 30 s at 2°C. Finally, 40 μL of boiling SDS-PAGE sample buffer was added to samples to a 
final 1.3x concentration, and samples were boiled for least 5 min prior to loading. Total 
lysate samples were diluted in 4× SDS-PAGE buffer to a final 1.3x concentration. Samples 
were then snap-frozen in liquid N2 and stored at -80°C prior to analysis. GTP-Rac and total 
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Rac were then quantified by running the samples on 13.5% SDS-PAGE and Western Blotting 
with Rac1 antibody (Millipore, 05-389, 1:3000) or Rac2 antibody (Millipore, 07-604, 1:5000) 
in Tris Buffered Saline (TBS), 0.05% Tween-20, 5% non-fat powdered milk. This was followed 
by five washes in TBS-T (1x TBS, 0.05% Tween-20) for a total of 1 h before addition of the 
secondary antibody (goat anti-mouse IgG-Horseradish Peroxidase [HRP] conjugate, BioRad, 
1:3000; or goat anti-rabbit IgG Horseradish Peroxidase [HRP] conjugate, BioRad, 1:3000, as 
appropriate) in blocking buffer. The incubation was carried out for 1 h and followed by a 
further five washes in TBS-T for a total of 1 h. Proteins were detected by enhanced 
chemiluminescence (ECL) or ECL Prime (GE Healthcare) according to the manufacturer’s 
instructions. Films were developed using an X-ray film processor (Xograph Imaging Systems). 
Blots were scanned and GTP-Rac and total Rac levels were quantified using ImageJ software. 
 
3.8 Analysis of GPCR signalling pathways: Erk, p38Mapk, Jnk, Akt 
Purified bone marrow derived neutrophils were resuspended at 1 × 107 cells.mL-1 in HBSS--++. 
Cells were primed with 20 ng.mL-1 murine TNFα and 40 ng.mL-1 GM-CSF, for 45 min at 37°C, 
prior to stimulation for 10, 45 or 180 s with 0.3 or 1 M fMLP (Sigma) in DPBS++, or mock 
treatment with DPBS++ alone. The reaction was stopped by the addition of excess ice-cold 
DPBS++ for 2 min. Samples were centrifuged at 12,000 xgfor 30 s at 2°C. Cell pellets were 
lysed with 9 volumes of ice-cold RIPA buffer (30 mM Hepes pH 7.4, 150 mM NaCl, 1% 
Nonidet P-40, 0.5% deoxycholate, 0.1% SDS, 5 mM EGTA, 4 mM EDTA), supplemented with 1 
mM DTT, 1 mM PMSF, protease inhibitors (1 µg.mL-1 leupeptin, 1 µg.mL-1 pepstatin A, 1 
µg.mL-1 aprotinin, 1 µg.mL-1 antipain) and phosphatase inhibitors (50 mM NaF, 10 mM β-
Glycerophosphate, 10 mM Na2P2O7 and 1.5 mM Na3VO4) for 5 min on ice with frequent 
vigorous vortexing. Cell lysates were centrifuged at 12,000 xg for 30 s at 2°C to sediment 
debris. SDS-PAGE sample buffer was added to the supernatant to a final 1.3x concentration, 
and samples were boiled for least 5 min prior to loading. Western blotting was performed to 
probe levels of total and active, phosphorylated protein for p38, Erk, Jnk and Akt (see Table 




3.9 Analysis of endogenous receptor levels on the neutrophil 
plasma membrane 
Mouse bone marrow cells were flushed from femurs, tibias and pelvic bones with ice-cold 
HBSS--++, passed through 40 μm filters, and counted using a haemocytometer. Cells were 
pelleted at 326 × g, brake 7, for 10 min at 4°C and resuspended in ice-cold DPBS++ at 4 × 107 
cells.mL-1, before being subjected to one of the following conditions: some were kept on ice 
throughout, to maintain basal levels of the receptors at the cell surface and minimise any 
receptor trafficking. Alternatively, cells were incubated for 30-45 min at 37°C to allow 
constitutive receptor trafficking to occur, or they were primed with 20 ng.mL-1 murine TNFα 
and 40 ng.mL-1 GM-CSF, for 45 min at 37°C, in order to induce maximal upregulation of 
receptors to the plasma membrane. In some instances, cells were also stimulated for 10 or 
30 min with 100 nM recombinant C5a (Sigma, C5788) in order to elicit agonist-induced 
receptor internalisation. Cells were then centrifuged at 10,000 ×g, brake 9, for 30 s at 4°C, 
resuspended in an ice-cold staining cocktail with antibodies for GPCRs (Table 3.9) and 
neutrophil markers, FITC-Gr1 or BV510-Ly6G and AF647-Cd11b (Table 3.4) and containing Fc 
block (BD Biosciences, 553141) diluted 1:1,000 in DPBS++, followed by incubation for 20 min 
on ice for staining. Stained cells were spun at 10,000 ×g, brake 9, for 30 s and pellets 
resuspended in 1 mL of ice-cold HBSS--++ with 1 mM EDTA and kept on ice until the analysis. 
Flow cytometry of cells was performed using a BD Biosciences LSR-Fortessa or BD 
Biosciences Fortessa A flow cytometer and data analysis was performed using FlowJo single-
cell analysis software. Neutrophils were identified by Gr1 or by Ly6G and CD11b staining, 
and GPCR surface expression levels were measured as the mean intensity of the PE signal 
from the PE-GPCR antibody. Figure 3.5 illustrates the differences in CD11b (Mac-1) staining 
that was obtained after using each of the different neutrophil priming and mock priming 
techniques. This show that the neutrophils left on ice had low levels of the integrin on their 
surface, suggesting that they were truly basal cells. It suggested furthermore that mock 
priming (incubation at 37°C) upregulated integrin to the neutrophil surface to some extent, 













Table 3.9: Antibodies used for GPCR detection 
Antibody target Fluorochrome 
Clone/Source and Provider 




















Figure 3.5: Priming of neutrophils upregulates CD11b to the surface 
Bone marrow cells from Ncdn
fl/fl
 mice were either left on ice, unprimed (left panel), mock primed for 45 min 
at 37°C (middle panel) or primed with 20 ng.mL
-1
 murine TNFα and 40 ng.mL
-1
 GM-CSF, for 45 min at 37°C 
(right panel), before staining with Ly6G and CD11b antibodies on ice. Flow cytometric analysis for testing 
forward and side scatter (top panel). Neutrophils were identified by Ly6G staining and the extent of priming 
was assessed by the amount of CD11b (Mac-1 integrin) on the neutrophil surface. The data are 
representative of ≥6 experiments. 
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3.10 In vivo models 
To test the role of Norbin in neutrophil recruitment to sites of inflammation and infections, 
and to investigate the antibacterial immunity of Norbin and Norbin/Prex1 deficient mice in 
vivo, I used two different inflammatory animal models: (i) thioglycollate (TGC)-induced 
sterile peritonitis; (ii) Streptococcus pneumoniae induced pulmonary infection which was 
done either with or without prior neutrophil depletion. 
3.10.1 Peritoneal neutrophil recruitment assay (TGC-induced aseptic 
peritonitis) 
Mice of the specified genotypes were subjected to 0.25 mL intraperitoneal injections of 
sterile H2O (mock) or 3% thioglycollate (Sigma, T9032) that had been preprepared in sterile 
H2O and autoclaved prior to injection (test). At 3 h after the injections, mice were culled by 
CO2 asphyxiation and pithing, and were subjected to peritoneal lavages. Lavages involved 
the injection of 8 mL DPBS/5 mM EDTA into the peritoneum and aspirating the liquid back 
into the syringe to collect recruited cells. A second injection of 8 mL PBS/5 mM EDTA was 
then performed followed by an incision in the peritoneal wall to collect any remaining liquid, 
which was pooled with the previous lavage. Collected cells were pelleted at 10,000 xg for 30 
s at room temperature, and most of each sample was resuspended in a staining cocktail of 
antibodies for neutrophil markers FITC-Gr1 and AF647-Cd11b (Table 3.4) with Fc block (BD 
Biosciences, 553141) diluted 1:1,000 in DPBS++. Cells were incubated in the staining cocktail 
for 20 min on ice in the dark and then washed in DPBS/5 mM EDTA before being 
resuspended in DPBS/5 mM EDTA/1 μg.mL-1 DAPI for flow cytometric analysis. An addition of 
5.0-5.9 μm Spherotech beads (Spherotech, ACBP-50-10) was made to each sample, giving a 
final concentration of 1.25 × 105 particles.mL-1, to enable the quantification of the number of 
cells per given volume by flow cytometry using a BD Biosciences LSRII flow cytometer. 
Neutrophils were detected as cells with high levels of Gr1 and Cd11b staining. Analysis of the 
flow data was done using FlowJo single-cell analysis software, and the number of cells 
recorded corrected to the volume initially recovered during the peritoneal lavage, to account 
for any cells lost in the process. 
In parallel, the remaining cells were counted using a haemocytometer, taking a mean 
of at least 4 counts per sample. Other aliquots of the cells were cytospun onto microscope 
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slides at 300 xg for 3 min at room temperature and stained with Kwick-Diff staining (Thermo 
Scientific Shandon, 9990700). Cytospin slides were assessed by light microscopy to 
determine the percentage of neutrophils present, using their characteristic nuclear shape to 
identify neutrophils (see Section 6.2, Figure 6.1A). At least 200 cells from 3 different fields of 
view were counted per slide. The number of neutrophils that had migrated to the inflamed 
peritoneum upon TGC challenge was calculated based on the total cell count and differential 
cell count. Both methods, flow cytometry and cytospin, which I used in parallel throughout, 
gave similar results. 
3.10.2 Streptococcus pneumoniae model 
Inoculum preparation 
Streptococcus pneumoniae (TIGR4, serotype 4) was grown to mid-log phase (OD500 = 0.5-0.7) 
in Todd-Hewitt broth (Oxoid) supplemented with 0.5% yeast extract (Oxoid) at 37°C, 5% CO2. 
The bacteria were collected by centrifugation, and resuspended at OD500 = 1.0 PBS/20% 
glycerol (Sigma-Aldrich) prior to snap-freezing in liquid N2 and storage at -80°C. Stocks were 
assessed for viable CFU counts and homogeneity by plating out serial dilutions of three 
frozen samples on blood agar plates (LB agar, supplemented with 5% defibrinated horse 
blood (Oxoid) after incubation for 24 h at 37°C, 5% CO2. S. pneumoniae colonies were 
confirmed by the presence of an α-haemolytic zone and sensitivity to optochin (Millipore, 
74042). Virulent stocks were maintained by performing an in vivo passage every 6-12 
months (A. K. Stark et al., 2018).  
Intranasal infection 
In a category 2 laboratory, frozen stocks of S. pneumoniae were thawed on ice, and washed 
twice by centrifugation in HBSS (Sigma-Aldrich, 6648), before being resuspended at 4 x 107 
CFU.mL-1 in HBSS. The suspension was kept on ice at all times, and used for infection within 2 
h of thawing (no loss of viability was observed under these conditions). In the category 2 unit 
of the small animal facility, light anaesthesia was induced in one mouse at the time, by 
inhalation of 3% isoflurane and maintained with 2 % isoflurane. Anaesthetised mice (males 
aged 8-12 weeks) were made to inhale 2 x 106 CFU S. pneumoniae in 50µL sterile HBSS 
through both nostrils. Mock-treated animals received the same volume of sterile DPBS. 
Animals were observed closely to confirm inhalation of the dose and full recovery from 
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anaesthesia. Once the animal was fully recovered, the next mouse was treated. In most 
experiments, generally, the infection dose was confirmed by plating out serial dilutions of 
the inoculum on blood agar plates, as described above.  
Pulmonary lavages 
At the specified times following infection, mice were euthanized by CO2 inhalation, followed 
by severing of the femoral artery. Broncho-alveolar lavage (BAL) was performed by making a 
small incision in the trachea using sharp forceps, inserting a venflon device (1.1 x 32 mm, BD 
391452) and lavaging manually by slow injection and subsequent aspiration of 1 mL of DPBS. 
The BAL was stored on ice until further use. 
Homogenisation of perfused lung 
Lungs were perfused with 10 mL DPBS through the right ventricle using a 10 mL syringe. The 
lungs were removed surgically using aseptic technique and placed in a GentleMACS C Tube 
(Miltenyi Biotec, 130093237) containing 2 mL DPBS. Lungs were homogenized using the 
mouse lung dissociation enzyme kit from Miltenyi (130095927) according to the 
manufacturer’s instructions, and placed into a GentleMACS tissue homogeniser (on setting 
2.1 Lung) for 40 s for tissue dissociation. The lung homogenate was incubated for 45 min at 
37°C. The digestion was stopped by placing the tubes on ice, and the homogenate was 
transferred to 15 mL tubes (BD Falcon, 1130502) and washed by centrifugation at 500 xg for 
5 min at 4°C in 10 mL cold DPBS. The pellet was resuspended in 3 mL 37.5% isotonic Percoll 
(GE Healthcare) in DPBS at room temperature and centrifuged at 650 xg for 20 min with low 
acceleration and no brake. The supernatant including tissue debris was removed, and the 
cell pellet was washed and resuspended in cold DPBS. Single-cell suspensions were 
processed for flow cytometry as described below.  
Leukocyte recruitment into the lung (lavages and tissue) 
The pulmonary recruitment of leukocytes following infection with S. pneumoniae was 
analysed in aliquots of the BAL and the perfused lung homogenate by flow cytometry. Cells 
were incubated in antibody staining cocktail (detailed in Table 3.10) for 40 min on ice in the 
dark and then washed in sterile DPBS before being resuspended in Fixation Buffer 
(Biolegend, 420801) for flow cytometric analysis. An addition of 5.0-5.9 μm Spherotech 
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beads (Spherotech, ACBP-50-10) was made to each sample, giving a final concentration of 
1.25 × 105 particles.mL-1, to enable quantification of the cells. The flow cytometric analysis 
was done using a BD Biosciences Fortessa A flow cytometer. Neutrophils were detected as 
cells with high levels of Ly6G and CD11b staining (Cotter & Muruve, 2006). Macrophages and 
inflammatory monocytes were identified as cells with high levels of CD11b and CD11bhi 
Ly6Chi staining. The gating strategy for the cell population obtained from the lung 
homogenisation is shown in Figure 3.6. Analysis of flow data was done using FlowJo single-
cell analysis software and the number of cells recorded, corrected for the volume initially 






Figure 3.6: Gating strategy for lung myeloid populations 18h post S. pneumoniae infection 
Flow cytometry plots show the separation of myeloid single-cell suspensions from whole lungs. FSC-A and SSC-
A indicate forward and side scatter, respectively. Live cells were gated based on viability dye (FVD) and CD45 
expression. Representative plots demonstrate the expression of CD11c+ and SiglecF+ cells (Alveolar 














Table 3.10: Antibodies used for leukocytes recruitment detection in S. Pneumoniae model 
































































Bacterial counts in pulmonary lavages and lung tissue 
In parallel, 200 μL aliquots of the lung homogenate and BAL were subjected to bacterial 
counts, by preparing serial dilutions in DPBS and plating on blood agar plates. Plates were 
incubated for 24 h at 37°C and bacterial colonies counted. The bacterial load within the lungs 
and the BAL was determined from plates of appropriate colony density (≈20-200 
colonies/plate), using the following formula:  
CFU (Colony forming units) = colony count × dilution factor 
3.10.3 Neutrophil depletion in the Streptococcus pneumoniae model 
To achieve robust neutrophil depletion, mice were injected intraperitoneally with two doses 
of 1A8 monoclonal anti-Ly6G antibody (BioXCell, BE0075-1) at 25 mg.kg-1 in 200 μL PBS at 24 
h and 0 h prior to infection, followed by intranasal challenge with S. pneumoniae, or mock 
treatment (Table 3.11), as described above. Neutrophil-depleted animals were compared 
with animals that had been mock-treated with the equivalent dose of isotype control IgG 
(monoclonal 2A3 anti-trinitrophenol, BioXCell, BE0089). Prior to injections of Ly6G or isotype 
control antibodies, a 50 μL tail blood sample was taken for the enumeration of peripheral 
blood neutrophil counts. Tail blood samples were collected into microvette capillary tubes 
covered with EDTA, to prevent blood clotting. Blood samples were spun at 600 ×g, for 6 min 
at room temperature, and the supernatant discarded. Erythrocytes were lysed by 
resuspending the cells in 500 L of fresh Geye’s A solution (130 mM NH4Cl, 5 mM KCl, 780 
µM Na2HPO4, 176 µM KH2PO4, 5.5 mM glucose) for 5 min at RT. DPBS was then added to a 
volume of ≥1.5 mL to dilute the Geye’s solution and cells spun at 300 ×g, 6 min at RT. The 
supernatant was discarded and the pellet resuspended in a staining cocktail with antibodies 
for neutrophil markers (Table 3.10). An addition of 5.0-5.9 μm Spherotech beads was made 
to each sample, giving a final concentration of 1.25 × 105 particles.mL-1, to enable the 
quantification of the by flow cytometry using a BD Biosciences Fortessa A flow cytometer. 
Neutrophils were detected as cells with high levels of CD24 and CD11b staining, with CD24 
antibody being used instead of Ly6G, as the 1A8 depleting antibody targets the Ly6G 
epitope. Analysis of flow data was done using FlowJo single-cell analysis software and the 
number of cells recorded corrected for the number of beads acquired. 
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Table 3.10: Schematic diagram of the neutrophil depletion time points in the S. pneumoniae model  
 
3.11 Experimental design and statistical analysis 
Wherever feasible, mice from the same sex and matched age where used. The setting for 
sample sizes was based on previous knowledge in the laboratory, from the literature or from 
pilot studies. Simple comparisons between single independent measurements from two 
groups were made using two-tailed unpaired Student’s t-tests or Mann-Whitney U-tests as 
appropriate. Depending on experimental design, single or repeated measures one-way 
analysis of variance (ANOVA), two-way ANOVA, or three-way ANOVA were used to test for 
effects of interventions. The threshold for statistical significance was set at P<0.05. P-values 
reported are from t-tests, or from multiplicity-adjusted Dunnett’s or Holm-Sidak’s post-hoc 
adjustments, as appropriate. Where hypothesis testing was non-significant, the p values 
have not been explicitly noted. Prior to statistical analysis, data were tested for normality of 
distribution, in order to determine if parametric or non-parametric analysises were 
appropriate. Where appropriate, data were log-transformed or square root-transformed 
prior to statistical analysis to adjust for variance between groups. Statistical outliers were 
identified using Tukey’s test and where removed from the datasets. Effect sizes and 
variances are reported throughout the text as group means ± standard error with the 
relevant P-values from group comparisons. Data are graphed and reported as the means ± 
standard error of raw, log-transformed, normalised or individual data points, as appropriate. 
Group sizes (n) are listed in Figure legends. The software packages Excel 2016 (Microsoft 
Office) and Prism 8.0 (GraphPad) were used for tabulation, statistical analysis and graphing. 
 24 h pre infection  0 h infection 6 h post-infection 
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 - Myeloid Norbin deficiency increases the Chapter 4
responses of isolated neutrophils 
4.1 Introduction: Expression of Norbin in neutrophils and 
generation of mice with myeloid Norbin-deficiency 
As described in section 1.6.2 of Chapter 1, our lab recently discovered that the GPCR-adaptor 
protein Norbin is a direct binding partner of P-Rex1 (Pan et al., 2016). Norbin activates P-
Rex1 Rac GEF activity both in vitro and in vivo and promotes the membrane localisation of 
the GEF. Co-expression of Prex1 and Norbin in PAE cells induces Rac-dependent actomyosin 
cytoskeletal dynamics, causing the cells to assume the characteristic morphology of active 
Rac, namely lamellipodia and membrane ruffling (Pan et al., 2016). As Pan et al investigated 
the consequences of the Norbin/Prex1 interaction for cell functions largely by using 
overexpression systems, we decided to assess the biological consequences of this interaction 
at the endogenous level. A tissue distribution analysis carried on by Dr Dingxin Pan, a former 
PhD student in the laboratory, showed that Norbin is expressed in myeloid cells, including 
neutrophils (Supplement Figure 1A) which was surprising given that Norbin was expected to 
be selectively neuronal (Pan et al., 2016). These findings, together with the well-known role 
of P-Rex1 in neutrophil responses (Welch et al., 2005) opened the opportunity to study 
endogenous Norbin and P-Rex1 in neutrophils, using Norbin and/or Prex deficient mice. 
Neutrophils are terminally differentiated and short-lived cells, in which protein expression 
levels are difficult to manipulate other than by genetic methods. In addition, neutrophil-like 
cell lines are not a suitable alternative, because they represent immature stages of 
neutrophil development and therefore insufficiently recapitulate normal neutrophil biology. 
Hence, we often use genetically modified mice to study the functions of proteins in 
neutrophils in vitro and in vivo. In order to study the functional role of endogenous Norbin in 
primary neutrophils, Dr Pan generated a mouse strain with a deletion of Norbin specifically 
in the myeloid linage, namely neutrophils, monocytes and macrophages. This strain Ncdn‒/‒ 
(unpublished) was derived by crossing Ncdnfl/fl mice (Mochizuki-Sakisaka et al., 2004a) with 
the myeloid lineage Cre strain LysM-Cre (Clausen et al., 1999). In addition, the Norbin-
deficient mice were crossed with a strain that carries a general Prex1 and Prex2 deficiency 
(Prex‒/‒) (Welch et al., 2005) to generate the Ncdn‒/‒ Prex‒/‒ strain with combined Norbin 
and Prex deficiency (unpublished; see Figure 3.1 for a schematic diagram of the breeding 
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strategy). Moreover, she showed by western blotting that the 79 kDa band of Norbin was 
successfully deleted in the Ncdn‒/‒ mice both in resident peritoneal leukocytes (which are 
90% macrophages) and in septic peritonitis leukocytes (50% neutrophils and 40% peritoneal 
macrophages under these conditions) (Supplement Figure 1B, unpublished). 
 
4.2 Norbin is efficiently deleted in neutrophils from mice with 
myeloid Norbin deficiency 
Many experiments presented in this thesis were performed with isolated bone marrow-
derived neutrophils. Therefore it was important to demonstrate that Norbin was efficiently 
deleted from isolated neutrophils in the Ncdn‒/‒ strain. For this aim, I freshly purified mature 
neutrophils from the bone marrow of Ncdnfl/fl, LysMCre and Ncdn–/– mice using double 
Percoll+ density gradient and, assessed their purity by cytospin and DiffKwik staining, which 
confirmed >90% purity. The cells were then pretreated with the potent serine protease 
inhibitor di-isopropyl fluorophosphate (DFP) and total cell lysates prepared. These cell 
lysates were subjected to western blotting with Norbin C1 antibody, and equal protein 
loading was assessed by coomassie staining. The WBs of Ncdnfl/fl and LysMCre cells showed a 
79 kDa band, the size expected for Norbin, and this was efficiently deleted in the Ncdn‒/‒ 
neutrophils (Figure 4.1). The efficiency of the deletion was 93% and 90%, compared to 
Ncdnfl/fl and LysMCre, respectively, as assessed by densitometric analysis using ImageJ, and 
taking into account that the the purity of the neutrophil preparations was 98%. Furthermore, 
the normal morphology of the cells, as assessed by cytospin, and the number of mature 
neutrophils recovered from the bone marrow suggested that neutrophil development is 
normal in mice with myeloid Norbin deficiency (Figure 4.2A and B). In order to determine the 
proportion of neutrophils in the control and Norbin deficient mice, blood samples were lysed 
and stained for viable cells, CD45, Ly6G and CD11b. Following analysis, both strains were 
seen to contain 20% neutrophils amongst their white blood cells (Figure 4.2C), as expected 
(Cotter, Norman, Hellewell, & Ridger, 2001; O'Connell & E Brown, 2015). Finally, the 
expression of the neutrophil markers was comparable between control and Norbin-deficient 








Figure 4.1: Norbin is deleted in Ncdn
–/–
 mouse neutrophils 
Norbin western blot of total lysates (5% v/v) of isolated diisopropyl fluorophosphate-treated bone marrow 
derived-neutrophils from Ncdn
fl/fl
 (floxed Norbin), LysM
Cre
 (myeloid Cre) and Ncdn
–/–
 (myeloid Norbin KO) 




 lysates showed a 79 kDa band that 
was efficiently deleted in Ncdn
–/–








Figure 4.2: Neutrophil development is normal in mice with myeloid Norbin deficiency 















 mice using double Percoll
+
 density 
gradient. (B) Quantification of mature neutrophils from the bone marrow isolated as in A shows that 
neutrophil numbers are normal in mice with myeloid Norbin deficiency. (C) Flow cytometry analysis of 
peripheral blood shows that neutrophil numbers assessed by Ly6G and Cd11b staining are normal in mice 
with myeloid Norbin deficiency. (D) Bone marrow neutrophils were labelled with Ly6G and CD11b markers 
and analysed by flow cytometry. Representative dot plots are shown with neutrophil numbers quantified as 





4.3 Norbin deficiency increases neutrophil adhesion and 
spreading but it does not affect polarisation 
As described in section 1.4.5 of chapter 1, Prex1 deficiency causes a mild impairment in 
neutrophil adhesion and actin polymerisation (Lawson et al., 2011; Welch et al., 2005). 
Moreover, we observed that Norbin affects P-Rex1 dependent actin cytoskeletal structure 
and cell morphology in endothelial cells (Pan et al., 2016). Therefore, I assessed the ability of 
purified bone marrow derived Ncdn‒/‒ and Ncdn‒/‒ Prex‒/‒ neutrophils to adhere, spread and 
polarise on glass cover slips, compared to neutrophils from sex- and age-matched Prex‒/‒ 
and Ncdnfl/fl mice. Neutrophils were either primed with 20 ng.mL-1 TNFand 50 ng.mL-1 GM-
CSF or left unprimed and then left to adhere to coverslips for 10 min either in the presence 
of 1.5 μM fMLP in DPBS, or in DPBS alone, before fixing with paraformaldehyde. Fixed 
neutrophils were stained for the neutrophil-specific marker Gr1 (Ly6C & Ly6G) with a FITC-
tagged antibody, as well as for DNA with Hoechst stain. This allowed the identification of 
neutrophils by their Gr1 staining and their characteristic horseshoe-shaped nuclear staining. 
Imaging was performed using a Nikon Eclipse Ti-E widefield immunofluorescence 
microscope. To assess adhesion, the number of neutrophils per field of view was counted 
manually and expressed as the mean number of cells per mm2. Under basal conditions 
(unprimed and unstimulated) 547 Ncdnfl/fl neutrophils adhered per mm2 within 10 min 
(Figure 4.4A), whereas Prex deficiency caused a small decrease in adhesion to 440 cells per 
mm2, as expected from previous work (Lawson et al., 2011; Welch et al., 2005). However, 
there was a striking increase in the adhesion of Ncdn‒/‒ neutrophils to 1000 cells per mm2. 
Surprisingly, this result showed that Norbin has the opposite effect on neutrophil adhesion 
compared to Prex1. Furthermore, this increase was sustained in the Ncdn‒/‒ Prex‒/‒ cells, 
where 806 cells adhered per mm2. These differences in adhesion between Ncdn‒/‒ and Prex‒
/‒ and between Ncdn‒/‒ and Ncdn‒/‒ Prex‒/‒ cells were statistically significant. Hence, Norbin 
deficiency trumped the effects of Prex1 deficiency on neutrophil adhesion under these 
conditions. Similar results were obtained upon fMLP stimulation, except that the slight 
reduction in adhesion observed in Prex‒/‒ cells was rescued by this treatment (641 cells per 
mm2 adhered), as expected from previous work (Lawson et al., 2011). Similar to the basal 
condition, the increase in the adhesion of Ncdn‒/‒ neutrophils, was highly significant 
compared to Ncdnfl/fl under these fMLP-stimulated conditions.  
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Next, primed conditions were tested, where neutrophils were pre-treated with TNF 
and GM-CSF prior to the assay in order to upregulate receptors to the cell surface. Under 
these primed conditions, neutrophils from the Prex‒/‒ strain no longer showed a defect in 
adhesion. However, the increase in adhesion of unprimed Ncdn‒/‒ and Ncdn‒/‒ Prex‒/‒ was 
also observed in primed cells, and additional stimulation with fMLP increased the number of 
adherent Ncdn‒/‒ Prex‒/‒ neutrophils even further. Therefore, Norbin deficiency causes 
increased neutrophil adhesion under all conditions tested, and this effect was independent 
of Prex1 as it was preserved in the absence of the GEF. 
To test whether Norbin and the Norbin/Prex1 interaction play a role in regulating 
neutrophil spreading, I measured the surface area of the cells analysed above using ImageJ 
analysis of a cell-mask (Figure 4.4B). Unprimed and unstimulated Ncdnfl/fl neutrophils had an 
average surface area of 127 μm2 without and of 159 μm2 with fMLP stimulation. Prex1 
deficiency caused a small decrease in cell spreading, although this did not quite reach 
statistical significance under this condition. In contrast, Ncdn‒/‒ neutrophils had a 
significantly larger surface average area of 150 μm2 without and 176 μm2 with fMLP 
stimulation. TNF/GM-CSF priming increased the surface area of Ncdnfl/fl neutrophils, as 
expected (this is assumed to be due to the up-regulation of integrins during priming), to 144 
μm2 without and 154 μm2 with fMLP stimulation. However, the area of Ncdn‒/‒ neutrophils 
was larger again, 164 μm2 and 176 μm2, respectively. This difference between Ncdnfl/fl and 
Ncdn‒/‒ neutrophils reached statistical significance under basal, primed and fMLP stimulated 
conditions. In contrast, Prex-deficiency significantly reduced neutrophil spreading both upon 
fMLP stimulation and upon priming. Therefore, in contrast to Prex1 deficiency, Norbin 
deficiency increases neutrophil spreading under all conditions tested. Furthermore, the 
spreading of Ncdn‒/‒ Prex‒/‒ cells was at least as much as that of Ncdnfl/fl cells under all 
conditions, showing that the additional Prex1 deficiency cold not override the increase in 
neutrophil spreading that was caused by the Norbin deficiency. 
Adhering neutrophils adopt different morphologies between priming and stimulation 
conditions. To assess the effects of Norbin deficiency on these morphologies, I proceeded by 
assigning each cell to one of four different categories, depending on morphology. The 
categories were (I) unspread/round (yellow), (II) unspread/polar (purple), (III) spread/round 
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(green), and (IV) spread/polar (blue). Under basal conditions, most cells were 
unspread/round, whereas fMLP stimulation mostly increased the proportion of polarised 
cells and TNF/GM-CSF priming the proportion of spread cells (Figure 4.4C). In Ncdn‒/‒ 
neutrophils, the proportion of polarised cells was not greatly affected, neither under basal 
conditions, nor upon fMLP stimulations or upon priming. Hence, overall Norbin deficiency 
increased the ability of neutrophils to adhere and spread, but does not affect their ability to  
polarise. 
 












Neutrophils isolated from mice of the indicated genotypes were primed with 50 ng.mL
-1
 murine TNFα and 
20 ng.mL
-1
 GM-CSF, for 45 min at 37°C, or left on ice (unprimed). Cells were plated onto glass coverslips and 
stimulated with 1.5 μM fMLP or mocked treated with buffer for 10 min. Cells were fixed with PFA and 
stained with FITC-Gr1 antibody and Hoechst (Gr1 staining is shown here). Images are one representative 
field of view from 3 sets of 9 adjacent images taken across the width of each coverslip. Duplicate coverslips 
were assessed for each condition. Images shown are from one experiment representative of 3 independent 





Figure 4.4: Norbin-deficient neutrophils show increased adhesion and spreading but normal polarisation 
Neutrophils isolated from mice of the indicated genotypes were primed with 50 ng.mL
-1
 murine TNFα and 20 
ng.mL
-1
 GM-CSF, for 45 min at 37°C, or left on-ice (unprimed). Cells were plated onto glass coverslips and 
stimulated with 1.5 μM fMLP or mocked treated with buffer for 10 min. Neutrophils were fixed with PFA and 
stained with FITC-Gr1 antobody and Hoechst. Images from 3 sets of 9 adjacent fields of view from across the 
width of each coverslip were analysed. Duplicate coverslips were assessed for each condition. 
Representative images are shown in Figure 4.3. (A) Adhesion of neutrophils, calculated as mean number of 
cells per mm
2
. (B) Spreading of neutrophils, determined by assigning a mask using ImageJ and calculating the 
surface area of the mask. (C) Polarisation of neutrophils, assessed by assigning each cell to one of four 
morphology categories, as indicated in table 3.6 in section 3.6.1. Polar/unspread and polar/spread cells are 
scored in this quantification as % of total. Data (A-C) are mean ± SEM of 3 independent experiments. All 
conditions were assessed in parallel. The statistical significance was assessed using two-way Anova with 
Holm-Sidak’s multiple comparisons test. 
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4.4 Norbin deficiency increases GPCR-dependent and fungal-
particles dependent of ROS production 
ROS formation by the neutrophil NADPH oxidase is a Rac-dependent response (Nguyen, 
Green, & Mecsas, 2017). One way of eliciting the ROS response in isolated neutrophils is by 
priming with inflammatory agents such as TNF/GM-CSF or lipopolysaccharide (LPS) to 
upregulate surface receptors and NADPH oxidase components to the cell membrane, 
followed by stimulation of GPCRs such as the fMLP or the C5a receptors. I assessed the 
ability of isolated primed neutrophils from the different genotypes to produce ROS upon 
stimulation either through the fMLP or the C5a receptor. 
First, I studied TNF/GM-CSF-primed neutrophils stimulated with 3 M fMLP. Under 
these conditions, ROS production was rapid, finishing within a minute, as expected (Figure 
4.5A). Furthermore, as expected from our previous studies, Prex1 deficiency caused a defect 
in ROS production (Damoulakis et al., 2014; Lawson et al., 2011; Welch et al., 2005). In 
contrast, Ncdn‒/‒ neutrophils showed the opposite effect, as ROS production was increased 
compared to Ncdnfl/fl (Figure 4.5A). 
Quantification of this ROS production showed that the differences between Ncdn‒/‒ 
and Prex‒/‒ and between Ncdn‒/‒ and Ncdn‒/‒ Prex‒/‒ were statistically highly significant 
(Figure 4.5B). Therefore, endogenous Norbin limits ROS production when expressed. As 
previously seen for adhesion and spreading, again Norbin deficiency had the opposite effect 
on this response compared to Prex deficiency. Furthermore, in Ncdn‒/‒ Prex‒/‒ cells, ROS 
production was decreased to a similar level as in Prex‒/‒ cells. Thus, unlike for adhesion and 
spreading, the requirement for Prex1 in TNF/GM-CSF-primed and fMLP-stimulated ROS 
production could not be overridden by the Norbin deficiency. 
Next, I tested if this effect was specific to fMLP receptor-dependent ROS production. 
Neutrophils were primed with TNF/GM-CSF as before, and then stimulated with 25 nM C5a 
(Figure 4.5C). I obtained similar results as with the fMLP stimulation, which shows that 
Norbin limits GPCR-dependent ROS production more generally. Moreover, these responses 
again required Prex1, whether Norbin was expressed or not. 
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Next, I tested ROS production in neutrophils primed through a different pathway, using 
LPS, which signals through the TLR4. LPS-primed, fMLP-stimulated ROS production was 
reduced in Prex-deficient neutrophils (Figure 4.5D), as expected from previous work 
(Damoulakis et al., 2014; Lawson et al., 2011; Welch et al., 2005). However, as seen with 
cytokine priming, Norbin deficiency increased ROS production. This increase in ROS 
production was highly significant compared to the Ncdnfl/fl and Prex‒/‒ cells. Therefore, 
Norbin expression limits GPCR-dependent ROS production, regardless of the priming 
pathways used. However, in Ncdn‒/‒ Prex‒/‒ cells, ROS production was just as high as in 
Ncdn‒/‒ cells, which shows that Norbin could override the requirement for Prex in this 
response. This is in contrast to the cytokine-primed response, where Prex was required. 
Therefore, there is a difference in the functional roles of Norbin and Prex between the two 
priming pathways examined, Norbin expression limiting ROS production whether Prex is 
required or not, and Prex being required in Norbin-deficient cells primed with TNFand GM-
CSF but not in cells primed with LPS. 
ROS production plays a key role in neutrophil-dependent host defence against 
bacterial and fungal pathogens. Therefore, next I examined the importance of Norbin and 
Prex in ROS production elicited by zymosan yeast particles, which engage Fc, complement 
and pattern recognition receptors. Ncdn‒/‒ neutrophils showed a statistically significant 
increase in zymosan-induced ROS production compared to Ncdnfl/fl (Figure 4.6B), whereas 
the response in Ncdn‒/‒ Prex‒/‒ cells was similar to Prex‒/‒ cells. Hence, similar to GPCR-
dependent ROS formation, Norbin expression limits the ROS response to fungal particles, 











Figure 4.5: Norbin-deficient neutrophils show increased ROS production 










 (green) mice 
and primed with the indicated agent prior to stimulation with fMLP or C5a. ROS assays were carried out in 
the presence of 120 µM luminol and 16 units.mL
-1
 HRP, and chemiluminescence was assessed in real time by 
luminometer over 2 min to measure intracellular and extracellular ROS production. (A) Representative 
traces of ROS production in neutrophils primed with 5 ng.mL
-1
 TNFα and 100 ng.mL
-1
 GM-CSF for 45 min at 
37°C prior to stimulation with 3 M fMLP. (B) Quantification of the area under the curve (AUC) of ROS 





 GM-CSF for 45 min at 37°C prior to stimulation with 25 nM C5a. (D) AUC of ROS production 
in neutrophils primed with 500 nM.mL
-1
 LPS for 90 min at 37°C prior to stimulation with 3 M fMLP. (B-D) 
Each dot is the mean from one experiment of the AUC integrated over two minutes. Data are mean ± SEM 
of the indicated number of independent experiments. Statistical significance was assessed using one-way 
Anova with Tukey’s multiple comparisons test. Mock-stimulated ROS production was negligible and is not 













Figure 4.6: Zymosan-induced ROS production is increased in Norbin-deficient neutrophils 










 (green) mice 
and incubated with zymosan at a ratio of 3:1 particles per neutrophil at 37°C in the presence of 120 µM 
luminol and 16 units.mL
-1
 HRP. Chemiluminescence was measured by luminometer over 60 min. (A) 











(green) neutrophils. (B) Quantification of ROS production (AUC) in response to zymosan. Each dot is the 
mean of one experiment. Data are mean ± SEM of 3-4 of independent experiments. Statistical significance 




4.4.1 Norbin does not affect receptor-independent (PMA-stimulated) 
ROS production  
Receptor-independent ROS production in neutrophils can be stimulated by PMA, a direct 
activator of protein kinase C (PKC). This response is often used to test if the NADPH oxidase 
complex is functional. PMA-stimulated ROS production was normal in cells of all genotypes 
tested (Figure 4.7A and B). This indicates that the integrity of the NADPH oxidase complex 
was not compromised by Prex or Norbin deficiency, and importantly suggests furthermore 
that the increased ROS production observed in Ncdn‒/‒ neutrophils stimulated with fMLP, 
C5a or zymosan was not just not due to an overall increased amount of NADPH oxidase 
activity. Hence, Norbin deficiency affects the upstream signalling pathways rather than the 




Figure 4.7: PMA-dependent ROS production is normal in Norbin-deficient neutrophils 











 (green) neutrophils stimulated with 500 nM PMA. (B) AUC of PMA-stimulated ROS production over 10 







4.5 Norbin-deficiency increases the capacity of isolated 
neutrophils to kill bacteria by ROS production 
ROS production by NADPH oxidase activity is a major response that enables neutrophils to 
kill bacteria. Thus, next I examined the ability of isolated neutrophils from Ncdnfl/fl, LysMCre, 
Ncdn‒/‒ and Ncdn‒/‒ Prex‒/‒ mice to kill S. aureus. Isolated neutrophils were primed with 10 
g.mL-1 TNFα, 20 g.mL-1 GM-CSF for 45 min and then incubated for 15 min at 37°C with 
mouse serum opsonised S. aureus at a ratio of 1 bacterium per neutrophil with mixing every 
5 minutes. Samples were added to an excess of ice-cold LB 0.05% saponin and sonicated to 
liberate ingested bacteria. Surviving bacteria were enumerated by plating on LB agar 
overnight and subsequent counting of colonies. For this experiment, neutrophils from two 
different control strains, the Ncdnfl/fl mouse and the LysMCre mouse, were compared to the 
Ncdn‒/‒ and the Ncdn‒/‒ Prex‒/‒ deficient cells. In this assay, Norbin deficiency significantly 
enhanced the ability of neutrophils to kill S. aureus, as around twice as many bacteria were 
killed in Ncdn‒/‒ samples compared to Ncdnfl/fl and LysMCre control cells. Furthermore, this 
role of Norbin was independent of Prex1 because, a similar increase was seen in Ncdn‒/‒ 
Prex‒/‒ neutrophils (Figure 4.8A). 
To test whether the increased ability of Ncdn‒/‒ neutrophils to kill S. aureus was due 
to the increased ROS production, I performed the bacterial killing assay in the presence of a 
titration curve with the ROS inhibitor diphenyleneiodonium (DPI). Isolated neutrophils from 
Ncdnfl/fl and Ncdn‒/‒ mice were incubated with mouse serum-opsonised S. aureus for 15 min 
at 37°C at a ratio of 2:1, with a serial dilution of DPI. With increasing doses of DPI, the Ncdn‒
/‒ neutrophils gradually lost their advantage over Ncdnfl/fl cells in killing S. aureus, and at 
higher doses, both genotypes were equally sensitive to DPI (Figure 4.8B). Therefore, the 
increased ROS production observed in Ncdn‒/‒ neutrophils gave rise to the increased ability 







Figure 4.8: Norbin-deficient neutrophils have an increased capacity to kill bacteria, in a ROS-dependent 
manner 
Neutrophils isolated from mice of the indicated genotypes were primed with 50 ng.mL
-1
 murine TNFα and 
20 ng.mL
-1
 GM-CSF, for 45 min at 37°C prior incubation with mouse serum-opsonised S. aureus at a ratio of 
(A) 1:1 (B) or 1:2 (bacteria to neutrophils for 15 min), in (B) with the indicated concentrations of the ROS 
inhibitor diphenyleneiodonium (DPI). After the incubation, samples were added to an excess of ice-cold LB 
0.05% saponin and sonicated to liberate ingested bacteria. Surviving bacteria were enumerated by plating 
on LB agar overnight and counting of CFUs. Each dot in (A)and (B, right hand panel) is the mean of an 
experiment performed in duplicate. Data are mean ± SEM of 5-9 independent experiments. Statistical 
significance was assessed using (A) one-way Anova with Tukey’s multiple comparison test or (B) two-way 





4.6 Norbin-deficiency causes constitutive secretion of gelatinase 
granules  
Neutrophils store many of their cell surface receptors internally, on the membrane of 
various populations of secretory granules, in order to avoid full-blown activation of these 
cells while they are circulating in the blood stream. These cell surface receptors are 
upregulated onto the plasma membrane upon priming, by degranulation. One of the 
neutrophil granule subsets that is most easily mobilised are gelatinase granules, which are 
characterised by gelatinase (MMP9) that is released into the extracellular space upon 
degranulation. The increased ability of Norbin-deficient neutrophils to adhere and produce 
ROS, suggested that some cell surface receptors conferring these responses may be 
upregulated in Ncdn‒/‒ cells due to increased degranulation. Therefore, I next analysed the 
effect of Norbin deficiency on neutrophil degranulation by measuring gelatinase activity 
released into the supernatant of neutrophils stimulated with increasing concentrations of 
fMLP with or without cytochalasin B. Priming with 20 ng.mL-1 TNFand 50 ng.mL-1 GM-CSF 
was used to induce maximal gelatinase granule secretion. Indeed, basal Ncdn‒/‒ neutrophils 
showed a statistically significant increase in gelatinase activity in the supernatant compared 
to Ncdnfl/fl cells, suggesting a constitutively increased level of degranulation caused by the 
Norbin deficiency (Figure 4.9B). This constitutive degranulation was overcome by increasing 
dose of fMLP, priming with TNFand GM-CSF and cytochalasin B treatment, as stimulated 
neutrophils from Ncdnfl/fl and Ncdn‒/‒ mice released similar amounts of gelatinase activity 
under those conditions (Figure 4.9A). Hence, overall the gelatinase content of Ncdn‒/‒ 
neutrophils was normal. Therefore, Norbin-deficient neutrophils showed constitutive 
secretion of gelatinase, which could in part explain the increased responsiveness of Norbin-
deficient neutrophils to various receptor stimuli.  
 In summary, Ncdn‒/‒ neutrophils showed increased adhesion, spreading, ROS 
production, ROS-dependent bacterial killing and some constitutive degranulation. These 
findings showed that Norbin expression suppressed neutrophil responses, contrary to our 
initial expectations. Hence, myeloid Norbin is an important regulator of neutrophil 





Figure 4.9: Norbin deficiency causes constitutive neutrophil degranulation  





 neutrophils. Neutrophils were either primed with 20 ng.mL
-1
 TNF and 50 ng.mL
-1
 GM-CSF to induce 
maximal gelatinase granule secretion or left unprimed on ice prior to stimulation with increasing 
concentrations of fMLP and 10 M cytochalasin B, as indicated. (B) Quantification of gelatinase activity in 
unprimed cells, expressed as % of the primed response. Each dot is the mean of one experiment. Data are 
mean ± SEM of 7 independent experiments (in 1 experiment, 0.5 M fMLP was used instead of 0.3 M). 


























 - Myeloid Norbin deficiency increases GPCR-Chapter 5
dependent signalling and GPCR trafficking in neutrophils 
5.1 Introduction: Signalling and trafficking roles of Norbin 
Antibacterial and antifungal neutrophil responses require signalling through Rac and Rac-
GEFs. For example, these proteins control neutrophil adhesion, ROS production and 
degranulation (Pantarelli & Welch, 2018). P-Rex1 is one of the Rac-GEFs that generates Rac 
activity and Rac-dependent neutrophil responses, especially those elicited by GPCR 
signalling. 
Norbin has never been described in myeloid cells prior to our initial study on the 
Prex1/Norbin interaction (Pan et al., 2016). However, there is some literature on the role of 
Norbin in signalling, from studies on recombinant Norbin protein, on deletion of endogenous 
Norbin in neurons, and on overexpression of Norbin in other cell types. Together, these 
studies suggest possible mechanisms through which Norbin might regulate neutrophil 
responses. Recombinant Norbin binds directly to numerous GPCRs in vitro (33 out of the 45 
tested to date), at the membrane-proximal part of their intracellular C-terminal tail (Francke 
et al., 2006; H. Wang et al., 2009; Ward et al., 2009). Overexpression or deletion of Norbin 
can affect the constitutive trafficking of GPCRs to the plasma membrane, and/or the 
downstream signalling pathways of GPCRs. For example, deletion of Norbin alters the 
steady-state cell surface level of the GPCR mGluR5 in primary cortical neurons cells without 
affecting total mGluR5 levels (Wang, Westin et al. 2009). Norbin expression can either up- or 
downregulate Ca2+ signalling upon stimulation of the GPCRs MCHR1 and mGluR5 (Francke, 
Ward et al. 2006, Wang, Westin et al. 2009, Ward, Jenkins et al. 2009), and it can enhance 
mGluR5-induced ERK1/2 phosphorylation (Francke, Ward et al. 2006, Wang, Westin et al. 
2009). In general, however, it is unknown how Norbin binding affects the trafficking and 
signalling of these GPCRs. 
In our recent paper (Pan et al., 2016), we showed that recombinant Norbin binds P-
Rex1 and stimulates its Rac-GEF activity directly. Overexpression of Norbin in HEK293 cells 
promoted P-Rex1 activity upon stimulation of LPAR-family GPCRs with LPA. Co-expression of 
both Norbin and P-Rex1 in endothelial cells induced robust membrane translocation of both 
proteins and elicited Rac-mediated cell morphologies (Pan et al., 2016). From this study, we 
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concluded that Norbin promotes P-Rex1 function largely by bringing this Rac-GEF into 
proximity of its activators, PIP3 and G, and of its substrate Rac, thus facilitating Rac-
dependent cell responses.  
Based on this literature, I decided to perform the following assays in order to 
characterise the underlying molecular mechanism through which Norbin might affect 
neutrophil responses: (i) testing of the effects of Norbin deficiency on GPCR-dependent Rac 
activity, as well as other GPCR signalling pathways in neutrophils; (ii) evaluation of the 
effects of Norbin deficiency on GPCR trafficking in neutrophils. 
 
5.2 GPCR-dependent activation of Rac is increased in Norbin-
deficient neutrophils 
First, I tested Rac activity. I used PAK-CRIB pull down assay to isolate active Rac1 and Rac2 
from total lysates (TL) of isolated Ncdnfl/fl and Ncdn‒/‒ neutrophils after stimulation with 
increasing doses of fMLP for 10 seconds. This assay is based on the ability of GTP-loaded, but 
not the GDP-loaded, forms of Rac1 and Rac2 to bind to the CRIB domain of the kinase PAK 
with high affinitiy. As expected, Rac1 and Rac2 activity increased with increasing doses of 
fMLP in the Ncdnfl/fl control cells. Surprisingly, the fMLP-stimulated activity of both Rac1 and 
Rac2 was higher in Ncdn‒/‒ cells compared to Ncdnfl/fl control cells at all concentrations of 
fMLP tested, whereas basal Rac activity in mock-stimulated cells was near the detection limit 
and no higher in the Norbin-deficient cells than in controls (Figure 5.1A).  
Quantification of the Rac1 and Rac2 activities by densitometric analysis of WBs from 
3-7 independent experiments showed that active Rac1 made up 0.17±0.08% of the total 
Rac1 in buffer-treated Ncdnfl/fl control cells and 0.9±0.29% in fMLP-stimulated cells. No 
significant difference was seen between LysMCre and Ncdnfl/fl cells. Similarly, in buffer-
treated Ncdn‒/‒ cells Rac1 activity was no different to the control cells. However, fMLP 
stimulation increased Rac1 activity in Ncdn‒/‒ cells to 1.85±0.81% of the total, a two-fold 
increase compared to Ncdnfl/fl (Figure 5.1B). Quantification of Rac2 activity showed a similar 
pattern. 0.03% of Rac2 was active in buffer-treated Ncdnfl/fl cells and 0.41% upon fMLP 
stimulation. Again, LysMCre cells and buffer-treated Ncdn‒/‒ cells were no different to 
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controls, but fMLP stimulation of Ncdn‒/‒ cells increased active Rac2 to 1.08±0.32% of the 
total, a 2.5-fold increase compared to Ncdnfl/fl (Figure 5.1C). (Note that Figure 5.1 shows 
normalised data, for clearer graphical representation, but quantification and statistical 
analysis were done on raw data). 
Therefore, Norbin-deficiency increases the GPCR-dependent activation of Rac1 and Rac2.  
In addition, fMLP-stimulated Rac1 activity in Ncdn‒/‒ Prex‒/‒ neutrophils (1.16±0.34% 
of total) was similar to the level in Ncdn‒/‒ cells, which showed that Prex1 is not required for 
the effects of Norbin-deficiency on Rac1 activity (Figure 5.1B). In contrast, fMLP-stimulated 
Rac2 activity was not significantly increased in Ncdn‒/‒ Prex‒/‒ neutrophils compared to 
controls, which revealed that the GPCR-mediated activation of Rac2 depends on Prex1 even 
when Norbin is deleted (Figure 5.1C). These results are in accordance with the literature 
showing that Prex1 has a substrate preference for Rac2 over Rac1 (Welch et al., 2005).  
Hence, Norbin expression limits the GPCR-mediated activation of Rac1 and Rac2 in 
neutrophils, and the deletion of Norbin is sufficient to relieve this suppression. Furthermore, 













 (red) neutrophils were prewarmed to 37°C for 3 min and then 
stimulated with increasing concentrations of fMLP, as indicated, for 10 s, lysed and subjected to PAK-CRIB 
assay to measure Rac1 and Rac2 activation as described in Materials and Methods. The levels of active 
(GTP-loaded) Rac1 and Rac2 were determined by WB. 2% of the total lysate was blotted as a control for 
total Rac1 and Rac2 levels and blots were processed in parallel to allow a direct comparison. Representative 
WB from one experiment representative of 3 independent experiments are shown. (B and C, left-hand 











 neutrophils mock stimulated (top panel) or stimulated with 10 M fMLP (middle panel) and 
subjected to PAK-CRIB assay compared to 2% of total lysate control (bottom panel). (B and C, right-hand 
panels) Quantification of Rac1 and Rac2 activity by densitometric analysis of WBs such as those shown on 
the left panel. (B-C) Rac1 and Rac2 activities were calculated as a percentage of the total lysate control and 
are expressed as normalised to the fMLP-stimulated Ncdn
fl/fl
 condition. Each dot is the mean of one 
experiment. Data are mean ± SEM of the indicated number of independent experiments. Statistical 
significance was assessed on the log-transformed raw data (non-normalised) using two-way Anova with 
Dunnett’s multiple comparisons test.  
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5.3 Norbin deficiency increases GPCR-dependent Erk activity 
To analyse other GPCR-dependent signalling pathways, I measured the fMLP-stimulated 
activation of Erk, p38Mapk, Jnk and Akt in TNF/GM-CSF-primed isolated neutrophils from 
Ncdnfl/fl and Ncdn‒/‒ mice. Cells were mock-stimulated or stimulated with different doses of 
fMLP (0.3 M or 1 M) for 10, 45 or 180 seconds. Activity of the signalling pathways was 
assessed in total neutrophil lysates by western blotting for the activated phosphorylated 
form of proteins and the total protein (Figure 5.2A). The western blots showed that fMLP 
stimulation induced an activation of all these pathways, with a distinct peak of activity at 1 
M fMLP and 45 seconds. Quantification by densitometric analysis showed that, fMLP-
stimulated phospho-Erk levels were 2-fold higher in Ncdn‒/‒ neutrophils compared to 
Ncdnfl/fl cells under this conditions (Figure 5.2B). In contrast, no significant difference was 
seen between Ncdnfl/fl and Ncdn‒/‒ cells in the other GPCR signalling pathways (p38Mapk, Jnk 
and Akt) under any of the conditions tested (Figure 5.2B). In summary, Norbin deficiency 
increases fMLP-stimulated Erk activity, which shows that Norbin limits this pathway when it 
is expressed. However, Norbin did not obviously affect other GPCR signalling pathways 







Figure 5.2: Norbin-deficient neutrophils have increased fMLP-stimulated Erk activity, whereas several 
others GPCR signalling pathways seem unaffected 
(A) Representative WBs showing the phospho-protein levels and total protein levels of indicated signalling 




 mice. Neutrophils 
were primed for 45 min at 37°C with 20 ng.mL
-1
 TNF and 50 ng.mL
-1
 GM-CSF prior to stimulation with the 
concentrations of fMLP and the time points indicated. (B) Quantification of the activities of the indicated 
signalling proteins by densitometric analysis of WBs such as those shown on the left. Quantitated are the 
mock-stimulated conditions and the stimulation with 1 M fMLP at 45 s. Activity was calculated by dividing 
the band intensities of phospho-proteins by the total protein controls. Each dot is the mean of one 
experiment. Data are mean ± SEM of 3-6 independent experiments as indicated. Statistical significance was 
assessed using two-way Anova with Sidak’s multiple comparisons test. 
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5.4 Norbin-deficiency increases the cell surface levels of several 
GPCRs 
As introduced in section 5.1, Norbin is known to regulate the steady-state surface levels of 
GPCRs. Furthermore, preliminary data from Dr Martin Baker, a former PhD student in the 
laboratory, demonstrated that P-Rex1 also controls GPCR trafficking. He showed that Prex1 
deficiency affects the level of the endogenous GPCR C5aR1 on the surface of neutrophils 
upon stimulation with the chemoattractant ligand C5a. He also showed that overexpression 
of Prex1 in HEK293 cells blocks the internalisation of the GPCR S1PR1 induced by stimulation 
with the agonist S1P (unpublished). These data prompted me to investigate if Norbin 
modulates GPCR trafficking in neutrophils, and whether this function would be Prex1 
dependent.  
To assess the effects of Prex1 and/or Norbin deletion on the levels of GPCRs on the 
neutrophil surface, I used antibodies against the endogenous neutrophil GPCRs C5aR1, 
CXCR1, CXCR2 and CXCR4, to detect their cell surface levels by flow cytometry. These 
experiments were done in crude bone-marrow cells instead of purified neutrophils in order 
to preserve receptor levels on the cell surface as much as possible by minimising preparation 
time and handling. The cells were subjected to various different conditions: either they were 
kept on ice throughout, to maintain basal levels of the receptors at the cell surface and 
prevent any receptor trafficking. Alternatively, they were incubated for 30-45 min to allow 
constitutive receptor trafficking to occur, or they were primed in order to induce maximal 
upregulation of receptors to the plasma membrane. In some instances, cells were also 
stimulated with receptor ligand, in order to elicit agonist-induced receptor internalisation.  
First, I tested C5aR1, the receptor for C5a, because this was one of the stimuli that 
had induced increased ROS production in Ncdn‒/‒ cells in my previous experiments. Bone-
marrow cells from Ncdnfl/fl and Ncdn‒/‒ mice were stimulated with 100 nM C5a for 10 and 30 
min, or were mock-stimulated for 30 min at 37°C. Cells were then stained with PE-C5aR1 
antibody and with antibodies for neutrophil markers, FITC-Gr1 or BV510-Ly6G and AF647-
Cd11b, followed by analysis through flow cytometry (see Table 3.5 of antibodies in Materials 
and Methods for conditions). Neutrophils were identified by their characteristic forward and 
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side scatter as well as by these markers, whilst the mean signal of PE-C5aR1 was used as a 
measure of the surface expression of the endogenous GPCR.  
I found that, under mock-stimulated conditions, GPCR C5aR1 surface levels were 
1.56-fold higher in Ncdn‒/‒ cells compared to Ncdnfl/fl cells, which shows that, under 
conditions which allow some level of constitutive receptor trafficking, Norbin-deficient 
neutrophils have more C5aR1 on their surface than control cells. In contrast, the agonist-
induced internalization of C5aR1 in response to C5a stimulation was normal in Ncdn‒/‒ cells, 
in accordance with the literature on the role of Norbin in constitutive GPCR trafficking but 
not in ligand-induced trafficking (Figure 5.3A). To corroborate this further, TNF/GM-CSF-
primed neutrophils induced a five-fold increase in C5aR1 surface levels in Ncdnfl/fl cells 
compared to basal condition (cells on ice, no trafficking), but in Ncdn‒/‒ neutrophils this was 
even higher, by a further 1.33-fold compared to Ncdnfl/fl cells. In contrast, under basal 
condition that allow no trafficking, receptor surface levels were normal (Figure 5.3B). 
Moreover, comparison of mock-stimulated cells from four genotypes revealed that, despite 
the expected increase in C5aR1 surface levels in Ncdn‒/‒ compared to Ncdnfl/fl cells (1.48-
fold), the level of C5aR1 was normal in Prex‒/‒ and Ncdn‒/‒ Prex‒/‒ neutrophils, which showed 
that the upregulation of this GPCR to the cell surface of Norbin-deficient cells was 
dependent on the expression of Prex1 (Figure 5.3C). 
In summary, Norbin-deficiency leads to an upregulation of the GPCR C5aR1 on the 
neutrophil surface under conditions that allow constitutive receptor trafficking, in a Prex1-
dependent manner, but it does not obviously affect agonist-induced receptor internalisation. 
The increased surface level of C5aR1 could explain, at least in part, why C5a-stimualted ROS 









Figure 5.3: Norbin-deficient neutrophils have increased cell surface levels of the GPCR C5aR1 under 
conditions that allow constitutive GPCR trafficking 




 mice were incubated for 30 min at 37°C in the absence 
(mock) or presence of 100 nM C5a, or C5a was added for the last 10 min of this incubation, as indicated, 
before the cells were transferred onto ice and stained to investigate the levels of C5aR1 on the neutrophil 




 mice were primed with 20 
ng.mL
-1
 murine TNFα and 40 ng.mL
-1
 GM-CSF for 45 min at 37°C, or were left on ice (basal) before being 
transferred onto ice and stained to investigate the levels of C5aR1 on the neutrophil surface by flow 












 mice were incubated for 
30-45 min at 37°C, before being transferred onto ice and stained to investigate the levels of C5aR1 on the 
neutrophil surface by flow cytometry. Neutrophils were detected by their scatter characteristics and FITC-
Gr1 (Ly6C and LY6G) or BV510-Ly6G and AF647-Cd11b antibody staining, whilst C5aR1 surface levels were 
detected by PE-C5aR1 antibody. All conditions were assessed in parallel. Each dot is the mean of one 
experiment. Data are mean ± SEM of the indicated number of independent experiments. Statistical 
significance in (A) and (B) was assessed using two-way Anova with Sidak’s multiple comparison test and (C) 
by one-way Anova with Tukey’s multiple comparisons test.  
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The literature shows that primary sequence cannot predict which GPCRs Norbin can 
bind and which not (H. Wang et al., 2015; H. Wang et al., 2009). Therefore, to get a picture 
of how wide-ranging the effects of Norbin-deficiency are on surface levels of other GPCRs in 
addition to C5aR1, we decided to use a candidate approach, choosing a selection of other 
important neutrophil GPCRs for which antibodies were commercially available. I found 
antibodies against CXCR1, CXCR2 and CXCR4 which were able to detect endogenous GPCR 
levels by flow cytometry. Again, crude bone-marrow cells were used in order to preserve 
receptor levels on the cell surface as much as possible, and cells were either left on ice 
(basal) or primed with TNF/GM-CSF for 30 min at 37°C. Cells were then stained with the 
GPCR antibodies and neutrophil markers, followed by analysis through flow cytometry. The 
neutrophils were identified by their characteristic forward and side scatter and by their 
mean signal of PE-CXCR1, PE-CXCR2 or PE-CXCR4 was used as a measure of surface 
expression of the endogenous GPCRs.  
From these experiments, I saw that the surface levels of CXCR4 (the receptor for SDF-
1) were higher in Ncdn‒/‒ compared to Ncdnfl/fl cells under both basal and primed 
conditions (Figure 5.4A). Hence, as seen with C5aR1, Norbin-deficiency led to increased 
levels of this GPCR on the neutrophil surface. However, unlike C5aR1, the upregulation of 
CXCR4 occurred even under conditions that minimised receptor trafficking, which suggested 
that either CXCR4 is stored on a more readily mobilised type of vesicle than C5aR1, or the 
total cellular levels of CXCR4 could be elevated in Ncdn‒/‒ cells. Unlike either C5aR1 or 
CXCR4, the surface levels of CXCR1 and CXCR2 were unaffected by the Norbin deficiency 
(Figure 5.4B and C), which is in accordance with the literature that showed these GPCRs to 
be constitutively localised on the plasma membrane instead of granules, or alternatively 
they may not be affected because Norbin cannot physically interact with these particular 
GPCRs. 
The reduction of CXCR2 of the neutrophil surface upon priming was expected, as this 
GPCR is known to be shed rapidly from the neutrophil surface upon stimulation with TNF, 
by proteolysis cleavage (Asagoe, Yamamoto, Takahashi, Suzuki, et al., 1998). Both basal and 
shed levels of CXCR2 were normal in Ncdn‒/‒ cells (Figure 5.4C). Based on these results, we 
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can conclude that the effects of Norbin deficiency on receptor trafficking show some degree 
of specificity for certain types of GPCRs. 
 
In order to test whether Norbin can affect any other type of neutrophil surface 
protein, in addition to GPCRs, I tested the surface of Mac-1 integrin, one of the major 
neutrophil 2-integrins (Figure 5.5). Mac-1 surface levels were normal both under basal and 
primed conditions. Furthermore, Dr Dingxin Pan, who generated the Norbin-deficient mouse 
 
 
Figure 5.4: Norbin-deficient neutrophils have constitutively increased surface levels of the GPCR CXCR4 
and normal surface levels of CXCR1 and CXCR2 




 mice were primed with 20 ng.mL
-1
 murine TNFα and 40 ng.mL
-1
 
GM-CSF for 30 min at 37°C, or left on ice (basal), before being transferred onto ice and stained to investigate 
the levels of the GPCRs on the neutrophil surface by flow cytometry. Neutrophils were detected by their 
scatter characteristics and FITC-Gr1 (Ly6C and Ly6G) antibody staining, whilst GPCR surface levels were 
detected by (A) PE-CXCR4, (B) PE-CXCR1 or (C) PE-CXCR2 antibodies. All conditions were assessed in parallel.  
Each dot is the mean of one experiment. Data are mean ± SEM of 3 independent experiments. Statistical 




strains, tested the surface levels of the neutrophil selectin L-selectin and of the selectin-
ligand PSGL1, as well as of the other major neutrophil 2-integrin LFA-1 (unpublished data). 
Again, the levels of these proteins on the surface of Ncdn‒/‒ neutrophils were normal, both 
under basal and primed conditions (Appendix A, Supplementary Figure 2). 
To summarise, Norbin-deficiency leads to an upregulation of some but not all GPCRs 
onto the neutrophil surface, and it does not affect the surface levels of several other major 




Figure 5.5: Norbin-deficient neutrophils have normal cell surface levels of Mac-1 integrin 






 mice were primed with 20 ng.mL
-1
 murine TNFα and 
40 ng.mL
-1
 GM-CSF for 45 min at 37°C, or left on ice (basal), before being transferred onto ice and stained to 
investigate the level of Mac-1 integrin on the neutrophil surface by flow cytometry. Neutrophils were 
detected by their scatter characteristics and BV510-Ly6G and AF647-Cd11b (Mac-1) antibody staining. All 
conditions were assessed in parallel. Data are mean ± SEM of 3 independent experiments. Statistical 
significance was assessed using two-way Anova with Sidak’s multiple comparisons test. 
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 - Myeloid Norbin-deficiency increases immunity Chapter 6
6.1 Introduction: Neutrophils and macrophages in in vivo early 
inflammation models 
Based on the results described in Chapters 4 and 5, I decided to test the functional role of 
myeloid Norbin in vivo, regarding both the recruitment of leukocytes to sites of 
inflammation and antibacterial immunity. For this aim, I used two different animal models of 
inflammation: (i) thioglycollate (TGC)-induced sterile peritonitis and (ii) Streptococcus 
pneumoniae-induced pulmonary infection. 
The TGC-induced sterile peritonitis model is a well-established model for studying 
neutrophil recruitment to sites of inflammation (Baron & Proctor, 1982; Call et al., 2001; 
Leijh, Vanzwet, Terkuile, & Vanfurth, 1984; Y. M. Li, Baviello, Vlassara, & Mitsuhashi, 1997; 
Melnicoff, Horan, & Morahan, 1989). The peritoneal cavity of healthy mice contains resident 
macrophages (around 90% of leukocytes present), B1 lymphocytes (around 5-10%) and some 
basophils and mast cells. Mice respond to i.p. challenge with the irritant TGC by initially 
recruiting neutrophils, and then other types of inflammatory cells, into the inflamed 
peritoneal cavity. This recruitment starts immediately after challenge, with circulating 
neutrophils emigrating out of the blood stream into the inflamed peritoneum within the 
hour and peaking at 3 h (Pan et al., 2015), followed by mobilisation of a storage pool of 
mature neutrophils out of the bone marrow compartment (depending on the dose of TGC 
used), and then the maturation and mobilisation of bone marrow neutrophil precursors, 
which reach the peritoneal cavity later that day (Remick et al., 2001). Other leukocytes types 
are recruited more slowly. The recruitment of monocytes into the inflamed-peritoneal cavity 
usually occurs from 12 h onwards for several days (Cook, Braine, & Hamilton, 2003; Mooney 
et al., 2010), and these cells differentiate into macrophages at the site of inflammation, 
remaining present around 5-7 days after challenge, when lymphocytes become recruited. 
Overall, aseptic peritonitis is resolved within one week, although lymphocytes can remain in 
the peritoneal cavity until two weeks after challenge (Cook et al., 2003).  
I chose quite a low dose of TGC (i.p. administration of 0.25 mL of 3% TGC) (Pan et al., 
2015) compared to many other studies. Furthermore, I sacrificed the mice 3 h after TGC 
challenge, at the peak of early neutrophil recruitment (Pan et al., 2015), before culling the 
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mice and performing peritoneal lavages. These conditions were sufficient to elicit neutrophil 
recruitment while mice showed no more than mild clinical signs. Peritoneal lavage cells were 
counted by haemocytometer and identified by both cytostaining and flow cytometry.  
The second model was a bacterial infection, which allowed me to evaluate innate 
immunity as well as leukocyte recruitment. As the Babraham Institute is interested in host 
defence during ageing, I chose a model of bacterial pneumonia, as this type of infection is 
particularly relevant in ageing. There are several approaches for establishing bacterial 
pneumonia in mice, and I chose intranasal (i.n.) infection with Streptococcus pneumoniae. 
S. pneumoniae (pneumococcus) is a gram-positive category II pathogen that is the 
leading cause of community-acquired pneumonia, particularly harmful in young children, the 
elderly and immunocompromised adults, resulting in high morbidity and mortality in both 
developing and industrialized countries. Around 4 million people die worldwide each year 
from S. pneumoniae infections (Dockrell, Whyte, & Mitchell, 2012). 
In healthy individuals, S. pneumoniae is a common inhabitant of the upper 
respiratory tract where it persists as a commensal bacterium usually for a period of weeks or 
months, generally without any adverse consequences (Bogaert, De Groot, & Hermans, 
2004). Both in humans and in mice, the course of infection with S. pneumoniae commences 
with asymptomatic colonisation of the nasopharynx, which (despite the absence of 
symptoms) has an immunising effect (Gillespie & Balakrishnan, 2000; Richards, Ferreira, 
Miyaji, Andrew, & Kadioglu, 2010). Lower respiratory tract infection is presumed to occur 
upon microaspiration of S. pneumoniae from the nasopharynx, and can persist in the lower 
airway mucosa when resident alveolar macrophages fail to clear the bacteria through 
ineffective phagocytosis. These alveolar macrophages, as well as lung epithelial cells, release 
pro-inflammatory cytokines into the lung tissue and airways to attract first neutrophils 
(within a few hours) and later on other types of leukocytes (Bergeron et al., 1998; Gillespie & 
Balakrishnan, 2000). At high doses of S. pneumoniae, influx of neutrophils was reported to 
increase further even after 24 hours (Fillion et al., 2001). Neutrophil recruitment to the S. 
pneumoniae infected lung depends on the integrins Mac-1 and α4β1 (Kadioglu et al., 2011). 
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If the infection remains uncontrolled at this stage, the bacteria multiply rapidly in the 
alveoli followed by an increase in monocyte and lymphocyte recruitment, which peaks 3 
days after the inoculation. Then, the bacteria can also invade the blood stream, causing 
septicaemia. If bacterial infection is not sufficiently controlled during this final stage (72-96 
hours), due to an immune-suppression or immuno-deficiency, further bacterial 
multiplication occurs, leading to massive tissue damage and high mortality (Gillespie, 
Mcwhinney, & Kibbler, 1991; Braun, Novak, Gao, Murray, & Shenep, 1999; Cauwels, Wan, 
Leismann, & Tuomanen, 1997; Gillespie & Balakrishnan, 2000). 
There is some controversy in the literature as to how important neutrophils are for 
clearing pulmonary S. pneumoniae infections. During infection with low doses (104) of S. 
pneumoniae, no recruitment of neutrophils was seen, and alveolar macrophages alone were 
able to clear the infection, as shown by experimental macrophage depletion (Dockrell et al., 
2003). However, further studies clearly showed that neutrophils are important for 
accelerating the clearance of S. pneumoniae (Dockrell et al., 2012). Neutrophil depletion in 
neonate vs adult mice showed furthermore that neonates are more dependent on 
neutrophils than adults for clearing S. pneumoniae from lungs (Garvy & Harmsen, 1996). 
Moreover, neutrophils were shown to secrete TRAIL (TNF-related apoptosis-inducing ligand) 
during pulmonary infection with S. pneumoniae, and this neutrophil-derived TRAIL promoted 
macrophage death through the apoptotic rather than the necrotic route, thus limiting 
overwhelming lung inflammation, while at the same time improving bacterial clearance and 
survival of the mice (Steinwede et al., 2012). The drawback of neutrophil recruitment to the 
S. pneumoniae infected lung is that the activated neutrophils also mediate much of the 
tissue damage associated with this infection (Dockrell et al., 2012). Taken together, it seems 
clear that neutrophils are important for the early response to pulmonary infection with S. 
pneumoniae, except perhaps under conditions of very low bacterial titres and with some 
dependence on the age of the subject. 
I chose a medium-titre dose of S. pneumoniae (i.n. administration of 2 x 106 CFU 
bacteria per mouse in a volume of 50 L), which would result in around 50% of wild type 
mice dying after 4 days if the disease were allowed to progress to that stage (A. K. Stark et 
al., 2018). In the early phase of the infection this dose has been reported to induce a 
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moderate pneumonia characterised by a mild neutrophilic alveolitis peaking by 24 h (Taut et 
al., 2008). In order to optimise conditions, I also performed a time course of neutrophil 
recruitment, and based on these data I studied the effects of Norbin deficiency at two 
different time points. Finally, to address the controversy in the literature about the 
importance of neutrophils in clearing S. pneumoniae, I also tested this directly as part of my 
study, by depleting neutrophils prior to the infection. 
To summarise, in this chapter, I will describe the effects of murine Norbin deficiency 
and Norbin/Prex deficiency on neutrophil recruitment during (TGC)-induced sterile 
peritonitis and during pulmonary challenge with S. pneumoniae, as well as defining the 
ability of these mice to clear pulmonary S. pneumoniae infections, and the neutrophil-
dependence of this response. 
 
6.2 Norbin-deficiency does not affect neutrophil recruitment 
during aseptic peritonitis 
We know from previous work in the laboratory that Prex-deficiency reduces the recruitment 
of neutrophils to the peritoneum during TGC-induced aseptic peritonitis (Welch et al., 2005). 
Here, I tested the functional role of Norbin in neutrophil recruitment during TGC-induced 
aseptic peritonitis, by comparing Ncdnfl/fl, LysMCre and Ncdn‒/‒ mice using the conditions 
described in the introduction to this chapter (i.p. administration of 0.25 mL of 3% TGC, culls 
and lavages after 3 h). In order to assess the effect of combined Norbin- and Prex- 
deficiency, compared to Prex-deficiency alone, I also tested Prex+/+, Prex‒/‒ and Ncdn‒/‒ Prex‒
/‒ mice under the same conditions.  
In each experiment, mock-treated and TGC-treated mice from the different mouse 
strains were compared in parallel. I tested fewer mock-stimulated than TGC-stimulated 
mice, to reduce mouse numbers as much as possible, and as previous projects in the 
laboratory had shown that very few neutrophils are present in the peritoneum of control 
mice under the very clean conditions of the Babraham animal facility (individual ventilated 
cage (IVC) housing and all husbandry performed in air-filtered change stations). I analysed all 
experiments both by cytospin microscopy and by flow cytometry, again because previous 
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work in the laboratory had shown slight variations between the results obtained by these 
methods. The cytospin results are presented here first.  
As expected, mock-treated control animals from all strains had very few neutrophils 
in their peritoneum, fewer than 104 cells per animal. Most (around 90-95%) of the total 
peritoneal lavage leukocytes under these conditions (around 106 per mouse) were resident 
peritoneal macrophages, and the rest were mostly B1 lymphocytes (Figures 6.1A and 6.2A, 
left-hand panels). In contrast, at 3 h after TGC challenge there was substantial recruitment of 
neutrophils into the peritoneum (Figures 6.1A and 6.2A, right-hand panels). This was clearly 
visible both in the cytospins (Figure 6.1A) and in the flow cytometry plots (Figure 6.2A), 
where there was an evident increase in the number of Gr1 (Ly6C & Ly6G) high, Mac-1 high 
cells (neutrophils) between control and TGC-injected mice. 
Cytospin analysis showed that neutrophil recruitment into the peritoneum of the 
different control mouse strains 3 hours after TGC challenge was similar, where 0.69±0.10 x 
106, 0.96 ± 0.21 x 106 and 0.81 ± 0.11 x 106 neutrophils were recruited in Ncdnfl/fl, LysMCre 
and Prex+/+ control animals, respectively. In contrast, 1.15 x 106 neutrophils were recruited 
into the peritoneum of Ncdn–/– mice, suggesting that Norbin deficiency might cause a mild 
increase in the recruitment of neutrophils to the peritoneum (Figure 6.1B, left-hand panel). 
However, this increase reached statistical significance only compared to the Ncdnfl/fl control 
strain but not the LysMCre control strain. Hence, overall Norbin-deficiency had no significant 
effect on neutrophil recruitment, judging by cytospin analysis. 
As discussed above, a previous study from our lab had shown that TGC-induced 
neutrophil recruitment to the inflamed peritoneum is reduced by 50% in Prex1–/– mice 
(Welch et al., 2005). I obtained similar results here with Prex–/– animals. As shown in Figure 
6.1B (right-hand panel), 0.35 ± 0.12 x 106 Prex–/– neutrophils were recruited into the 
peritoneum of Prex–/– animals in response to TGC, a significant reduction compared to 0.91 x 
106 in the Prex+/+ control mice. Furthermore, in the Ncdn–/– Prex–/– double deficient mice, 
only an average of 0.26 ± 0.07 x 106 neutrophils were recruited into the peritoneum under 
the same conditions. This means the double-deficient mice have as little neutrophil 
recruitment as the Prex–/– mice, and less than the Ncdn–/– mice, which implies that Prex1 is 
required for neutrophil recruitment regardless of whether Norbin is expressed or not.  
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Comparison of the neutrophil counts with total leukocyte counts in the peritoneal 
lavages showed that neutrophil recruitment largely accounted for the increase in total 
leukocyte numbers observed in the TGC-inflamed peritoneum, showing an increase from the 
1 x 106 residential cells in mock-treated mice to 2 x 106 total leukocytes in TGC-treated mice 
across the various genotypes, except in the Prex–/– and Ncdn–/– Prex–/– strains which had low 
neutrophil recruitment. Because of the low number of mock-treated control mice used, I 
could not perform a statistical analysis of the TGC-induced increase in total leukocyte 
numbers. However, overall these total leukocyte numbers suggested that, after 3 h of TGC 
challenge, neutrophils were the predominant cell type recruited during this early 
inflammatory response, as expected (Figure 6.1B and C). 
To summarise the results obtained by cytospin analysis, Norbin deficiency does not 
significantly affect neutrophil recruitment during TGC-induced aseptic peritonitis, and Prex1 
















Figure 6.1: Norbin deficiency does not affect neutrophil recruitment during TGC-induced sterile peritonitis 
Mice of the indicated genotypes were challenged by intraperitoneal injection of 0.25 mL 3% thioglycollate 
(TGC) in water or were mock-treated with water. Mice were culled by CO2 asphyxiation 3 h after the 
injection. Peritoneal lavages were performed and the number of neutrophils recruited to the peritoneum 
assessed by haemocytometer and cytospin microscopy. (A) Representative cytospin images of peritoneal 
neutrophil recruitment from mock-treated (left-hand panel) and TGC-injected (right-hand panel) Ncdn
fl/fl
 
neutrophils. Peritoneal lavage cells were cytospun and then fixed and stained with Kwick-Diff reagent. The 
red arrows point to resident peritoneal macrophages, the blue arrow to a resident lymphocyte and the 
green arrows to neutrophils, identified by their characteristic nuclear morphology. (B) Quantification of the 
total number of neutrophils recruited into the peritoneum, and (C) the total number of leukocytes in the 
peritoneum, as assessed by cell counting and cytospin analysis. Each dot represents one mouse. Data are 
mean ± SEM of 2-7 mock-treated mice and 8-18 thioglycollate-injected mice per genotype, pooled from 7 
independent experiments. Statistical significance was assessed using two-way Anova with Tukey’s multiple 
comparisons test.  
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In parallel to the cytospin analysis, the same experiments were also analysed by flow 
cytometry (Figure 6.2). Quantification of the Gr1/Mac-1 high cells showed again that Ncdn–/– 
mice had increased neutrophil recruitment in response to TGC-challenge compared to the 
Ncdnfl/fl mice but not compared to the LysMCre mice (Figure 6.2B left-hand panel). Also, Prex 
deficiency was again seen to significantly decrease TGC-induced neutrophil recruitment, and 
Norbin deficiency could not override this requirement for Prex1 in the (Ncdn–/– Prex–/–) 
double KO mice (Figure 6.2B, right-hand panel). Compared to the cytospin analysis, fewer 
neutrophils were identified in the peritoneal lavages by flow cytometry, although the 
differences between genotypes were similar. The lower neutrophil numbers seen by flow 
cytometry can be explained by the flow cytometric analysis taking only single cells into 
account, whereas microscopy analyses allowed for identification of cells that were adherent 
to others. Indeed, we observed by cytospin that neutrophils were often recovered in groups, 
particularly upon TGC-challenge, presumably because the inflammation stimulated cell-cell 
adhesion. As a consequence of this apparently lower level of neutrophil recruitment 
detected by flow cytometry, the increase in total leukocytes that had been observed by 
cytospin analysis was not obvious by flow cytrometric analysis. 
Taken together, however, both methods of analysis gave essentially the same results, 
namely that Norbin deficiency does not significantly affect neutrophil recruitment during 
aseptic peritonitis, and that Prex1 is required regardless of whether Norbin is expressed or 
not. The apparent small increase in neutrophil recruitment in Norbin-deficient mice was only 
seen in comparison to the Ncdnfl/fl control strain but not compared to LysMCre, and the 
variability between individual mice was large enough to suggest that these control strains 













Figure 6.2: Norbin-deficiency does not affect neutrophil recruitment to the TGC-inflamed peritoneum 
The same peritoneal lavage samples of TGC-treated and mock-treated mice in Figure 6.1 were analysed in 
parallel by flow cytometry. (A) Representative gating of total leukocytes in forward (FSC) and side scatter 
(SSC) plots and identification of neutrophils by FITC-Gr1 (Ly6C & L6G) high and AF647-Mac-1 (Cd11b) high 
staining is shown for mock-treated and TGC-injected Ndnc
fl/fl
 mice, as indicated. Spherotech beads were 
used as a counting reference. (B) Number of neutrophils recruited to the peritoneum, identified by Gr1 (Ly6c 
& Ly6G) high and Mac-1 high staining. (C) Total number of leukocytes in the peritoneum, identified by FSC 
and SSC signals compared to the Spherotech bead standard. Each dot represents one mouse. Data are mean 
± SEM of 2-7 mock-treated mice and 8-18 TGC-injected mice per genotype, up to 3 mice per genotype per 
day, pooled from 7 independent experiments. Statistical significance was assessed using two-way Anova 
with Tukey’s multiple comparisons test. 
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6.3 Characterisation of pulmonary infection with S. pneumoniae 
I initially learnt the model of S. pneumoniae-induced acute lung inflammation from Dr Anne-
Katrien Stark (Okkenhaug lab, Laboratory of Lymphocyte Signalling and Development, 
Babraham Institute) who used it to study the role of lymphocytes in the late stage of this 
infection (A. K. Stark et al., 2018). Dr Stark also provided me throughout this study with 
bacterial stocks (TIGR4, serotype 4) that were kept virulent by in vivo passage at least once a 
year and were characterised for their haemolytic ability by growth on blood agar. I began by 
performing pilot experiments with Ncdnfl/fl control mice to adapt the conditions for the 
purpose of my study of the early, neutrophil-dependent stage of this infection model.  
To assess the dynamics of S. pneumoniae-induced neutrophil recruitment and the 
survival of bacterial colony-forming units (CFUs) in the infected lung in vivo, I carried out a 
time course study in Ndncfl/fl mice. Mice were inoculated with a 50 L inoculum containing 2 
x 106 S. pneumoniae CFU under light general anaesthesia, or were mock-treated with buffer 
only, and were then culled for analysis after various time points from 3 h up to 24 h. 
Broncho-alveolar lavage (BAL) was performed, followed by perfusion of the lung with DPBS 
and excision and homogenisation of the perfused lung. Both BAL and lung homogenates 
were analysed for the presence of leukocytes and for the survival of bacteria. 
The BAL recovers cells from the alveolar airspace. In mock-infected mice, these 
lavage cells are largely resident alveolar macrophages and a few lung epithelial cells. In S. 
pneumoniae infected mice, the lavage additionally contains leukocytes that extravasated 
from the alveolar vasculature through the interstitium and alveolar epithelium into the 
airspace. In contrast, the perfused lung homogenate contains leukocytes that are sufficiently 
firmly adhered (either within the vasculature, in the interstitium or on the surface of the 
lung epithelium) not to have been flushed away by the perfusion. 
To best describe the optimisation of the infection model, I present here the collated 
data from all experiments and time points performed with Ncdnfl/fl control mice, instead of 
showing data from individual pilot experiments. Mock-treated animals (stippled lines) had 
5.6 x 101 neutrophils and 5.20 x 103 macrophages in the BAL, and they had 1.72 x 103 
neutrophils and 4.21 x 104 monocytes/macrophages in the perfused lung (Figure 6.3A and 
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B). Hence, there were very few tissue resident neutrophils in the steady state, as previously 
reported (Kreisel et al., 2010). The number of neutrophils in the BAL increased to 1.49 x 103 
at 18 h (Figure 6.3A), likely because the i.n. mock treatment caused a low level of 
inflammation, whereas neutrophil numbers in the lung homogenate of mock-infected mice 
remained constant throughout the time course (Figure 6.3B). 
In mice infected with S. pneumoniae, neutrophil numbers were markedly increased 
even at the earliest time point tested, 3 h after inoculation, when 4-5 x more neutrophils 
(green line) were present in both BAL (2.06 x 102 cells) and lung homogenate (8.73 x 103 
cells) compared to mock-treated animals (Figure 6.3A and B). At the 6 h time point after 
infection, the number of the neutrophils recruited increased sharply to 4.14 x 103 in the BAL 
and 5.81 x 104 in the lung homogenate. It peaked at 18 h, with 7.74 x 104 neutrophils in the 
BAL and 1.92 x 106 in the lung, and remained constantly high until the final time point tested 
at 24 h (4.75 x 104 neutrophils in the BAL and 2.08 x 106 in the lung) (Figure 6.3A and B). 
Hence, these conditions of S. pneumoniae infection caused a rapid recruitment of 
neutrophils that was 52 times higher in the BAL and 330 times higher in the lung 
homogenate compared to mock-treated animals. 
In contrast to this acute neutrophil recruitment, the number of 
monocytes/macrophages (Cd11c+, Cd11b+, Ly6C+ cells) in BAL and lung homogenate 
remained much more even throughout these experiments. A constant number (5-9 x 103) of 
macrophages (purple stippled line) was present in the BAL of mock-infected mice, although a 
modest increase became evident only 24 h after the infection (1.59 x 104 cells, purple line 
(Figure 6.3A and B). Further flow cytometric analysis identified these resident leukocytes as 
alveolar macrophages, as expected (data not shown). Similarly, in the perfused lung 
homogenate of mock-treated mice, there was also a fairly constant number of macrophages 
(5-8 x 104) throughout the time course. In contrast, increased numbers of 
monocytes/macrophages were seen in the lung homogenate of S. pneumoniae infected mice 
from 6 h after the infection (4.17 x 105 cells) onwards, and this increased further to 1.25 x 
106 the end of the time course (Figure 6.3A and B). Further flow cytometric analysis 




Figure 6.3: Time course of neutrophil and monocyte recruitment in Ncdn
fl/fl 
control mice in the pulmonary 
S. pneumoniae infection model 
Ncdn
fl/fl
 mice were given an intranasal administration of 2 x 10
6
 CFU S. pneumoniae in 50 L sterile HBSS 
(solid lines) or were mock-treated with the same volume of buffer (stippled lines). Mice were culled by CO2 
asphyxiation at 3, 6, 18 and 24 h after the infection and the numbers of neutrophils (green lines), 
monocytes/macrophages (purple lines) and inflammatory monocytes (red lines) in BAL (A) and lung 






















 cells) recovered in the lung 




 cells) recovered in the lung 
homogenate. Data are mean ± SEM of 1-2 mock-treated and 2-3 S. pneumoniae-infected mice per time 
point and experiment, pooled from 4 individual experiments performed at the 3 h, 6 h and 18 h time points, 




In contrast to this presence of inflammatory monocytes in the lung homogenate, 
inflammatory monocytes (CD11b+ Ly6C+ cells) (J. Yang, Zhang, Yu, Yang, & Wang, 2014), as 
well as eosinophils (Siglec-F+, CD11C- cells) (Stevens, Taeg, Pujanauski, Hao, & Braciale, 2007) 
remained essentially absent from the BAL over the duration of the experiment (data not 
shown), as expected from other studies (Fillion et al., 2001). Therefore, it seems likely that 
the inflammatory monocytes in the lung homogenate were recruited into this tissue in 
response to the infection but had not yet transmigrated through the epithelium within the 
time-frame of these experiments.  
Overall, under the conditions tested, significant recruitment of neutrophils was seen 
both in the BAL and lung homogenate, whereas significant recruitment of monocytic cells 
was only observed in the lung homogenate, as expected (Figure 6.3). Furthermore, the 
numbers of cells recovered from the BAL were significantly lower than those in the lung 
homogenate throughout the different treatments, time points and cell types, also as 
expected.  
In parallel to neutrophil recruitment, I measured bacterial survival as colony forming 
units (CFUs), both in the BAL and in the perfused lung homogenate (Figure 6.4) of the same 
S. pneumoniae-infected and mock-treated Ncdnfl/fl control mice as shown in Figure 6.3. 
Mock-treated animals (stippled line) had 1.0-8.25 x 101 CFU of S. pneumoniae in the 
BAL and 1.0-9.66 x 101 CFU in the perfused lung, as identified by the haemolytic action of 
bacterial colonies on blood agar plates. Furthermore, the CFU in the BAL and lung 
homogenate of mock-infected mice remained constantly low throughout the time course. 
Hence, there was a negligible titre of S. pneumoniae both in the BAL and in the lung 
homogenate of control animals, as expected. This is testament to the high standard of 
cleanliness in our biological support unit. To maintain these low background titres and avoid 
cross-contamination, I adopted the practice of housing mock-treated and S. pneumoniae-
infected mice in separate isocages throughout the experiments. 
In mice infected with 2 x 106 S. pneumoniae (solid line), bacterial numbers remained 
markedly elevated in the BAL at the two earliest time point tested, 3 h and 6 h after 
inoculation. In the BAL, 1.16 x 105 CFU and 7.67 x 105 CFU were recovered at the 3 h and 6 h 
time points, respectively. The apparent increase in bacterial CFU between the 3 h and 6 h 
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time points could either reflect bacterial growth within the airspace, or be a result of 
variability between mice or technical issues. In any event, less than 40% of bacterial CFU 
were recovered at the 6 h time point compared to the titre used for infection. In contrast, 
the bacterial titre in the BAL had declined sharply at the 18 h time point to 3.26 x 102 CFU 
and dropped even further at the final 24 h time point, to 4.5 x 101 CFU, almost back to 
control levels. Hence, the largest impact on antibacterial immunity within the airspace was 
seen between the 6 h and 18 h time points.  
In the lung homogenate, 1.12 x 104 CFU and 3.81 x 105 CFU were recovered at the 3 h 
and 6 h time points after infection, respectively, and unlike in the BAL, numbers remained 
roughly at that level (5.39 x 104 CFU) at 18 h, before falling at the final 24 h time point tested 
to 3.14 x 102 CFU. Hence, bacteria are cleared from the airspace more rapidly than from the 
perfused lung tissue, presumably because bacteria survived in hard-to reach niches within 
the lung tissue. Overall, between the BAL and lung homogenate, 6 h and 18 h were the most 
interesting time points regarding the clearance of S. pneumoniae infections. 
 
 
Figure 6.4: Time course of bacterial survival in Ncdn
fl/fl 
control mice in the S. pneumoniae pulmonary 
infection model 
Serial dilutions of the same BAL (left hand panel) and perfused lung homogenate (right hand panel) samples 
from Ncdn
fl/fl
 mice infected with 2 x 10
6
 CFU S. pneumoniae or mock-treated mice as in Figure 6.3. were 
analysed for bacterial survival as colony forming units (CFU) on blood agar plates. Data are mean ± SEM of 
1-2 mock-treated and 2-3 S. pneumoniae-infected mice per time point and experiment, pooled from 4 
individual experiments performed at the 3h, 6 h and 18 h time points, and of 1 mock-treated and 6 S. 




Based on my optimisation assays, and taking into account both neutrophil 
recruitment and bacterial clearance, I chose the 6 h time point for subsequent experiments 
as a condition where substantial but not maximal neutrophil recruitment was seen, and the 
18 h time point as a condition where neutrophil recruitment was maximal and where these 
neutrophils (or alveolar macrophages) in the airspace had ample time to clear bacteria. 
 
6.4 Norbin deficiency increases the immunity of mice to 
pulmonary S. pneumoniae infection without affecting neutrophil 
recruitment 
In Chapter 4, I showed that in vitro Norbin-deficient neutrophils have elevated ROS 
production and degranulation, and an increased ability to kill S.aureus. These findings 
opened the hypothesis that Norbin deficient neutrophils might also have an increased 
capacity for killing pathogens in vivo. 
To learn whether Norbin-deficiency has an impact on antibacterial immunity in vivo, 
Ncdnfl/fl, LysMCre and Ncdn‒/‒ were tested in parallel in the pulmonary S. pneumoniae 
infection model at the 6 h and 18 h time points. To assess the effect of Prex deficiency and of 
combined Prex/Norbin deficiency, Prex+/+, Prex–/– and Ncdn‒/‒ Prex‒/‒ mice were also tested 
in the same model at the 18 h time point. 
As described in Figures 6.3 and 6.4, the mice were infected i.n. with 2 x 106 CFU S. 
pneumoniae or were mock-infected, culled after 6 h or 18 h, the bronchioles lavaged, lungs 
perfused, dissected and homogenised, and both the BAL and perfused lung homogenate 
were assessed for the survival of bacteria as CFU on blood agar, and for the numbers of the 
different leukocyte populations by flow cytometry.  
Firstly, animals from the two control strains, Ncdnfl/fl and LysMCre, were compared to 
Ncdn‒/‒ mice at the 6 h time point. As expected from the pilot experiments, mock-treated 
animals from all strains had no bacterial CFU in the BAL (Figure 6.5A, left-hand panel) or in 
the perfused lung homogenate (Figure 6.5A right hand panel). In mice infected with S. 
pneumoniae, bacterial numbers recovered in the BAL were markedly high in the Ncdnfl/fl and 
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LysMCre mice, with 6.74 x 105 and 8.82 x 105 bacteria remaining, respectively, at the 6 h time 
point, similar to the findings in the pilot experiments. In contrast, only 5.64 x 104 bacterial 
CFU were left in the BAL of Ncdn‒/‒ mice under the same conditions, a 12-fold and 16-fold 
decrease compared to Ncdnfl/fl and LysMCre mice (p=0.0003 and p<0.0001), respectively 
(Figure 6.5A left-hand panel). Therefore, Norbin deficiency increases the ability of mice to kill 
S. pneumoniae in the airspace during pulmonary infection by more than 10-fold.  
Similarly, in the perfused lung homogenates of the infected mice, bacterial numbers 
were high in Ncdnfl/fl and the LysMCre mice, with 3.33 x 105 and 1.07 x 106 bacteria present in 
the lung at the 6 h time point, whereas only 4.46 x 104 bacteria were left in the lung 
homogenate of Ncdn‒/‒ mice (Figure 6.5.A right-hand panel). Therefore, Norbin-deficient 
mice had a 7.5-fold increased capacity to kill bacteria in lung tissue compared to Ncdnfl/fl and 
24-fold increase compared to LysMCre mice (p=0.1252 and p=0.0006, respectively). 
Therefore, Ncdn–/– mice were able to clear bacteria more efficiently than the two control 
strains both from the airspace and the perfused lung tissue. 
With regards to the cell populations, mock-treated control animals from the Ncdnfl/fl, 
LysMCre and Ncdn–/– strains had very few neutrophils in the BAL, ranging between 2.2 x 101 - 
1.71 x 102 neutrophils, or 4.96 x 103 – 1.63 x 104 neutrophils in the perfused lung. Hence, 
there were very few tissue resident neutrophils in the steady state, as expected from the 
pilot experiments. In addition and again, as expected, S. pneumoniae infection caused a 
marked increase in neutrophil numbers both in the BAL and perfused lung homogenate. 
Neutrophil numbers in the BAL of infected Ncdnfl/fl, LysMCre and Ncdn–/– mice, ranged 
between 3.69 x 103 and 1.05 x 104. In the perfused lung, neutrophil numbers were 4.30 x 105 
in Ncdnfl/fl, 2.36 x 105 in LysMCre and 3.68 x 105 in Ncdn–/–. However, there was no significant 
difference in neutrophil recruitment between Ncdn‒/‒ mice and Ncdnfl/fl and LysMCre controls 













Figure 6.5: Norbin deficiency increases the immunity of mice to pulmonary S. pneumoniae infection 
Mice of the indicated genotypes were given an intranasal administration of 2 x 10
6
 CFU S. pneumoniae in 50 L 
sterile HBSS or were mock-treated with the same volume of buffer. Mice were culled by CO2 asphyxiation at 6 
h after the infection and (A) serial dilutions of BAL (left hand panel) and perfused lung homogenate (right hand 





 cells) of BAL (left hand panel) and perfused lung homogenate (right hand panel) 
were assessed by flow cytometry. Each dot represents one mouse. Data are mean ± SEM of 3-4 mock-treated 
mice and 10-13 S. pneumoniae-infected mice per genotype, pooled from 4 independent experiments. 
Statistical significance was assessed using Kruskal-Wallis analysis with Dunn’s multiple comparisons test. 
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In mock-treated control animals from all strains, the numbers of monocytes/ 
macrophages were around 104 - 105cells both in the BAL and in the lung homogenate (Figure 
6.6A, left-hand panel). In the BAL of infected mice, the same range of 
monocyte/macrophage numbers (104 - 105cells) was observed, and further flow cytometric 
analysis showed that these cells were mostly alveolar macrophages (Figure 6.6B, left-hand 
panel), whereas no inflammatory monocytes were present in the BAL, as expected (Figure 
6.6C, left-hand panel). In contrast, in the perfused lung homogenate, a significant population 
of inflammatory monocytes (104 cells) was recruited in response to the S. pneumoniae 
infection, to a similar level in all strains, and contributing to around half of the monocytes 
and macrophages present in this tissue, compared to the tissue of mock-infected control 
animals which only contained around 102 - 103 inflammatory monocytes. There appeared to 
be a modest significant difference in both alveolar macrophage numbers and inflammatory 
monocyte numbers between Ncdnfl/fl and Ncdn‒/‒ strains, with reduced numbers in the 
Ncdn‒/‒ strain, resulting in an overall significant difference also in total 
monocyte/macrophage numbers (Figure 6.6). However, there was a slight difference in 
monocyte and macrophage recruitment between the two different control strains, and these 
cell populations in the LysMCre strain were similar to those of Ncdn‒/‒ mice. Therefore, we 
can conclude that Norbin deficiency did not affect monocyte and macrophage numbers 
during pulmonary infection with S. pneumoniae. 
Taken together, the data model show that Norbin deficiency increases the ability of 
mice to clear pulmonary S. pneumoniae infection 10-fold, without affecting the recruitment 
of neutrophils or monocytes, or the numbers of resident macrophages. This increase in 
innate immunity in the absence of altered neutrophil recruitment suggests either that 
Norbin-deficient neutrophils can kill bacteria more efficiently in vivo, or that neutrophils are 
not the cause of this increased immunity. The increased antibacterial immunity of isolated 
Norbin-deficient neutrophils (see Chapter 4) would support the first possibility. However, I 







Figure 6.6: Norbin-deficiency does not affect neutrophil and monocyte recruitment during pulmonary 
infection with S. pneumoniae 
The same bronchoalveolar lavage and lung homogenates samples of S. pneumoniae-infected and mock-
















 cells) recovered in the BAL (left-hand panels) 
and in the perfused lung homogenate (right-hand panel) from mice of the indicated genotypes and infected 
with 2 x 10
6
 CFU S. pneumoniae or mock-treated mice, as assessed by flow cytometry. Data are mean ± SEM 
of 3-4 mock-treated mice and 10-13 S. pneumoniae-infected mice per genotype, pooled from 4 independent 




To examine whether the improved immunity of Norbin-deficient mice to S. 
pneumoniae infection would persist overtime, I also tested the later time point of 18 h. As 
expected from the pilot experiments, the control strains Ncdnfl/fl and LysMCre had cleared 
most of the bacteria from the airspace at that point, as only 1.34 x 103 – 1.03 x 103 bacterial 
CFU were recovered from the BAL at that point (Figure 6.7A, left-hand panel), 100-fold fewer 
compared to the 105 bacteria counted at the 6 h time point (Figure 6.5A). Compared to these 
control mice, the Ncdn‒/‒ strain cleared the bacteria to a similar level, having only 1.13 x 103 
bacterial CFU left in their BAL after 18 h (Figure 6.7A, left-hand panel). Hence, Norbin 
deficieny accelerated the clearance of bacteria from the airspace, but a low level of bacterial 
load remained in all strains after 18 h. 
In contrast to the BAL, and as expected from the pilot experiments, in the perfused 
lung homogenates of S. pneumoniae infected mice, bacterial numbers were still high at the 
18 h time point in the Ncdnfl/fl and the LysMCre control mice, with 5.39 x 104 and 4.76 x 104 
bacteria being recovered from this tissue, whereas only 1.35 x 104 bacteria were left under 
these conditions in Ncdn‒/‒ strain (Figure 6.7A, right-hand panel). Therefore, Norbin-
deficient mice still had a 4-fold increased capacity to kill bacteria compared to Ncdnfl/fl under 
these conditions, and a 3.5-fold increase compared to LysMCre mice. There was a significant 
difference in CFU numbers between LysMCre and Ncdn‒/‒ strains (p=0.0180) at this later time 
point, although the difference between Ncdnfl/fl and Ncdn‒/‒ did not quite reach significance 
(p=0.1153), likely due to the low “n” numbers used in Ncdnfl/fl mice. Therefore, Norbin 
deficient-mice cleared bacteria from the BAL and from the lung faster than the two control 
strains at an early time point (Figure 6.5A), and the increased immunity of Ncdn–/– mice also 
persisted in the lung tissue at this later time point. 
With regards to the leukocyte populations, mock-treated control animals from all 
strains had few neutrophils in BAL and lung at the 18 h time-point, ranging between 7.58 x 
102 – 3.56 x 103 in the BAL and 2.36 x 103 – 1.48 x 104 in the lung, as expected from the pilot 
experiments (Figure 6.7B). In S. pneumoniae infected Ncdnfl/fl and LysMCre control mice, 
neutrophil numbers in the BAL were 7.58 x 103 - 6.89 x 103, respectively, and 1.42 x 106 - 
7.65 x 105 in the lung. This neutrophil recruitment into the BAL was a little lower than 
expected from the pilot experiments, whereas neutrophil numbers in the perfused lung 
were as expected. Nevertheless, Ncdn‒/‒ infected mice had 7.14 x 103 neutrophil in their BAL 
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and 5.25 x 105 in their lungs under these conditions, and therefore showed no detectable 
difference in neutrophil recruitment compared to the control strains (Figure 6.7B). This 
means that, also at this time point, neutrophil numbers in the airways or lung tissue were 
normal and could not account for the increased antibacterial immunity of Norbin-deficient 
mice. 
Similarly, the numbers of monocytes/macrophages in mock-treated and S. 
pneumoniae infected Ncdnfl/fl and LysMCre control mice was also as expected, both in the BAL 
fluid and in the lung homogenate, and again no effect of Norbin-deficiency was seen on 






Figure 6.7: Norbin deficiency maintained the immunity of mice to pulmonary S. pneumoniae infection at a 
later time point 
Mice of the indicated genotypes were given an intranasal administration of 2 x 10
6
 CFU S. pneumoniae in 50 
L sterile HBSS or were mock-treated with the same volume of buffer. Mice were culled by CO2 asphyxiation 
at 18 h after the infection and (A) serial dilutions of BAL (left hand panel) and perfused lung homogenate 
(right hand panel) were analysed for bacterial survival as CFU on blood agar plates. In parallel the (B) 











 cells) from BAL (left hand panel) and perfused lung homogenate (right hand panel) were 
assessed by flow cytometry. Each dot represents one mouse. Data are mean ± SEM of 2-4 mock-treated 
mice and 7-12 S. pneumoniae-infected mice per genotype, pooled from 4 independent experiments. 
Statistical significance was assessed using Kruskal-Wallis analysis with Dunn’s multiple comparisons test. 
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6.5 Norbin-deficiency provides antibacterial immunity during 
pulmonary infection with S. pneumoniae even in immun-deficient 
(Prex‒/‒) mice  
In order to investigate the effects of Prex-deficiency and combined Norbin/Prex deficiency 
on antibacterial immunity, the same study of S. pneumoniae infection was carried out at the 
6 h and 18 h time point in Prex+/+, Prex–/– and Ncdn‒/‒ Prex‒/‒ mice. The panel of data from 
Prex+/+, Prex–/– and Ncdn‒/‒ Prex‒/‒ mice treated with S. pneumoniae for 6 h are shown in 
Figure 6.8. As both time points show similar trends, in the next paragraph only the 18h time 
point is decribed in detail. 
In mock-treated animals from all strains, no bacterial CFU were recovered from the 
BAL (Figure 6.9A left-hand panel) and only very few from the lung (Figure 6.9A, right-hand 
panel), as expected. In Prex+/+ control mice infected with 2 x 106 S. pneumoniae, the CFU of 
surviving bacteria in the BAL after 18 h were 2.66 x 103, similar to what was seen with the 
other (Ncdnfl/fl and LysMCre) control strains (Figure 6.7). In contrast, Prex–/– mice still had 6.28 
x 104 bacterial CFU in their BAL under the same conditions, 24-fold more than the Prex+/+ 
controls, meaning that Prex–/– mice are immune-deficient, which was not unexpected but 
had never been shown before (Figure 6.9A, left-hand panel). Importantly, in contrast to 
Prex–/– mice, Ncdn‒/‒ Prex‒/‒ double-deficient mice only had 3.53 x 103 CFU in their BAL, 18-
fold fewer than the immune-deficient Prex–/– mice and the almost same as the Prex+/+ 
control mice. Therefore, the deletion of Norbin in Ncdn‒/‒ Prex‒/‒ mice was sufficient to 
overcome the immuno-deficiency caused by the absence of Prex, effectively restoring 
immunity. A similar trend, but lacking statistical significance because of larger variability 
between Prex‒/‒ mice, was observed also in the perfused lung homogenate at 18 h (Figure 
6.9A, right-hand panel).  
Moreover, no detectable differences were seen either in neutrophil recruitment 
(Figure 6.9B) or in the numbers of monocytes/macrophages (Figure 6.9C) in the BAL and the 
perfused lung homogenate between Prex+/+ and Prex–/–. This demonstrates that P-Rex1 is 
not required for neutrophil recruitment into the infected lung, unlike in aseptic peritonitis. 
This was perhaps unsurprising, as different GEFs are required for recruitment to different 
organs, and our laboratory has shown previously that P-Rex1 and Vav family Rac-GEFs 
cooperate in neutrophil recruitment to the inflamed lung (Pan et al., 2015). However, in the 
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BAL, Ncdn‒/‒ Prex‒/‒ mice had a small, but significant decrease in the number of neutrophils 




Figure 6.8: Norbin-deficiency provides antibacterial immunity during pulmonary infection with S. 
pneumoniae, even in immune-deficient (Prex
‒/‒
) mice at 6 h after infection. 
Mice of the indicated genotypes were given an intranasal administration of 2 x 10
6
 CFU S. pneumoniae in 50 
L sterile HBSS or were mock-treated with the same volume of buffer. Mice were culled by CO2 asphyxiation 
at 6 h after the infection and (A) serial dilutions of BAL (left hand panel) and perfused lung homogenate 
(right hand panel) were analysed for bacterial survival as CFU on blood agar plates. In parallel the (B) 











 cells) from BAL (left hand panel) and perfused lung homogenate (right hand panel) were 
assessed by flow cytometry. Each dot represents one mouse. Data are mean ± SEM of 3-4 mock-treated 
mice and 12-18 S. pneumoniae-infected mice per genotype, pooled from 5 independent experiments. 



























Figure 6.9: Norbin-deficiency provides antibacterial immunity during pulmonary infection with S. 
pneumoniae, even in immune-deficient (Prex
‒/‒
) mice at 18h  
Mice of the indicated genotypes were given an intranasal administration of 2 x 10
6
 CFU S. pneumoniae in 50 
L sterile HBSS or were mock-treated with the same volume of buffer. Mice were culled by CO2 asphyxiation 
at 18 h after the infection and (A) serial dilutions of BAL (left hand panel) and perfused lung homogenate 
(right hand panel) were analysed for bacterial survival as CFU on blood agar plates. In parallel the (B) 











 cells) from BAL (left hand panel) and perfused lung homogenate (right hand panel) were 
assessed by flow cytometry. Each dot represents one mouse. Data are mean ± SEM of 3-4 mock-treated 
mice and 12-18 S. pneumoniae-infected mice per genotype, pooled from 5 independent experiments. 
Statistical significance was assessed using Kruskal-Wallis analysis with Dunn’s multiple comparisons test. 
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In conclusion, expression of Norbin in myeloid cells suppresses the antibacterial 
immune function of these mice in vivo. Deletion of Norbin relieves this suppression, thus 
increasing the capacity of myeloid cells to kill bacteria, without affecting the recruitment of 
these myeloid cells to the site of infection. Finally, deletion of myeloid Norbin is sufficient to 
overcome the immune-deficiency caused by Prex-deficiency. 
 
6.6 The increased immunity to S. pneumoniae infection in 
myeloid Norbin deficiency derives from neutrophils 
The fact that neutrophil recruitment was normal during pulmonary infections despite the 
increased clearance of bacteria in Norbin-deficient mice (Figure 6.4) suggested two 
possibilities: (i) that the bactericidal capacity of neutrophils is increased, which my 
experiments in Chapter 4 have shown to be the case, or (ii) that this immune protection 
might be derived from other cell types. The latter possibility was pertinent in light of the 
controversy in the literature as to the importance of neutrophils in this infection, as detailed 
in the introduction to this chapter. Indeed, macrophage depletion assays have shown that 
resident alveolar macrophages are required for the resolution of S. pneumoniae infections 
and the importance of neutrophils was shown to depend on the titre of the inoculum and on 
the age of the animal (Dockrell et al., 2003; Herbold et al., 2010). To evaluate whether the 
increased immunity of Norbin-deficient mice stems from neutrophils, I therefore performed 
antibody-mediated neutrophil depletion prior to infecting the mice with S. pneumoniae. 
To deplete neutrophils, Ncdn‒/‒ and Ncdnfl/fl mice were given i.p. monoclonal anti-
Ly6G antibody 1A8 (25 mg.kg-1) (Bruhn, Dekitani, Nielsen, Pantapalangkoor, & Spellberg, 
2016), whereas control animals received the equivalent amount of isotype control antibody 
at -24 h and 0 h prior to infection with 2 x 106 CFU of S. pneumoniae. The 1A8 clone is 
selective for the Ly6G epitope and does not deplete Ly6C+ inflammatory monocytes, unlike 
the Gr1 monoclonal antibody that had been widely used for neutrophil depletion in earlier 
studies (Daley et al., 2008).  
To confirm neutrophil depletion, 50 L tail blood samples were taken from Ncdnfl/fl 
and Ncdn‒/‒ mice before dosing with isotype control IgG or 1A8 antibody, at time 0 h, 24 h 
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after the first administration of the antibodies. Isotype control IgG-treated Ncdnfl/fl and 
Ncdn‒/‒ mice had 4.82 x 103 and 3.65 x 103 neutrophils in 50 L of peripheral blood, 
respectively (Figure 6.10A), very close to the expected 106 neutropils.mL-1. In contrast, 
Ncdnfl/fl and Ncdn‒/‒ mice treated with 1A8 monoclonal antibody only had 1.50 x 103 and 
0.63 x 103 neutrophils, respectively, in 50 L peripheral blood, a decrease of 70% and 83%, 
respectively. Hence, 1A8 monoclonal antibody-treated animals from both strains showed a 
significant depletion of neutrophils from their systemic circulation after only a single dose of 
antibody treatment (Figure 6.10A). 
After establishing that neutrophil depletion was efficient, I proceeded to infect 
Ncdnfl/fl and Ncdn‒/‒ mice treated with either isotype control or 1A8 antibody at time 24 h 
and 0 h with 50 L of 2 x 106 S. pneumoniae, or mice were mock infected with buffer only. 
After 6 h, the mice were culled, bronchioles lavaged, and the survival of bacteria in the BAL 
assessed as CFU on blood agar, as well as leukocyte numbers by flow cytometry. 
As expected, mock- infected animals from both the Ncdnfl/fl and Ncdn–/– strains had 
very few neutrophils in their BAL, regardless of whether they had been injected with isotype 
control or 1A8 antibody. Isotype control IgG-treated Ncdnfl/fl and Ncdn‒/‒ mice had 8.8 x 101 
and 2.5 x 102 neutrophils in the BAL and 1A8 monoclonal Ly6G-treated animals 2.4 x 102 and 
6.2 x 101 neutrophils, respectively (Figure 6.10B). In addition, isotype control IgG-treated and 
S. pneumoniae-infected Ncdnfl/fl and Ncdn‒/‒ mice showed the marked recruitment of 
neutrophils into the airspace that was expected for this 6 h time point (Figure 6.10B), with 
no difference between the genotypes (5.48 x 103 and 3.78 x 103 neutrophils, respectively). In 
contrast, 1A8 antibody-treated and S. pneumoniae-infected Ncdnfl/fl and Ncdn‒/‒ mice, 
recruited far fewer neutrophils into the BAL, again with no difference between the 
genotypes, (6.34 x 102 and 4.55 x 102 neutrophils, respectively) (Figure 6.10B). This is a level 
of depletion of neutrophils in the BAL of S. pneumoniae-infected mice equivalent to 89% in 
Ncdnfl/fl mice and 88% in Ncdn‒/‒ mice compared to the isotype-treated control mice. 
In contrast to this efficient depletion of neutrophils, the number of 
monocytes/macrophages recovered in the BAL remained unaltered by either the isotype 
control or 1A8 antibody treatment, both in mock-infected and S. pneumoniae-infected 
Ncdnfl/fl and Ncdn‒/‒ mice (Figure 6.10C). 
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Under these conditions, which efficiently depleted neutrophils without altering 
monocyte/macrophage numbers, I then proceeded to analyse whether neutrophil depletion 
affects the increased antibacterial immunity observed in Ncdn‒/‒ mice. First, no bacterial CFU 
were found in the BAL of mock-infected animals from the Ncdnfl/fl and Ncdn‒/‒ mice strains 
after 6 h, regardless of whether they mice had received isotype control IgG or 1A8 antibody, 
as expected (Figure 6.10D). In contrast, isotype control IgG-treated Ncdnfl/fl animals infected 
with 2 x 106 S. pneumoniae had a substantial number of bacteria left in the BAL after 6 h 
(1.02 x 104) (Figure 6.10D), although somewhat less than expected from previous 
experiments without any antibody pre-treatment. Importantly, isotype control IgG-treated 
Ncdn‒/‒ mice infected with S. pneumoniae had far fewer bacteria (1.5 x 103) left in the BAL 
under the same conditions (Figure 6.10D). Hence, as expected from experiments performed 
without prior isotype control antibody treatment, 7-fold more bacteria were killed in Ncdn‒/‒ 
mice compared to Ncdnfl/fl mice (p=0.0074), confirming again that Norbin deficiency 
substantially increases antibacterial immunity. Interestingly, 1A8 antibody-treated Ncdnfl/fl 
animals infected with S. pneumoniae had 6.73 x 103 bacteria left in their BAL, only 
insignificantly (34%, p=0.9992) fewer than their isotype control-treated counterparts, and 
significantly (4.5 times) more than in isotype control-treated Ncdn‒/‒ mice (p=0.0089) (Figure 
6.10D). Thus, my data suggest that in otherwise healthy adult control mice, neutrophils are 
not essential for the early clearance of S. pneumoniae bacteria, at least not at the titre and 
timing used here. This is in agreement with some of the literature which claims that alveolar 
macrophages play a more central role than neutrophils in clearing this type of bacteria under 
similar conditions.  
However, very surprising results were obtained in the 1A8 antibody-treated Ncdn‒/‒ 
mice infected with S. pneumoniae, which had 7.81 x 103 CFU left in their BAL, similar to the 
1A8-antibody treated Ncdnfl/fl mice (6.73 x 103) meaning that neutrophil depletion had 
removed any advantage that Norbin-deficient mice had in killing bacteria, compared to 
Ncdnfl/fl control mice. Neutrophil depletion made their immunity 5 times worse than that of 
their isotype control-treated counterparts (p=0.0076) and indistinguishable from that of S. 
pneumoniae–infected Ncdnfl/fl mice (p=0.9995) (Figure 6.10D).  
Therefore, unlike in control mice, neutrophils were important for the clearance of S. 
pneumoniae in Ncdn‒/‒ mice. The results show that Norbin-deficiency has afforded a more 
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important role to neutrophils in clearing of S. pneumoniae infection than these cells have 
under normal circumstances. Considering that neutrophil recruitment is unaffected in Ncdn‒
/‒ mice, this suggests that the increased antibacterial responses of Ncdn‒/‒ neutrophils that I 
demonstrated in Chapter 4 are the root cause of the increased importance of neutrophils in 





























Figure 6.10: The increased immunity to S. pneumoniae infection in myeloid Norbin deficiency 
derives from neutrophils 





 mice. Mice were administered either with isotype control IgG or 1A8 monoclonal 
Ly6G antibody at 24 h and 0 h, and tail blood samples were taken at 0 h before intranasal 
administration of DPBS or 2 x 10
6
 S. pneumoniae. Blood neutrophil counts were quantified by 
labelling cells for CD24 and CD11b and analysis by flow cytometry. (B-C) Mice treated either with 
isotype control IgG or 1A8 monoclonal Ly6G antibody were given an intranasal administration of 
2 x 10
6
 CFU S. pneumoniae in 50 µL sterile HBSS, or mock-treated with buffer as a control. Mice 
were culled and BAL performed 6 h after the infection. (B) Total number of neutrophils recruited 
to the lung was identified by staining of CD24 and Mac-1. (C) Total number of macrophages 
recruited to the lung was identified by staining of Mac-1. (D) BAL were subjected to bacterial 
counts, by plating serial dilutions on blood agar plates. The bacterial load was determined from 
blood agar plates with 20-200 colonies per plate. Each dot represents one mouse. Data are mean 
± SEM of 5 mock-infected mice and 10 S. pneumoniae-infected mice per genotype, up to 3 mice 
per genotype per day pooled from 5 independent experiments. Statistical significance was 




 – Discussion Chapter 7
 The main findings of my PhD are that the GPCR adaptor and P-Rex1 interacting 
protein Norbin has important functional roles in neutrophils and in neutrophil-mediated 
antibacterial immunity. In essence, myeloid Norbin is an immune-suppressor. Norbin 
deficiency makes neutrophils more important for the clearance of pneumococcal infection in 
the lung by increasing their capacity for killing bacteria. Briefly isolated Norbin-deficient 
neutrophils showed increased adhesion and spreading, as well as increased ROS production, 
constitutive degranulation and an increased capacity to kill S. aureus in a ROS dependent 
manner. Norbin deficiency raised the cell surface levels of some GPCRs as well as increasing 
GPCR-dependent Ras/Erk and Rac signalling. Norbin deficiency provided immunity against 
pulmonary infection with S. pneumoniae in a neutrophil-dependent manner and was 
sufficient to restore the impairment in immunity caused by Prex-deficiency, without 
affecting neutrophil recruitment. Only some of these functions of myeloid Norbin required 
P-Rex1 (Figure 7.1). 
History and rationale of this study 
My study built on previous work in our lab, which had identified Norbin as a direct 
binding partner and regulator of the Rac-GEF P-Rex1 (Pan et al., 2016). The main conclusion 
from this initial study was that Norbin is a major regulator of P-Rex1 plasma membrane 
localisation, bringing P-Rex1 into close contact with its substrate Rac and its activators PIP3 
and G, and thereby increasing signalling through the P-Rex1/Rac pathway to induce 
changes in cell morphology. Furthermore, the study also showed that Norbin is expressed 
not just in neurons, as was previously thought, but also in myeloid cells (neutrophils and 
macrophages) (Pan et al., 2016). This previous study had largely been done using 
recombinant proteins and overexpression in cell lines. The aim of my project was to assess 
the role of Norbin, and the interdependency of Norbin and P-Rex1, in a physiologically 
relevant biological system, and as P-Rex1 is a well-known regulator of neutrophil responses, 
we decided to study this in primary mouse neutrophils. My objectives were to assess the 
signalling pathways, antimicrobial responses and tissue recruitment of Norbin and 





Dr Dingxin Pan, the former PhD student in the laboratory who conducted the original Norbin 
study, also generated the Ncdn‒/‒ mouse strain with Norbin deletion in the myeloid linage 
and the Ncdn‒/‒ Prex‒/‒ strain with combined Norbin and Prex deficiency, prior to leaving the 
laboratory. She also showed that Norbin expression was successfully deleted in the Ncdn‒/‒ 
mice, in their resident peritoneal macrophages and in neutrophils recruited to the 
peritoneum during LPS-induced peritonitis. I began my study by confirming that Norbin was 
also efficiently deleted from isolated mature bone-marrow derived Ncdn‒/‒ neutrophils, and 
I used a combination of cell counting, flow cytometry and cytospin analysis to show that 
neutrophil development was normal in Ncdn‒/‒ and Ncdn‒/‒ Prex‒/‒ mice. 
The antibacterial and antifungal innate immune functions of neutrophils require 
signalling through the small GTPase Rac and the Rac-GEFs that activate Rac. These proteins 
  
Figure 7.1: Summary of Norbin and Prex functions in neutrophil 
Up and down direction of arrows denote increased and decreased responses, respectively. 
Thickness of arrows denote the magnitude of responses 
= symbol denotes normal response compared to controls. 
Symbol in brackets denote effect under specific experimental conditions. 
? symbol denotes experiments to be done. 
Rac, Erk, p38
Mapk
 and Akt activity data and Mac-1 surface levels for Prex1-deficient mice were taken from 
(Welch et al., 2005) and (Lawson et al., 2011). 
148 
 
control neutrophil adhesion and migration, as well as neutrophil effector responses essential 
for immunity, such as the production of reactive oxygen species (ROS) and the release of 
proteases by degranulation (Pantarelli & Welch, 2018). P-Rex1, which was discovered in our 
lab (Welch et al., 2002) is one such Rac-GEF that regulates actin polymerisation, adhesion, 
migration speed and ROS production in neutrophils, as well as neutrophil recruitment to 
sites of inflammation (Pantarelli & Welch, 2018; Welch et al., 2005). From our initial study on 
the Norbin/Prex1 interaction (Pan et al., 2016), we expected that - if Norbin had any 
discernible role in mouse neutrophils at all – it was likely to act largely through Prex1, and 
that Norbin-deficiency would exacerbate the impairment in neutrophil responses that the 
lab had previously described for Prex1-deficient mice (Welch, 2015). Hence, I began by 
characterising neutrophil responses that are known to require Prex1. 
Role of Norbin in neutrophil adhesion, spreading and polarity 
First, I assessed the ability of Norbin-, Prex1- and Norbin/Prex1-deficient bone marrow-
derived isolated neutrophils to adhere, spread and polarise on glass, using 
immunofluorescence microscopy. These experiments revealed that the deletion of Norbin 
promotes neutrophil adhesion and spreading, both in unprimed and TNF/GM-CSF-primed 
cells, and both with and without stimulation with fMLP, without affecting neutrophil 
polarity. This was in contrast to Prex1 deficiency, which caused a trend to reduced 
neutrophil adhesion in basal cells, as expected from previous work (Lawson et al., 2011), and 
significantly reduced neutrophil spreading under several conditions. 
The increased adhesion and spreading in Norbin-deficient neutrophils was my first 
completely unexpected finding, as it suggested that Norbin may have a largely opposite role 
to Prex in neutrophils, instead of promoting Prex function, as was expected (Pan et al., 
2016). Interestingly, Prex was not required for the increased adhesion caused by Norbin 
deficiency, as Norbin/Prex-double deficient cells also adhered more, but the Rac-GEF was 
required for the Norbin-deficiency dependent increase in neutrophil spreading. The reason 
for this discrepancy in Prex dependency is unclear, but it likely derives from the different 
roles of Rac1 and Rac2 in neutrophil adhesion and spreading. For example, Rac2 deficiency 
reduces whereas Rac1-deficiency increases the spreading of neutrophil-like cells derived 
from haematopoietic stem cells (Gu et al., 2003). Prex1 has a substrate preference for Rac2 
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over Rac1 in neutrophils (Welch et al., 2005), so perhaps the loss of Prex1-dependent Rac2 
activity limits the spreading of Norbin/Prex-deficient cells. Along the same lines, Rac1 was 
shown to be more important for neutrophil adhesion than Rac2, although both GTPases 
contribute (Gu et al., 2003), and it is perhaps for this reason that Prex expression was less 
important for Norbin deficiency-induced neutrophil adhesion. Overall, it seems that Norbin, 
when expressed, limits neutrophil adhesion and spreading, likely by suppressing Rac1 and 
Rac2 activity, rather than being primarily a regulator of Prex1 that promotes Rac activity.  
It would be interesting to investigate the effects of Norbin and Norbin/Prex1 on 
neutrophil adhesion and spreading further under shear-flow conditions, as previous work 
had shown that Prex1 plays a much more important role in neutrophil adhesion under flow 
conditions that mimic the shear stress in postcapillary venules, by controlling the affinity 
state of the neutrophil 2-integrins LFA-1 and Mac-1 (J. M. Herter et al., 2013). To pursue 
the relevance to integrins, a summer student in the laboratory whom I co-supervised, Anna 
Mandel, performed adhesion assays with Norbin and Norbin/Prex-deficient neutrophils on 
various surfaces, and found a larger increase in the adhesion of Norbin/Prex-deficient cells 
plated on the integrin ligands poly-RGD and ICAM-1, compared to cells on glass. This 
suggested that Norbin deficiency might increase the activity of 2-integrins on the 
neutrophil surface. Indeed, she conducted further experiments using blocking antibodies 
against CD11a (LFA-1), CD11b (Mac-1) and CD54 (ICAM-1) which abrogated the increased 
adhesion of Norbin/Prex1-deficient neutrophils, showing that it was indeed dependent on 
these integrins. Detailed titration curves of such blocking antibodies should enable us to 
reveal if the Norbin/Prex1-deficient cells are more sensitive to integrin inhibition than 
control neutrophils.  
Finally, neutrophil polarisation, just like adhesion and spreading, is also a Rac-
dependent response (Pantarelli & Welch, 2018), but unlike these processes it remained 
unaffected both by the Prex deficiency (as expected) and by the Norbin deficiency. This 




Role of Norbin in ROS production 
Next, I tested ROS production, starting with GPCR-dependent ROS in primed cells, using 
stimulation of either the C5a receptor or the fMLP receptor. Even more clearly than in 
adhesion and spreading, Norbin and Prex showed opposite effects on the ROS response, 
with Norbin-deficiency increasing and Prex-deficiency decreasing it, both upon stimulation 
with fMLP or with C5a, and regardless of the priming pathway used. These results showed 
that Prex is required for GPCR-dependent ROS production whereas Norbin expression limits 
it. Interestingly, when both Prex and Norbin were knocked-out, GPCR-dependent ROS 
production was reduced in neutrophils primed through the TNF/GM-CSF cytokine 
pathways, to the same level as in Prex-deficient cells, whereas it was elevated in cells primed 
through the LPS pathway, to the level seen in Norbin-deficient cells. Hence, Norbin 
deficiency-induced LPS-primed ROS production is independent of Prex, whereas Norbin 
deficiency-induced TNF/GM-CSF-primed ROS production requires Prex. Therefore, among 
the signalling pathways upstream of ROS production that are limited by Norbin expression, 
some require Prex and some do not.  
Previous work showed that priming of the ROS response through both the TNF/GM-
CSF cytokine pathways and the LPS/TLR4 pathway involves Prex1, but the requirement for 
Prex1 was much more pronounced in the LPS/TLR4 pathway (Damoulakis et al., 2014; 
Lawson et al., 2011; Welch et al., 2005). Therefore, the lack of effect of Prex-deficiency in 
LPS-primed Ncdn‒/‒ Prex‒/‒ cells compared to Ncdn‒/‒ cells was surprising and suggested that 
another GEF or regulator of Rac might compensate for the loss of Prex1 in this response. 
Different types of Rac-GEFs in neutrophils couple to different upstream regulators, and thus 
contribute to distinct downstream responses. For example, Vav1 and P-Rex1 can both signal 
downstream of the fMLP receptor, but they are regulated in different ways. P-Rex1 is mainly 
activated by PIP3 and G, whereas Vav1 is mainly activated by tyrosine phosphorylation. We 
imagine that, within the same receptor pathway, there is redundancy to make sure there is 
always sufficient Rac activity available in the cells. A previous study from our lab showed that 
Prex1 and Vav1 can cooperate in the LPS priming of ROS production (Lawson et al., 2011). I 
have therefore begun to investigate the possibility of Vav1 being regulated by Norbin (see 
discussion on Rac activity below). 
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In addition to soluble agonists, I also tested ROS production in response to bacteria 
(ongoing) and to fungal particles (zymosan). As with the soluble stimuli, I observed that ROS 
production was significantly increased in Ncdn‒/‒ neutrophils upon stimulation with 
zymosan. Furthermore, this Norbin deficiency-induced ROS production was also again 
dependent on Prex1, as it was abrogated in Ncdn‒/‒ Prex‒/‒ cells, to the level seen in Prex‒/‒ 
neutrophils. My preliminary experiments with S. aureus bacteria show the same pattern. 
Bacteria and fungi activate a wide range of receptors, including pattern recognition 
receptors and receptors that recognise opsonisation, such as FcRs and integrins. This 
suggests that Norbin-deficiency might not only affect GPCR-coupled neutrophil signalling 
pathways, but also signalling through other types of receptors, although it may be difficult to 
evaluate the extent to which bacteria and zymosan stimulate ROS production via GPCRs. 
Most inhibitors of GPCR signalling only affect one or a subset of GPCRs. However, a small 
molecule, BIM-46187, has been described as a pan-GPCR inhibitor that prevents the 
interaction of GPCRs with all classes of heterotrimeric G protein (Ayoub et al., 2009), 
although it does seem to affect Gq preferentially (Schmitz et al., 2014). Use of this 
compound in adhesion assays and in particle-stimulated ROS assays might help evaluate to 
what extent Norbin regulates these responses through GPCR signalling. 
One possible explanation for why more ROS was produced in Ncdn‒/‒ neutrophils than 
in control cells could have been that the NADPH oxidase complex which produces ROS is 
hyperactive. However, firstly there was no constitutive ROS production in Norbin-deficient 
cells in the absence of a stimulus, precluding the possibility that the NADPH oxidase is 
constitutively active. Secondly, to test if there might simply be more NADPH oxidase 
complex in Ncdn‒/‒ neutrophils, I treated the cells with PMA, an artificial activator of PKC 
that stimulates the oxidase complex in a receptor-independent way. These data showed 
normal ROS production in neutrophils from all strains, meaning that there is a normal 
amount of NADPH oxidase complex in Ncdn‒/‒ neutrophils. Therefore, Norbin deficiency 
affects the upstream signalling pathways of ROS formation rather than the integrity, amount 
or constitutive activity of the NADPH oxidase complex itself. 
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Role of Norbin in bacterial killing by isolated neutrophils  
The elevated ROS production in Norbin-deficient neutrophils suggested that these cells may 
have an increased capacity for killing pathogens. I tested this by incubating purified 
neutrophils with serum-opsonised S. aureus bacteria and by counting of the bacterial CFU 
that survived after 15 min. Indeed, more S. aureus were killed by Norbin-deficient 
neutrophils compared to control neutrophils. These experiments defined Norbin as a 
suppressor of neutrophil-mediated bacterial killing in vitro. Furthermore, Prex was not 
required for Norbin deficiency-induced bacterial killing, because when both Norbin and Prex 
were deleted, the same number of bacteria were killed as with Norbin-deficiency alone.  
Neutrophils use ROS production to kill bacteria, as exemplified by the inability of 
neutrophils from chronic granulomatous disease (CGD) patients who have inactivating 
mutations in one of the catalytic NADPH oxidase subunits to kill bacteria, which leads to 
recurrent infections (Roos, 2016). Therefore, I investigated next whether the increased 
bacterial killing by Ncdn‒/‒ neutrophils was due to their increased ROS production. Using a 
titration curve of DPI, an inhibitor of ROS production, in the bacterial killing assay, I saw that 
the increased killing of S. aureus in Norbin-deficient neutrophils was indeed ROS-dependent, 
because at DPI concentrations of 1 M or higher, these cells had no more advantage over 
Ncdnfl/fl control cells in killing S. aureus. 
In this study, I only explored the ability of Norbin-deficient neutrophils to kill S. aureus, a 
gram-positive aerobic organism, in vitro. It would be interesting to also assess the ability of 
Ncdn‒/‒ neutrophils to kill other types of gram-positive bacteria (e.g. S. pneumoniae) and 
gram-negative bacteria (e.g. E. coli), as well as fungal pathogens such as Candida albicans 
and Aspergillus fumigatus. Gram-positive bacteria have a relatively porous cell wall, whereas 
gram-negative bacteria have two lipid bilayers and middle layer of peptidoglycan which 
provides a permeability barrier, and yeast have an even more impermeable cell wall 
(Vatansever et al., 2013). Hence, it is conceivable that the increased ROS production in Ncdn‒
/‒ neutrophils only protects from a subset of bacterial and fungal pathogens. For example, in 
vivo studies have shown that neutrophils kill S. pneumoniae in as ROS-independent (but 
degranulation-dependent) manner (see discussion of in vivo results below).  
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It would also be interesting to test the intra- vs extra-cellular killing of bacteria by 
performing the killing assay at longer time-points that allow phagocytosis of the bacteria and 
then comparing the level of bacterial killing the presence and absence of antibiotics such as 
gentamycin that cannot penetrate into the neutrophil. Neutrophils produce ROS both intra-
and extracellularly, and ROS assays can distinguish between these. For example, HRP can be 
omitted from our assay in order to measure only intracellular ROS produced by the NADPH 
oxidase and endogenous myeloperoxidase. Furthermore, ROS is required for the production 
of NETs, which is an important mechanism for killing extracedllular bacteria, and we could 
evaluate NET formation as is briefly described below. 
Role of Norbin in degranulation 
In addition to ROS production, neutrophils kill pathogens via degranulation. For example, 
patients with CGD usually only suffer from infections with certain types of bacteria and 
fungi, because the lytic enzymes contained in granules are still able to kill many pathogens. 
In support of this notion, mice deficient in the neutrophil granule serine proteases elastase 
and/or cathepsin G have a reduced ability to clear fungal infections (Tkalcevic et al., 2000). 
Thus, I tested the mobilisation of neutrophil gelatinase granules through degranulation, by 
measuring the activity of gelatinase released into the extracellular milieu.  
I observed that Norbin-deficiency causes some degree of constitutive degranulation 
of gelatinase granules in cells that are incubated at 37°C under condition that allow 
constitutive receptor trafficking. In contrast, stimulation of the cells with fMLP and 
cytochalasin B and/or priming of the cells with TNF/GM-CSF induced similar levels of 
gelatinase activity release in Ncdn‒/‒ and Ncdnfl/fl control cells, which showed that Ncdn‒/‒ 
neutrophils did not simply contain more gelatinase. This constitutive degranulation may 
explain the increased ability of Norbin-deficient neutrophils to adhere and produce ROS, as 
many receptors that mediate these responses are stored on the surface of neutrophil 
granules and become upregulated on the neutrophil surface upon fusion of the granule 
membrane with the plasma membrane (see discussion on GPCR surface levels below).  
Neutrophil adhesion and ROS production, the other responses that were increased in 
Norbin-deficient cells, are absolutely dependent on Rac, whereas the role of Rac in 
neutrophil degranulation is thought to be restricted to only one subset of granules. Rac2 was 
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reported to be critical for azurophil (primary) granule exocytosis, but dispensable for the 
degranulation of lactoferrin-containing (secondary and gelatinase) granules (Abdel-Latif et 
al., 2004). This has always been puzzling, as the degranulation of all granule types requires 
re-arrangements of the actin cytoskeleton. In view of that report, it therefore seemed likely 
that the increased gelatinase secretion in Ncdn‒/‒ neutrophils might be a Rac-independent 
response. To test this directly, Dr Kirsti Hornigold in the laboratory tested the secretion of 
gelatinase activity by isolated neutrophils from control and Rac2-deficient mice, using the 
same conditions I used in my assays with Norbin-deficient cells, and she obtained clear proof 
that Rac2 is indeed required for the degranulation of gelatinase granules (unpublished data). 
We believe that, as azurophil granules are the population which is hardest to mobilise, 
perhaps Abdul-Latif et al used conditions which were too blunt to reveal a role for Rac in the 
degranulation of other granule types. It would be interesting to repeat our experiments with 
Ncdn‒/‒ neutrophil degranulation also for secondary and azurophil granules. In summary, 
however, all neutrophil responses tested so far were affected by Norbin and were also Rac-
dependent neutrophil responses. In addition to the neutrophil responses that I have tested 
to date in Ncdn‒/‒ and Ncdn‒/‒ Prex‒/‒ neutrophils, there are other important effector 
responses that I have not tested, due to time-constraints, including cytokine production, 
migration/chemotaxis, NET formation and apoptosis. I have started optimising a 
phagocytosis assay either with adhering cells or cells in suspension, however further 
optimisation work needs to be done before any conclusions can be drawn. 
Role of Norbin in neutrophil GPCR signalling  
To link the increased adhesion, spreading, ROS production, degranulation and bacterial 
killing in Norbin-deficient neutrophils to possible underlying molecular mechanisms, I 
evaluated the effects of Norbin deficiency on neutrophil signalling and cell surface receptors. 
First, I tested Rac activity, as P-Rex1 activates Rac, Norbin regulates P-Rex1, and so far all 
Norbin-mediated neutrophil responses are also Rac-dependent. 
Our previous studies showed that Prex1-deficient isolated neutrophils have a defect 
in fMLP-stimulated Rac activation, mostly affecting the Rac-homologues Rac2 and RhoG, but 
also Rac1 (Damoulakis et al., 2014; Lawson et al., 2011; Welch et al., 2005). Surprisingly, 
Norbin again showed the opposite effect to Prex1: there was more fMLP-stimulated Rac1 
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and Rac2 activity in Ncdn‒/‒ neutrophils compared to control cells at all concentrations of 
fMLP tested. In contrast, basal Rac1 and Rac2 activities, in the absence of fMLP stimulation, 
were nearly undetectable in cells from both strains. In addition, I saw a similarly significant 
increase in Rac1 activity, but not in Rac2 activity, when both Norbin and Prex were deleted, 
which means that Prex is not required for the increase in Rac1 activity caused by Norbin 
deficiency. In contrast, GPCR-mediated activation of Rac2 was low in Ncdn‒/‒ Prex‒/‒ cells, 
meaning that Rac2 activity was dependent on Prex even when Norbin was deleted (although 
there appeared to be a non-significant tendency for increased Rac2 activity also in Ncdn‒/‒ 
Prex‒/‒ cells). These results are in accordance with the literature showing that Prex1 has a 
substrate preference for Rac2 over Rac1 (Welch et al., 2005).  
In summary, Norbin expression limits GPCR-stimulated Rac1 and Rac2 activity in 
neutrophils, and the deletion of Norbin is sufficient to relieve this suppression. Furthermore, 
Norbin-deficiency does not overcome the requirement for Prex1 in activating Rac2 upon 
GPCR stimulation. It is worth discussing that basal Rac activity in Norbin deficient cells was 
normal. Therefore, Norbin expression only limited Rac activity upon GPCR stimulation but 
did not lead to constitutive Rac activity, meaning that Norbin-deficiency poises the system to 
receptor activation but does not cause intrinsically active neutrophils (see also the section 
on cell surface receptors below). 
The Rac activity experiments up to now were done in unprimed cells that were 
prewarmed to 37°C for 3 min prior to the addition of fMLP, conditions where GPCR levels on 
the cell surface are likely to be limiting. Thus, it would also be interesting to study the effects 
of Norbin deficiency on Rac activity in the context of various priming pathways and in 
response to other agonists that stimulate Rac activity. In addition, it would be interesting to 
test the effects of Norbin-deficiency on the activity of the more distantly related Rac-family 
member RhoG, which is also a substrate of Prex1. 
The laboratory has previously shown that Norbin does not affect Rac activity directly, 
neither in vitro nor when overexpressed in HEK293 cells in the absence of P-Rex1 (Pan et al., 
2016). Therefore, as Norbin-deficiency affects Rac1 activity in Ncdn‒/‒ Prex‒/‒ neutrophils, 
other Rac-GEFs or regulators of Rac, in addition to Prex1, must couple to Norbin in these 
cells, and Norbin must limit their ability to activate Rac. This led me to speculate that one of 
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the GEFs which compensates for the loss of Prex in Norbin/Prex-deficient neutrophils might 
be Vav1. Vav1-deficient neutrophils have a similar phenotype to Prex1-deficient neutrophils 
regarding GPCR-dependent responses, but unlike Prex1, Vav-GEFs have a substrate 
preference for Rac1 over Rac2 (Lawson, Donald, Anderson, Patton, & Welch, 2011). In 
contrast, Dock-deficient neutrophils have impaired ROS production even upon stimulation 
with PMA, which is not the case in Ncdn‒/‒ and Ncdn‒/‒ Prex‒/‒ neutrophils. Furthermore, 
ongoing work in our lab showed that Tiam1-deficient neutrophils have defects only when 
cells are adherent, which is again not the case here. Hence, Vav1 seemed the most likely 
candidate, and I therefore conducted preliminary experiments using western blots to test for 
the activating phosphorylation of Vav1 on Tyr173, which indicated that fMLP-stimulated 
Vav1 activity is indeed elevated in Ncdn‒/‒ neutrophils compared to Ncdnfl/fl neutrophils. 
Further experiments are currently ongoing, but if these results can be confirmed, they imply 
that Norbin limits neutrophil Rac1 activity by blocking Vav1. 
In addition to Rac, I also tested other GPCR signalling pathways in Ncdn‒/‒ and 
Ncdnfl/fl neutrophils, namely the activation of Erk, p38Mapk, Jnk and Akt in response to fMLP 
stimulation. All of these pathways were maximally activated after stimulation with 1 M 
fMLP for 45 seconds. Importantly, I observed that Erk activity was significantly increased in 
Norbin-deficient neutrophils under these conditions compared to Ncdnfl/fl control cells, 
whereas the other pathways seemed unaffected under all conditions tested. Therefore, 
there is a degree of pathway specificity in Norbin-dependent regulation of GPCR signalling in 
neutrophils, some pathways being blocked by Norbin expression (Rac and Erk) and some not 
(Akt, p38Mapk and Jnk), at least under the conditions tested. It was surprising which pathways 
were affected by the Norbin deficiency and which were not, because p38Mapk and Jnk are 
downstream targets of Rac, and therefore one could have expected for these pathways to be 
increased in a similar manner to Rac activity. However, I measured Rac activity under 
somewhat different conditions, so this remains to be investigated further. The fact that 
Norbin deficiency increased Erk activity, and considering that Erk is activated by MEK 
downstream of Ras, suggests that Norbin might regulate Ras as well as Rac. I have started 
testing this possibility by performing Raf-RBD pull down assays for Ras activity. However, 
preliminary analysis would suggest that Norbin may not regulate Ras, which would imply 
that other signalling pathways upstream of Erk may be involved.  
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Increased GPCR-dependent activation of Erk had been described previously upon co-
expression of Norbin in HEK293 cells together with mGluR5 (H. Wang et al., 2009), but not 
upon co-expression with histamine-receptor 1 or melanin-concentrating hormone receptor 1 
(Ward et al., 2009), although all of these GPCRs interact with Norbin; therefore the reason 
why Erk signalling is regulated by Norbin downstream of one, but not the other receptors is 
unknown. Also, the mechanism of Norbin-dependent regulation of Erk activity has never 
been elucidated. In contrast to the study by Wang et al, who saw increased Erk signalling 
upon overexpression of Norbin, I saw increased Erk activity upon deletion of Norbin. 
Therefore, the signalling pathways from Norbin to Erk seem to depend on the GPCR and the 
cell line, and remain to be elucidated. As indicated above, I am planning to test the effects of 
Norbin-deficiency on Ras, which is an upstream key regulator of Erk. In addition to the 
pathways I have already tested, one could also test Ca2+ signalling, as Norbin is known to 
regulate GPCR-dependent intracellular Ca2+ transients upon overexpression in HEK293 cells 
(Francke et al., 2006; H. Wang et al., 2009; Ward et al., 2009). One could load Norbin-
deficient and control neutrophils with Fluo-4 prior to stimulation with fMLP to monitor Ca2+ 
fluxes by imaging, and use titration curves of the Ca2+ inhibitor BAPTA-AM to determine 
differences in sensitivity between genotypes. 
In would be interesting to investigate whether the elevated GPCR-stimulated Rac and 
Erk activities in Norbin-deficient neutrophils are required for the increased cell responses of 
Norbin-deficient cells. One could use titration curves with Rac inhibitors such as NSC23766 
and EHT1864, and with Erk inhibitors such as SCH772984 and BVD-523, during fMLP-
stimulated ROS assays in Norbin-deficient and control neutrophils. ROS assays would provide 
a sufficiently sensitive read-out for this purpose. Rac inhibitors have limited specificity but 
should be adequate for reporting differences in sensitivity between the genotypes.  
Role of Norbin in neutrophil GPCR trafficking 
The literature has shown that Norbin can regulate the steady-state surface levels of GPCRs. 
For example, co-expression of metabotropic glutamine receptor-5 (mGluR5) with Norbin in 
neuronal N2a cells led to constitutively increased levels of the receptor on the neuronal 
surface, whereas downregulation of Norbin in primary cortical neurons reduced mGluR5 
levels on the cell surface. The same paper also showed less mGluR5 on the cell surface in 
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primary cortical neurons of mice with conditional deletion of Norbin in the forebrain (H. 
Wang et al., 2009). Similarly, co-expression of Norbin with melanin-concentrating hormone 
receptor-1 (MCHR1) in HEK293 cells was shown to inhibit Gαi/o and Gαq dependent Ca
2+ 
signalling, but increased the steady-state cell surface levels of the receptor, without affecting 
the MCH stimulation-dependent internalisation of the receptor (Francke et al., 2006), 
although a more recent paper by the same laboratory reported normal levels of the MCHR1 
in HEK293 with inducible overexpression of Norbin (Ward et al., 2009). The mechanisms 
through which Norbin regulates this steady-state surface expression of GPCRs has not yet 
been elucidated.  
In addition, as described above, I saw constitutive degranulation in Norbin-deficient 
neutrophils. This is relevant because several types of neutrophil GPCRs, including the fMLP 
receptor FPR1 and the C5a receptor C5aR1, are stored on the membrane of granules and 
upregulated onto the neutrophil surface when granules fuse with the plasma membrane 
(Monari et al., 2002; Rorvig et al., 2013; Sengelov, 1995). In view of this literature, combined 
with the increased GPCR signalling that I found in Norbin-deficient neutrophils, I decided to 
investigate the levels of GPCRs on the neutrophil surface under several different conditions. I 
compared cells that were either kept ice-cold throughout to prevent receptor trafficking, or 
were mock-primed or primed at 37°C, conditions which allow degranulation as well as 
normal receptor trafficking by endo- and exocytosis to occur.  
Indeed, I found an increase of the GPCR C5R1 at the cell surface in the Ncdn‒/‒ cells 
that had been mock-primed or primed with TNF and GM-CSF, but not in cells that were 
kept on ice. These results showed that, under conditions where receptor trafficking can 
occur, Norbin expression limits the cell surface levels of this GPCR. This increased surface 
level of C5aR1 could explain, in part, why GPCR signalling was increased in Norbin-deficient 
cells. In contrast to this Norbin-dependent steady-state transport of the C5aR1 to/from the 
plasma membrane, the agonist-induced internalisation of the receptor in response to 
neutrophil stimulation with C5a was unaffected by the Norbin deficiency. It is also 
interesting that priming of neutrophils with TNF and GM-CSF increased the level of C5aR1 
both in Ncdn‒/‒ and Ncdnfl/fl cells further, so that primed Ncdn‒/‒ neutrophils had the highest 
surface levels of C5aR1. This result suggests that the constitutive degranulation of gelatinase 
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granules observed in Ncdn‒/‒ neutrophils cannot be the only mechanism underlying the 
increased GPCR level on the neutrophil surface, because priming overcame the Norbin 
deficiency-dependent increase in degranulation. Therefore, it seems likely that, once GPCRs 
are delivered onto the neutrophil surface, Norbin expression promotes their re-
internalisation, and that this step is blocked by the Norbin deficiency. 
Relevant to my findings, Dr Martin Baker, a former PhD student in the laboratory, 
demonstrated that Prex1 also controls GPCR trafficking (Martin Baker, PhD Thesis University 
of Cambridge, 2015, unpublished data). He showed that Prex1 deficiency reduces the level 
of C5aR1 on the surface of neutrophils, but only upon stimulation with C5a. Inversely, he 
showed that overexpression of Prex1 in HEK293 cells blocks the internalisation of the GPCR 
S1PR1 upon stimulation with the agonist S1P, by regulating the agonist-stimulated 
phosphorylation of the GPCR. Therefore, although it might appear that Prex1 and Norbin 
have opposing roles in GPCR trafficking, this is not actually the case, because Norbin controls 
constitutive GPCR trafficking whereas Prex1 regulates the agonist-induced internalisation of 
GPCRs. Interestingly, however, I found that the upregulation of C5aR1 in mock-primed 
Norbin-deficient neutrophils was Prex1 dependent, because cell surface levels of the 
receptor were normal in Ncdn‒/‒ Prex‒/‒ cells. We showed previously that P-Rex1 is 
dispensable for the secretion of azurophil granules (Welch et al., 2005). However, it is 
unknown if P-Rex1 is involved the degranulation of gelatinase and/or specific granules. If so, 
then Norbin/ Prex deficiency would reduce both the delivery of GPCRs to the neutrophil 
surface by degranulation (Norbin- and Prex-dependent) and the constitutive re-
internalisation of GPCRs (Norbin-dependent). Degranulation assays with Prex-deficient, and 
Norbin/Prex-deficient cells could test this hypothesis. 
According to the literature, primary sequence cannot predict which GPCRs Norbin 
can bind and which not. Therefore, to further investigate which types of neutrophil 
receptors are controlled by Norbin, we used a candidate approach, looking at CXCR1, CXCR2 
and CXCR4 surface levels, as these are important neutrophil GPCRs, in addition to C5aR1, 




In these experiments, I found an increase of CXCR4 on the cell surface in Ncdn‒/‒ cells 
that had been kept either basal (on ice) or primed with TNF and GM-CSF. Hence, as 
previously seen with C5aR1, Norbin-deficiency led to increased levels of this GPCR on the 
neutrophil surface. Nevertheless, unlike with C5aR1, the upregulation of CXCR4 occurred 
even under conditions that minimised receptor trafficking, which suggested that either 
CXCR4 is stored on a more readily mobilised type of vesicles than C5aR1, or the total cellular 
levels of CXCR4 might be elevated in Ncdn‒/‒ cells. I am planning to verify the latter 
hypothesis by blotting total lysates from Ncdn‒/‒ neutrophils with CXCR4 antibody. 
Unlike either C5aR1 or CXCR4, the surface levels of CXCR1 and CXCR2 were 
unaffected by the Norbin deficiency. This was perhaps unsurprising, because these two 
GPCRs are known not to be stored on granules, but to be constitutively localised on the 
plasma membrane (Murphy, 1997). In consequence, CXCR1 was not upregulated during 
neutrophil priming, and CXCR2 surface levels in fact dropped dramatically in response to 
priming, as expected, because this receptor is shed by proteolysis under inflammatory 
conditions (Asagoe, Yamamoto, Takahashi, Suzuki, et al., 1998). Furthermore, these 
particular GPCRs may also not be affected by the Noribin deficiency because Norbin cannot 
physically interact with them. This remains to be investigated. 
Finally, in order to assess whether the role of Norbin in receptor trafficking is 
restricted to GPCRs or also seen with other classes of receptors, I tested Mac-1 levels on the 
neutrophil surface. Both in basal Ncdn‒/‒ cells (on ice) and in cells primed with TNF and 
GM-CSF, Mac-1 surface levels were normal. These data are complemented by further data 
from Dr Pan, who observed that Norbin-deficient neutrophils had normal surface levels of 
several other types of receptors and adhesion molecules, including L-selectin, PSGL-1, and 
the 2-integrin LFA-1, both in the basal and primed state. The finding that Mac-1 levels, in 
particular, were normal was surprising, considering that Mac-1 is stored on overlapping 
granule subtypes to C5aR1. This suggests again that the delivery of GPCRs to the neutrophil 
surface by degranulation is only one of the roles of Norbin in trafficking. The other is to 
specifically regulate the re-internalisation of GPCRs that it can directly interact with, and this 
step would not apply to integrins. The finding that both LFA-1 and Mac-1 surface levels were 
normal was also surprising considering the increase of neutrophil adhesion observed in 
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Norbin-deficient cells in vitro. However, this does not exclude the possibility that Norbin 
deficiency might increase the activity of 2-integrins on the neutrophil surface, as discussed 
above in the section on blocking antibodies. Overall, based on these results on neutrophil 
receptor levels, we can conclude that the effects of Norbin deficiency on receptor trafficking 
show some degree of specificity for certain types of GPCRs (Figure 7.2). 
 
It seems likely that other neutrophil GPCRs could be affected by Norbin, in addition 
to the ones I already investigated. To test this, one could identify other GPCRs controlled by 
Norbin in an unbiased manner using biotinylation of neutrophil surface proteins, isolation of 
these biotinylated proteins from lysates of Norbin-deficient and control neutrophils using 
streptavidin, and identification by mass spectrometry. The literature shows that Norbin only 
affects the trafficking of those GPCRs that it can bind to directly, suggesting a direct 
mechanism (Francke et al., 2006; H. Wang et al., 2009). Moreover, from the literature and 
my data combined, it appears that Norbin can both up- or downregulate the cell surface 
levels of GPCRs. Therefore, to assess how Norbin controls GPCR levels on the neutrophil 
surface (delivery, retention or internalisation), one could biotinylate proteins on the surface 
of Norbin-deficient and control neutrophils using pulse-chase labelling, combined with cell 
fractionation (Clemmensen, Udby, & Borregaard, 2014) into plasma membrane, endosome 
and granule fractions, and analysis of the fractions by western blotting and mass 
spectrometry. 
 
Figure 7.2: Summary of surface receptor levels in Ncdn
‒/‒
 deficient neutrophils 
162 
 
Role of Norbin in neutrophil recruitment  
As discussed so far, I discovered that Norbin-deficiency increases antibacterial responses of 
isolated neutrophils, and that its effects on neutrophil responses might be explained by 
altered GPCR surface levels and by increased Rac/Erk pathway activities. To explore the 
functional role of myeloid Norbin and the Norbin/P-Rex1 interaction in vivo, I studied the 
recruitment of leukocytes to sites of inflammation, and I tested antibacterial immunity. For 
this aim, I used two different inflammation animal models, thioglycollate (TGC)-induced 
sterile peritonitis and S. pneumoniae-induced pulmonary infection. 
I compared in parallel, mock-treated and TGC-treated mice from different mouse 
strains and analysed all experiments both by cytospin microscopy and by flow cytometry. 
Taken together, both methods revealed a neutrophil recruitment defect during aseptic 
peritonitis when Prex1 was deleted, as expected (Welch et al., 2005). In contrast, Norbin 
deficiency seemed to increase neutrophil recruitment slightly, but this reached statistical 
significance only compared to the Ncdnfl/fl control strain but not the LysMCre control strain. 
As there was a slight but not significant difference in neutrophil recruitment between the 
two different control strains, and as neutrophil numbers in the LysMCre strain were similar to 
that of Ncdn‒/‒ mice, we concluded that myeloid Norbin deficiency overall did not alter 
neutrophil recruitment. Interestingly, Ncdn‒/‒ Prex‒/‒ mice had as little neutrophil 
recruitment as Prex–/– mice, and less than Ncdn–/– mice, which implied that Prex1 is required 
for neutrophil recruitment in vivo regardless of whether Norbin is expressed or not.  
TGC-induced peritonitis is a model of sterile inflammation. As there was no effect of 
Norbin deficiency on neutrophil recruitment in this model, it is difficult to speculate whether 
Norbin has a role in sterile inflammatory conditions. One could test the levels of 
inflammatory cytokines in this model to investigate further, or test Norbin-deficient mice in 
other models of sterile inflammation. If the presence of Norbin suppresses these types of 
inflammation as it suppresses anti-bacterial immunity, one would assume that inflammation 
is increased when Norbin is deleted, potentially causing auto-immunity like phenotypes. 
The absence of any significant effect on neutrophil recruitment observed in Norbin 
deficient mice during sterile peritonitis is inconsistent with the constitutive increase in 
adhesion I observed in isolated Norbin-deficient neutrophils. As there were increased 
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surface level of GPCRs in Norbin-deficient neutrophils, we could have expected more 
integrin to be activated by GPCR signalling, with consequently increased neutrophil adhesion 
and more neutrophils adhering to the blood vessel wall and able to migrate to the site of 
inflammation. It is possible that more Ncdn‒/‒ cells adhered on the vessel side, prior to 
transmigrating, or that they are adhered more firmly on the peritoneal wall and could 
therefore not be lavaged out. This could be addressed by histological analysis of the 
peritoneal wall vasculature. However, the data in the lung homogenate of S. pneumoniae 
infected mice (see below) would argue against that option, as they suggested normal 
neutrophil numbers in the whole perfused lung tissue. 
Role of Norbin in S. pneumoniae infection 
To investigate the capacity of Norbin-deficient mice to kill bacteria in vivo, and to further 
investigate neutrophil recruitment, I adapted a protocol of S. pneumoniae-induced acute 
lung inflammation from our Lymphocyte Signalling programme. My time course study 
revealed that neutrophils appeared in the lung as early at 3 h after inoculation with S. 
pneumoniae. The number of the neutrophils recruited in response to bacterial infection 
peaked at the 18 h time point and remained high at 24 h. In contrast to this acute neutrophil 
recruitment, the number of monocytes/macrophages in the BAL remained even throughout 
the time course. Moreover, as expected from other studies (Fillion et al., 2001), 
inflammatory monocytes and eosinophils remained essentially absent in the BAL over the 
duration of the experiment. However, increased numbers of monocytes/macrophages were 
seen in the lung homogenate of S. pneumoniae infected mice from 6 h after the infection 
onwards, and increased more at the end of the time course. Flow cytometric analysis 
identified these newly infiltrated cells as inflammatory monocytes. Regarding bacterial 
survival, colony forming units (CFUs) were still markedly elevated at the two earliest time 
point tested, 3 h and 6 h after inoculation, both in the BAL and lung homogenate whereas 
the bacterial titre in the BAL declined sharply at the 18 h time point and dropped even 
further at the final 24 h time point, almost back to control levels. In contrast, in the lung 
homogenate, bacterial numbers remained high at 18 h, before falling at the 24 h time point. 
Hence, bacteria were cleared from the airspace more rapidly than from the perfused lung 
tissue, presumably because they could survive in hard to reach niches within the lung tissue. 
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Compared to the titre of bacteria used for infection (2 x 106 CFU/mouse), even at the 
earliest time points tested (3 h and 6 h), less than 40% of bacterial CFU were recovered from 
the BAL. Therefore, either the lavages were inefficient, and only a subset of live bacteria 
were lavaged out of the airspace, or bacteria had already been killed at these early time 
points. The latter seems likely, considering that neutrophil recruitment was already 
significant after 3 h. To test the efficacy of lavages, one could infect the mice and then lavage 
them after a much shorter time, long enough for bacteria to disperse in the airspace but not 
to be killed. I chose 6 h and 18 h time point for subsequent experiments because this time 
window was the most interesting regarding the clearance of S. pneumoniae and the 
presence of leukocytes.  
To our surprise, the results showed that Norbin deficiency improved immunity 
against pulmonary infection with S. pneumoniae. Indeed, at the 6 h time point, Norbin-
deficient mice had a 12-16 fold increased capacity to kill bacteria compared to the two 
control strains, and at the 18 h time point, they still had a 3.5-4 fold increased capacity to kill 
bacteria in the perfused lung homogenate. Hence, Norbin-deficient mice were able to clear 
bacteria from the airspace faster than the two control strains, and this increased immunity 
of Ncdn–/– mice persisted at later time points. Therefore, Ncdn–/– mice were able to clear 
bacteria more efficiently than the two control strains both from the airspace and from 
perfused lung tissue. 
Both At the 18 h time point, when most mouse strains were able to clear the 
infection from the airspace, Prex–/– mice still had a significant level of live bacteria in their 
BAL, a 24-fold increase compared to Prex+/+ controls, showing that they were immune-
deficient, which was not unexpected but had never been demonstrated before in vivo. 
Interestingly, Ncdn‒/‒ Prex‒/‒ mice had almost the same level of immunity as Prex+/+ control 
mice, with 18-fold fewer live bacteria surviving in their BAL than in the immune-deficient 
Prex–/– mice, showing that that the additional deletion of Norbin could overcome this 
immune-deficiency.  
In parallel, I was interested to understand whether Norbin deficiency protects from 
bacterial infection through increased neutrophil recruitment. Although neutrophil 
recruitment was normal in Norbin-deficient mice in the aseptic peritonitis, this had to also 
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be assessed in the pneumonia model, as neutrophil recruitment to different organs is 
controlled by different adhesion molecules and adhesion signalling pathways (Baker et al., 
2016). However, Ncdn‒/‒ infected mice showed no detectable difference in neutrophil 
recruitment upon infection with S. pneumoniae compared to Ncdnfl/fl and LysMCre control 
mice. Therefore, just like in the aseptic peritonitis, Norbin was dispensable for neutrophil 
recruitment into the infected lung. Likewise, a lack of defect in neutrophil recruitment was 
seen also between Prex+/+ and Prex–/– mice. This demonstrates that P-Rex1 is not required 
for neutrophil recruitment into the infected lung, unlike in aseptic peritonitis. This was 
perhaps unsurprising, as different GEFs are required for recruitment to different organs, and 
our laboratory has shown previously that P-Rex1 and Vav family Rac-GEFs cooperate in 
neutrophil recruitment to the inflamed lung (Pan et al., 2015). Interestingly, Ncdn‒/‒ Prex‒/‒ 
mice had a small, but significant decrease in the number of neutrophils in the BAL compared 
to the Prex+/+ and Prex–/– mice, suggesting that combined Norbin/Prex-deficiency might 
cause a slight decrease in recruitment. However, the Prex+/+ control strain showed slightly 
more recruitment than the Ncdnfl/fl and LysMCre control strains in parallel experiments. 
Hence, this result should be interpreted with caution, and more experimental evidence 
would be required to investigate thie potential decrease in neutrophil recruitment of Ncdn‒/‒ 
Prex‒/‒ mice. Overall, therefore, neutrophil recruitment was normal in Ncdn‒/‒ and Ncdn‒/‒ 
Prex‒/‒ mice, meaning that the improved immunity of these mice did not result from 
increased neutrophil recruitment. In addition, there was no effect of Norbin deficiency on 
the numbers of monocytes or resident macrophages in the infected lung under any of the 
conditions tested. 
Taken together, the pulmonary S. pneumoniae infection model showed that Norbin 
deficiency increases the ability of mice to clear bacterial infection around 10-fold, without 
affecting the recruitment of neutrophils or monocytes, or the numbers of resident 
macrophages. 
Role of Norbin in neutrophil-mediated bacterial killing in vivo 
The fact that neutrophil recruitment was normal during pulmonary infection despite the 
increased clearance of bacteria in Norbin-deficient mice suggested that, either neutrophils 
killed bacteria more efficiently, or the immune-protective phenotype derived from other cell 
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types. As mentioned in the introduction to Chapter 6, the literature is controversial as to 
how important neutrophils are in this particular type of infection. Indeed, macrophage 
depletion assays have shown that resident alveolar macrophages are required for the 
resolution of S. pneumoniae infections (Dockrell et al., 2003; Herbold et al., 2010), and that 
the importance of neutrophils depends on the titre of the inoculum and on the age of the 
animal (Dockrell et al., 2003; Garvy & Harmsen, 1996). To evaluate whether the increased 
immunity of Norbin-deficient mice resulted from neutrophils, I performed antibody-
mediated neutrophil depletion prior to infecting the mice with S. pneumoniae. 
Acute treatment with 1A8-antibody was efficient in depleting neutrophils, achieving 
a level of depletion of around 85%, both in Ncdnfl/fl and Ncdn‒/‒ mice, and both in the 
peripheral blood and in the BAL upon S. pneumoniae infection, without altering the numbers 
of alveolar macrophages. However, this level of neutrophil depletion did not affect the 
ability of Ncdnfl/fl control mice to kill bacteria during S. pneumoniae infection. This result 
confirmed the current consensus that neutrophils are not essential in this infection, at least 
in immune-competent adult mice, and that macrophages play a more central role in clearing 
S. pneumoniae. Surprisingly, however, when neutrophils were depleted in Ncdn‒/‒ mice, 
these mice lost completely the 10-fold advantage they had in killing the pathogen compared 
to Ncdnfl/fl controls. Therefore, this result showed that neutrophils in Ncdn‒/‒ mice have a 
more important role in clearing S. pneumoniae than they have under normal circumstances. 
The increased immunity of Norbin and Norbin/Prex1-deficient mice, in the absence 
of increased neutrophil recruitment, together with the increased responses of isolated 
Norbin- and Norbin/Prex1-deficient neutrophils, suggest that the immune-protection is 
afforded by enhanced neutrophil function in vivo. To examine this, one could test ROS 
production, degranulation (elastase release), and NET formation in the lungs of Norbin-
deficient and control mice infected with S. pneumoniae. It would be also interesting to 
measure the levels of inflammatory cytokines and chemokines (TNF, IL6, KC) during S. 
pneumoniae infections in BAL and plasma by ELISA, to determine if myeloid Norbin 
deficiency increases these systemically, although this seems unlikely, as neutrophil 
recruitment into the lung was normal. 
 167 
 
The literature shows that ROS production by the NADPH oxidase is not required for 
the killing of S. pneumoniae in vivo, and that killing is rather dependent on the secretion of 
the neutrophil serine proteases cathepsin G and elastase (Hahn et al., 2011; Standish & 
Weiser, 2009). For example, mice with a deletion of the catalytic gp91phox subunit of the 
NADHP oxidase show no defect in the killing of S. pneumoniae (Marriott et al., 2008). In that 
study, the loss of ROS was shown to increase neutrophil recruitment, which was most likely 
a consequence of reduced neutrophil apoptosis, and therefore longer survival of neutrophils 
in the lung in the absence of ROS production. This resulted in increased cytokine production, 
MPO release and survival of the mice in pneumococcal pneumonia (Marriott et al., 2008). In 
order to test whether the increased ability of Norbin-deficient mice to kill S. pneumoniae 
derives from their increased ROS production, it may be possible to treat them with ROS 
inhibitors in vivo, or perhaps to cross them with gp91phox‒/‒ mice. In any event, I did also 
observe constitutive degranulation of gelatinase granules in Norbin-deficient mice, and it is 
possible that other granules subtypes are also affected. Measurement of MPO and elastase 
release in addition to inhibition of ROS would address the relative importance of these two 
responses. In addition, it would be interesting to measure the occurrence of NETs and the 
level of neutrophil apoptosis in the infected lung of Norbin-deficient mice. 
As Norbin is expressed in macrophages as well as neutrophils, and as it is also deleted 
by the LysM-directed Cre recombinase in our Ncdn‒/‒ mice, it would also be interesting to 
investigate if macrophages and monocytes contribute to the increased resolution of S. 
pneumoniae infection in these mice, together with neutrophils. In order to address this, one 
could deplete macrophages using clodronate liposomes (Weisser, van Rooijen, & Sly, 2012), 
prior to S. pneumoniae infection, in a similar manner to the neutrophil depletion 
experiments I performed. If Norbin was also important in macrophages, one could also 
investigate its role in macrophages in vitro. Macrophage precursors can be isolated from 
mouse bone marrow, differentiated in vitro, and assayed for principal responses such as 
phagocytosis of apoptotic neutrophils, ROS production and bacterial killing. 
Final conclusion and future directions 
The results of my PhD project demonstrated for the first time that neutrophils from Norbin-
deficient mice have increased adhesion, spreading, ROS production, degranulation and 
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bactericidal capacity in vitro, that Norbin-deficient mice have a 10-fold better antibacterial 
immunity against pneumococcal infection than control mice, and that this increased 
immunity derives from neutrophils. Hence, Norbin is an important regulator of neutrophil 
functions and acts as an immune suppressor. Furthermore, Norbin/Prex-deficient mice 
showed that only a subset of Norbin-dependent neutrophil responses require Prex1. Norbin 
is more important for neutrophil function than we had anticipated, and overall has a 
stronger impact than Prex. We hypothesise that Norbin regulates neutrophil responses by a 
combination of two major mechanisms, the control of GPCR trafficking and the control of 
GPCR signalling through Rac and Erk (Figure 7.3). These mechanisms will need to be explored 
by future work as outlined here above.  
Seeing how important myeloid Norbin is for antibacterial innate immunity, it seems 
possible that deregulation of myeloid Norbin may play a causal role in human immune-
deficiencies or inflammatory disease. It would be very interesting to investigate this 
possibility in the future, by assessing Norbin expression levels during inflammatory disease 
and infection both in mouse and human. Using mouse models of inflammation (for example 
aseptic peritonitis and S. pneumoniae-induced lung infection), one could isolate neutrophils 
and monocytes from the inflamed tissues and western blot lysates for Norbin levels. 
Similarly, Norbin levels could be investigated in sputum or blood samples of human patients 
with inflammatory or infectious diseases of the lung, such as ARDS and COPD. To further 
evaluate Norbin expression in human inflammatory and immune diseases, a bioinformatic 
analysis of disease databases could be performed. If such investigations find that Norbin is 
indeed deregulated in human inflammatory or immune-conditions, then the Norbin pathway 
could become interesting for pharmaceutical and biotechnology companies, who might 
benefit from our project in the future. By characterising a novel pathway that could be a 
therapeutic target in inflammatory and immune disorders, we would inform their strategies 
for developing anti-inflammatory drugs or drugs that improve the immune response. 
Moreover, the molecular mechanisms controlled by myeloid Norbin are unlikely to be 
disease-specific, so their exploitation could have wider applications. Finally, it seems 
unfeasible to inhibit Norbin directly, as it is an intracellular adaptor protein that works 
through protein/protein interaction. However, it seems feasible to exploit the effects of 
Norbin on cell surface GPCR levels. If specific GPCRs could be identified in diseases with 
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deregulation of Norbin, then drugs could be developed against these GPCRs. Half of the 







Figure 7.3: Working model  
In control neutrophils, GPCRs are stored on the membrane of granules. Secretion of these granules upon 
neutrophil activation upregulates the GPCRs to the neutrophil plasma membrane. When GPCRs become 
activated, Norbin permits signalling through Prex1 to Rac2, but it blocks GPCR signalling through other GEFs. 
To which extent Norbin affects Prex1 activity or Prex1 localisation in neutrophils remains to be tested. 
Norbin-deficient neutrophils show constitutive degranulation and upregulation of GPCRs on the neutrophil 
surface. In addition, Norbin-deficiency likely results in GPCRs being selectively retained at the cell surface, as 
the surface levels of other receptor types (e.g. Mac-1) are normal. The increased GPCR surface levels allow 
for more GPCR signalling. In the absence of Norbin, Prex1 can still activate Rac2 in response to the 
stimulation of GPCRs, but the block on other GEFs is removed, so Rac1 is more active. Preliminary data 
suggest that one of the GEFs inhibited by Norbin is Vav1. Erk is also more active in Norbin-deficient cells, 
suggesting that the Norbin may regulate Ras-GEFs and Ras activity as well as the Rac pathway, which also 
remains to be explored. 
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(A) Norbin is expressed in neutrophils. Total lysates of bone marrow cells, macrophages and neutrophils 
isolated from adult wild-type mice (100 µg tissue per lane) were western blotted for Norbin expression using 
Norbin C1 antibody and protein loading assessed by coomassie staining. 
(B) Norbin is deleted in myeloid cells. Mature neutrophils and monocyte/macrophages were isolated from 
peritoneal exudates of Ncdn
fl/fl
 (floxed Norbin), LysM
Cre
 (myeloid Cre) and Ncdn
–/–
 (myeloid Norbin KO) mice 
before and after LPS stimulation (Sigma, 25 µg.kg
-1
, prepared in sterile saline to a final volume of 200 µL) for 
4 h. Total cell lysates were subjected to Western blotting with Norbin C1 antibody and equal protein loading 




 lysates showed a 79 kDa 
band that was efficiently deleted from Ncdn
–/–
 lysates. Previous PhD student, Dr Dingxin Pan, generated the 











Supplementary Figure 2: Norbin-deficient neutrophils have normal cell surface levels of integrins 






 mice were primed with 20 ng.mL
-1
 murine TNFα and 40 
ng.mL
-1
 GM-CSF for 45 min at 37°C, or left on ice (basal), before being transferred onto ice and stained to 
investigate the level of L-selectin, PSGL-1 and LFA-1 integrins on the neutrophil surface by flow cytometry. 
Neutrophils were detected by their scatter characteristics and BV510-Ly6G antibody staining and the various 
integrin identified by the signal of the appropriate antibody staining. All conditions were assessed in parallel. 
Each dot is the mean of one experiment. Data are mean ± SEM of 4-8 independent experiments. Statistical 
significance was assessed using two-way Anova with Sidak’s multiple comparisons test. Previous PhD 
student, Dr Dingxin Pan, generated the data from this figure. 
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